new iqvia holdings inc.d18rn0p25nwr6d.cloudfront.net/cik-0001478242/b281c364-3... · 2020. 2....

Table of Contents

UNITED STATESSECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14AProxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No. 1)

Filed by the Registrant ☒Filed by a Party other than the Registrant ☐

Check the appropriate box:☐ Preliminary Proxy Statement☐ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2))☒ Definitive Proxy Statement☐ Definitive Additional Materials☐ Soliciting Material Pursuant to §240.14a-12

IQVIA HOLDINGS INC.(Name of Registrant as Specified In Its Charter)

N/A(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒ No fee required.

☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. 1) Title of each class of securities to which transaction applies:

2) Aggregate number of securities to which transaction applies:

3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on

which the filing fee is calculated and state how it was determined):

4) Proposed maximum aggregate value of transaction:

5) Total fee paid:

☐ Fee paid previously with preliminary materials.

☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. 1) Amount Previously Paid:

2) Form, Schedule or Registration Statement No.:

3) Filing Party:

4) Date Filed:

Table of Contents

Table of Contents

February18,2020

IQVIAHOLDINGSINC.83WoosterHeightsRoadDanbury,CT06810

DearStockholder:Youarecordiallyinvitedtoattendthe2020AnnualMeetingofStockholdersofIQVIAHoldingsInc.onMonday,April6,2020,at9:00amE.D.T.attheEthanAllenHotel,21LakeAvenueExtension,Danbury,Connecticut.TheNoticeof2020AnnualMeetingofStockholdersandtheProxyStatementaccompanyingthisletterdescribethebusinesstobeconductedatthemeetingandprovidefurtherinformationaboutIQVIA.

AtIQVIA,weremainkeenlyfocusedonexecutingourstrategytoadvancehealthcaretreatmentthroughleveragingunparalleledinformation,analytics,technologyandknowledgeassets.Everystepwetakeinthisjourneybringsusclosertoourstrategicpurposeofimprovingpatientoutcomes.Inthefinalyearofourthree-yearmergerintegrationprogram,IQVIAdeliveredstrongoperationalandfinancialperformance,aswellasattractivereturnstoyou,ourshareholders.

2019exceededexpectations.Reportedrevenuegrewto$11.1billion,representing8.0percentyear-over-yearconstantcurrencygrowth.OurTechnologyandAnalyticsSolutionsandResearchandDevelopmentSolutionssegmentscontributedsignificantlytoourresults,delivering10.7percentand6.9percentgrowth,respectively.AdjustedDilutedEarningsperShareof$6.39,increased15.1percent.

Thesestrongresultsweredrivenbynumerousoperationalachievementsacrossourorganization.

• OurTechnologySolutionsbusinesshadapivotalyear,withOrchestratedCustomerEngagement(OCE)gainingsignificanttraction,earningdeservedcredibilityinthemarket.Wewon50newOCEdealsin2019,comparedto30in2018,thefirstfullyearpost-launch.Todate,wehavefourtop-15pharmaceuticalclientswhohavemadethedecisiontoadoptoursuperiorplatform.

• InRealWorld,wecontinuedtobuildonourpositionasthemarketthoughtleader,drivinginnovationssuchastheuseofrealworldcomparatorarmstoeliminatetheneedforaplacebogroup.Theteamcontinuestoinvestinourrichclinicaldataassets,whichnowstandsat800millionnon-identifiedpatientsglobally.

• TheResearchandDevelopmentSolutionsteamwonbusinesswithover250newclientsduringtheyear.Importantly,weformedtwopreferredprovideragreementswithtop15pharmaceuticalclients.Our“seemore,winmore”strategyisworking.Weareclearlyseeingmoreandwinningmoretrialsassponsorscometorealizethebenefitofourhighlydifferentiatedcapabilities.OurResearchandDevelopmentSolutionsbacklogatDecember31,2019reachedarecord$19billion.

• ContractSalesandMedicalSolutionscontinueditsturnaroundin2019.Anewregionalizedgo-to-marketapproach,combinedwithadifferentiatedoffering,drovenewwinsinthemarketandreturnedthisbusinesstogrowth.

• WewerenamedtoFORTUNE’slistofWorld’sMostAdmiredCompanies,recognizedasoneofAmerica’sBestEmployersforWomenbyForbes,awardedBestContractResearchOrganizationFull-serviceProviderbyScripAwards,andselectedastheleaderinRealWorldDataandRealWorldEvidenceServicesina2019LifeScienceStrategyGroupreport.

Wemaintainastrongbalancesheet,flexiblecapitalstructureandattractivefreecashflowprofilethatenablesinvestmentstofurtherdriveinnovationandthecontinuedreturnofcashtoshareholders.During2019,wecompletedanumberoftuck-inacquisitionstofurtherexpandourtechnologyplatformandinvestedafurther$582millionininternaldevelopment,mainlyinsoftwaredevelopmentandourtechnologyinfrastructure.Wealsoreturned$945milliontoshareholdersthroughtherepurchaseof6.6millionshares.

Ourcompanyremainsuniquelypositionedtoaddresssomeofhealthcare’smostcomplexchallenges.Wewillcontinuetoinvestandinnovatetoadvancepatientoutcomesanddelivervaluetoourshareholders.

AriBousbibChairmanandChiefExecutiveOfficer

Table of Contents

IQVIA2020PROXYSTATEMENT Noticeof2020AnnualMeetingofStockholders

2020ANNUALMEETINGINFORMATION

TimeandDate:9:00a.m.E.D.T.,Monday,April6,2020

Place:EthanAllenHotel21LakeAvenueExtensionDanbury,Connecticut

RecordDate:February12,2020

ImportantNoticeRegardingtheAvailabilityofProxyMaterialsforthe2020AnnualMeetingofStockholderstoBeHeldApril6,2020:

OurNoticeofMeeting,ProxyStatement,FormofProxyCardand2019AnnualReportareavailableat:https://materials.proxyvote.com/46266C

YOURVOTEISIMPORTANT

Tomakesureyoursharesarerepresented,pleasecastyourvoteassoonaspossibleinoneofthefollowingways:

INTERNETGotothewebsiteshownonyourproxycardandrelatedinstructions

TELEPHONEUsethetoll-freenumbershownonyourproxycardorvotinginstructionform

MailMark,signanddateyourproxycardandreturnitinthepostage-paidenvelope

AGENDA • Proposal1:ElectionofthreeClassIdirectornomineesnamedin

theaccompanyingProxyStatementforathree-yearterm

• Proposal2:Advisory(non-binding)votetoapproveexecutivecompensation(say-on-pay)

• Proposal3:RatificationofourAuditCommittee’sappointmentofPricewaterhouseCoopersLLPasourindependentregisteredpublicaccountingfirmfor2020

• Otherbusiness,ifproperlyraised

TheBoardofDirectorsrecommendsthatyouvote“FOR”eachdirectornomineeincludedinProposal1and“FOR”eachoftheotherproposals.ThefulltextoftheseproposalsissetforthintheaccompanyingProxyStatement.RegisteredstockholdersoftheCompanyatthecloseofbusinessontherecorddateareeligibletovoteatthemeeting.

Werecommendthatyoureviewtheinformationontheprocessfor,anddeadlinesapplicableto,voting,attendingthemeetingandappointingaproxyunder“Aboutthe2020AnnualMeeting”onpage90oftheProxyStatement.

ByOrderoftheBoardofDirectors,

EricM.SherbetExecutiveVicePresident,GeneralCounselandSecretary

February18,2020Danbury,Connecticut

Table of Contents

IQVIA2020PROXYSTATEMENT |i

TableofContents 1 ProxyStatementSummary

11

ProposalNo.1:ElectionofDirectors12 BoardComposition14 BoardofDirectors

21

IQVIA’sCorporateGovernance21 DocumentsEstablishingourCorporateGovernance22 CorporateGovernancePractices23 LeadershipStructure24 BoardStructure24 DirectorIndependence25 CommitteesoftheBoard29 Board’sRoleinRiskOversight29 SuccessionPlanningforDirectorsandExecutiveOfficers30 HowtoContacttheBoardanditsCommittees31 SustainabilityandCorporateCitizenship34 StockholderEngagement

36

DirectorCompensation36 Non-EmployeeDirectorCompensationProgram37 2019DirectorCompensation

39

ProposalNo2:Non-BindingVoteonExecutiveCompensation

40

CompensationDiscussionandAnalysis41 StrongPerformance43 SoundPayPractices43 CompensationPhilosophy44 OverviewofourExecutiveCompensationProgram46 ElementsofCompensation50 Retirement,PerquisitesandTerminationBenefits52 DisciplinedAssessmenttoDeterminePay52 2019NamedExecutiveOfficers52 2019CompensationDeterminations52 2019AmendmenttoChiefExecutiveOfficer’sEmploymentAgreement53 2019BaseSalary53 2019Short-TermIncentiveAwards61 2019Long-TermIncentiveAwards62 Perquisites63 PayisAlignedwithPerformance64 RigorousAccountability,Risk-MitigationandRecoveryProvisions65 RiskAssessment65 TaxDeductibility

66

CompensationCommitteeReport

67

CompensationofNamedExecutiveOfficers67 2019SummaryCompensationTable68 2019AllOtherCompensation69 2019GrantsofPlan-BasedAwards72 OutstandingEquityAwardsatFiscalYear-Endfor201974 2019OptionExercisesandStockVested75 2019PensionBenefits76 DefinedBenefitRetirementPlans77 2019Non-QualifiedDeferredCompensation78 PotentialPaymentsuponTerminationorChangeinControl81 CEOPayRatio

82

ProposalNo.3:RatificationoftheAppointmentoftheIndependentRegisteredPublicAccountingFirm

83

Audit83 AuditCommitteeReport84 FeesPaidtoIndependentRegisteredPublicAccountingFirm

85

SecurityOwnershipofCertainBeneficialOwnersandManagement

88

CertainRelationshipsandRelatedPersonTransactions

88 RelatedPartyTransactionsApprovalPolicy88 ShareholdersAgreement89 CorporateOpportunities

90

Aboutthe2020AnnualMeeting

95

OtherRelevantInformation95 CompensationCommitteeInterlocksandInsiderParticipation95 OtherMatters95

StockholderProposalsandNomineesfor2021AnnualMeetingofStockholders

96 IncorporationbyReference96 SolicitationofProxies96 ReduceMailings96 CautionaryNoteRegardingForward-LookingStatements

98

AppendixA–FinancialReconciliations

Table of Contents

IQVIA2020PROXYSTATEMENT |1

ProxyStatementSummary

ThisProxyStatementSummaryhighlightsinformationcontainedelsewhereinthisProxyStatement,whichisfirstbeingsentormadeavailabletostockholdersonoraboutFebruary18,2020.Thissummarydoesnotcontainalloftheinformationyoushouldconsider,sopleasereadtheentireProxyStatementcarefullybeforevoting.

MATTERSTOBEVOTEDUPON

Thefollowingtablesummarizestheproposalstobevoteduponatthe2020AnnualMeetingofStockholdersofIQVIAHoldingsInc.(“IQVIA”,the“Company”,“we”or“our”)tobeheldonApril6,2020(the“2020AnnualMeeting”)andvotingrecommendationsoftheBoardofDirectorsoftheCompany(the“Board”)withrespecttoeachproposal.

Proposals RequiredApproval BoardRecommendation

PageReference

ElectionofDirectors Pluralityofvotescast FOR 11

Advisoryvotetoapproveexecutivecompensation(say-on-pay) Notapplicable1 FOR 39

Ratificationofindependentauditor Majorityofvotescast FOR 82

1 Becausethisisanadvisoryvote,thereisnorequiredapproval.

COMPANYOVERVIEW

IQVIAisaleadingglobalproviderofadvancedanalytics,technologysolutionsandcontractresearchservicestothelifesciencesindustry.PoweredbytheIQVIACORE™,wedeliveruniqueandactionableinsightstohelpbiotech,medicaldevice,andpharmaceuticalcompanies,medicalresearchers,governmentagencies,payersandotherhealthcarestakeholderstapintoadeeperunderstandingofdiseases,humanbehaviorsandscientificadvances,inanefforttoadvancetheirpathtowardcures.Withapproximately67,000employees,weconductoperationsinmorethan100countries.

Wehaveoneofthelargestandmostcomprehensivecollectionsofhealthcareinformationintheworld,whichincludesmorethan800millioncomprehensive,longitudinal,non-identifiedpatientrecordsspanningsales,prescriptions,promotions,medicalclaims,electronicmedicalrecords,genomics,andsocialmedia.Westandardize,curate,structureandintegratethisdatabyapplyingoursophisticatedanalyticsandleveragingourglobaltechnologyinfrastructure.Thishelpsourclientsruntheirorganizationsmoreefficientlyandmakebetterdecisionstoimprovetheirclinical,commercialandfinancialperformance.

Weareagloballeaderinprotectingindividualpatientprivacy.Weuseawidevarietyofprivacy-enhancingtechnologiesandsafeguardstoprotectindividualprivacywhilegeneratingandanalyzinginformationonascalethathelpshealthcarestakeholdersidentifydiseasepatternsandcorrelatewiththeprecisetreatmentpathandtherapyneededforbetteroutcomes.

Table of Contents

2|ProxyStatementSummary IQVIA2020PROXYSTATEMENT

OURSTRATEGYANDPURPOSE

Webelievewearewellpositionedforcontinuedgrowthacrossthemarketsweserve.Ourstrategyforachievinggrowthincludes:

Continuingtoinnovatebyleveragingourinformation,advancedanalytics,transformativetechnologyandsignificantdomainexpertise

Buildinguponourextensiveclientrelationships

Improvingpatientoutcomesbyacceleratinghealthcarestakeholders’effortstovalueanddelivertreatmentstopatients

Expandingthepenetrationofourofferingstothebroaderhealthcaremarketplace

Expandingourportfoliothrougheffectivecapitaldeployment,includingstrategictuck-inacquisitions

Table of Contents

IQVIA2020PROXYSTATEMENT ProxyStatementSummary|3 FINANCIALHIGHLIGHTS

2019KeyFinancialMetrics

Year-over-YearGrowth

Revenue

$11.1Bn 6.5%AdjustedEBITDA1

$2.4Bn 7.9%AdjustedDilutedEPS1

$6.39

15.1%

TotalStockholderReturn

33% 2019CapitalDeployment

CashRepatriation

$1.1Bn

CashReturnedtoStockholdersviaRepurchases

$945M

InvestmentsinProductDevelopmentandTechnology

$582M

InvestmentsinAcquisitions

$588M

2019BusinessHighlights

ClinicalDevelopmentNetBook-toBillRatio

1.34x

ClinicalDevelopmentContractedBacklog

$19Bn

ClinicalDevelopmentCustomers

250+R&DSolutionscontractedbusinesswithover250newcustomers,including13ofthetop20pharmaceuticalcompaniesusingCORE-poweredsmarttrials

NewOCETechnologyCustomerWins

50Versus30in2018,thefirstfullyearsinceproductlaunch

1 Seereconciliationofnon-GAAPitemsintheAppendix

Table of Contents


MergerIntegrationHighlightsAtthetimeoftheMerger(asdefinedherein),wesetthefollowinggoals:

• Accelerateclinicaldevelopmenttohelpbringdrugstomarketfasterandmoreefficiently

• Integratelegacycompanycapabilitiesintheevolvingrealworldevidencespace

• LeveragetechnologyacrosstheorganizationtofurtherdifferentiateourcombinedofferingsWealsomadeacommitmenttoacceleraterevenuegrowthby100to200basispointsexiting2019.

Entering2019,thefinalyearofourthree-yearMergerintegrationperiod,wedeliveredonourcommitmentofacceleratedtoplinegrowth,withtotalrevenuegrowthacceleratingbyover200basispointsin2019,comparedto2018.Wealsomadesignificantprogressleveragingtechnologyacrosstheorganization.InDecember2017,theOrchestratedCustomerEngagement(“OCE”)SaaSplatformwaslaunched.OCEisadisruptivetechnologyandishighlydifferentiatedcomparedtothecurrentpointsolutionsthatexistinthemarket.ItisnotatraditionalCustomerRelationshipManagement(“CRM”)tool.BuiltonSalesforce’sForce.comandMarketingCloud,aswellasotherbest-in-classplatforms,OCEisacollaborativetoolthatutilizesartificialintelligenceandmachinelearningtointegratethevariousfunctionswithinourlifesciencesclient’scommercialoperations.AtDecember31,2019,wehad80clientsdeployingOCEglobally.InadditiontoOCE,weinvestedinmanyothertechnologies,including:

• furtherdevelopmentofE360,aprovenSaaSplatformtoaccessanddrivescalableandglobalanalyticsoncomplexRealWorldData

• thelaunchofE360Genomics

• thelaunchofvirtualtrials,alsoplatformedonSalesforce,atransformativetechnologythatbringsclinicalresearchdirectlytopatientsandultimatelyincreasestrialparticipationaswehelpclientsreachdiverseanddifficulttorecruitpatients

• clinicalandcommercialcontentmanagementtools

• regulatory,pharmacovigilanceandmanyothers

Table of Contents

IQVIA2020PROXYSTATEMENT ProxyStatementSummary|5

AtthetimeoftheMerger,wealsosetouttointegratetheoperationsofbothlegacyorganizations,committingtorun-ratecostsavingsof$200millionexiting2019,agoalthatweachievedearlierthanexpectedin2019.

MergerIntegrationPeriodCapitalDeployment

CashRepatriation

$3.4Bn

CashReturnedtoStockholdersviaRepurchases

$6.0Bn

InvestmentsinProductDevelopmentandTechnology

$1.5Bn

InvestmentsinAcquisitions

$1.9Bn

Table of Contents


HistoricalFinancialPerformance

1 Dollarvaluesinmillions2 Growthratesareatactualforeigncurrencyexchangerates3 Seereconciliationofnon-GAAPitemsintheAppendix HistoricalFinancialPerformance

TotalStockholderReturnSinceMergerAnnouncement(May3,2016toDecember31,2019)

(1) PeergroupconsistsofCernerCorporation,CharlesRiverLaboratories,Inc.,EquifaxInc.,ICONplc,IHSMarkitLtd.,LaboratoryCorporationofAmericaHoldings,NielsenN.V.,PRAHealthSciences,Inc.,SyneosHealth,Inc.,ThomsonReutersCorporationandVeriskAnalytics,Inc.

Thisperformancegraphshallnotbedeemed“filed”forpurposesofSection18oftheSecuritiesExchangeActof1934,asamended(the“ExchangeAct”)orincorporatedbyreferenceintoanyfilingofIQVIAHoldingsInc.undertheExchangeActorundertheSecuritiesActof1933,asamended(the“SecuritiesAct”),exceptasshallbeexpresslysetforthbyspecificreferenceinsuchfiling.

Table of Contents

IQVIA2020PROXYSTATEMENT ProxyStatementSummary|7 CORPORATEGOVERNANCEHIGHLIGHTS

Wehaveahistoryofstrongcorporategovernance.Webelievegoodgovernanceiscriticaltoachievinglong-termstockholdervaluecreation.Wearecommittedtogovernancepracticesandpoliciesthatservethelong-terminterestsoftheCompanyanditsstockholders.Thefollowingtablesummarizescertainhighlightsofourcorporategovernancepracticesandpolicies:

Eachshareofourcommonstockoutstandingontherecorddateisentitledtoonevotepermatterpresentedtostockholders

SecuritiesTradingPolicy,includingAnti-HedgingandAnti-Pledgingterms

RegularBoardandCommitteeExecutiveSessionsofNon-ManagementDirectors

RiskOversightbytheBoardandCommittees

Multi-YearVestingRequirementsforPerformanceShareAwards

AnnualBoardandCommitteeSelfAssessments

AlldirectorsexceptourChiefExecutiveOfficerareindependent

AuditCommitteeApprovalRequiredforRelatedPartyTransactions

ShareOwnershipGuidelinesforbothDirectorsandKeyExecutives

ComprehensiveWhistleblowerPolicyinplace

Adoptedaproxyaccessbylaw

LeadDirector,electedbytheindependentdirectors

Considerabroadrangeofdiversedirectorcandidates,includingwithrespecttogender,raceandethnicity

DirectorResignationPolicywherebydirectorsarerequiredtotendertheirresignationiftheyreceiveanumberofwithholdvotesthatisgreaterthan50%ofallvotescast

Enhancedproxystatementdisclosureonboardcomposition,stockholderengagementandsustainabilityandcorporatecitizenshipmatters,amongotherenhancements

No“PoisonPill”(StockholderRightsPlan)

NoExciseTaxGross-UpsonSeveranceorChangeinControlPaymentsorBenefits

Table of Contents

8|ProxyStatementSummary IQVIA2020PROXYSTATEMENT COMPENSATIONPRACTICES

TheLeadershipDevelopmentandCompensation(“LDC”)CommitteeoftheBoardoverseesthedesignandadministrationofourcompensationprograms.Theexecutivecompensationprogramisdesignedandadministeredinamannerthatappropriatelymanagesrisktosafeguardtheinterestsofourstockholders,aswellasouremployees.Thefollowingtablesummarizeskeyhighlightsofourcompensationpracticesthatdriveournamedexecutivecompensationprogram:

WHATWEDO

WHATWEDON’TDO

Alignexecutivepaywithperformance

Setchallengingperformanceobjectivesforournamedexecutiveofficers

Appropriatelybalanceshort-andlong-termincentives

Alignexecutivecompensationwithstockholderreturnsthroughperformance-basedlong-termincentiveawards

Usemulti-yearvestingrequirementsforlong-termawards

Implementmeaningfulshareownershipguidelines

AnnualnamedexecutiveofficerperformanceevaluationbytheLDCCommittee

Robustclawbackpolicyinplaceforourcashandequityincentivecompensationforfinancialrestatements

Includenon-solicitationandnon-competitionprovisionsinawardsagreements

Conductanannualcompensationriskreviewandassessment

Utilizeexpertiseofanindependentcompensationconsultant

Nocontractswithmulti-yearguaranteedsalaryincreasesornon-performancebonusarrangements

Noexcisetaxgross-ups

Nosingletriggerequityvesting

NorepricingofunderwaterstockoptionsorSARswithoutstockholderapproval

Nopaymentofunearneddividendspriortovesting

NohedgingorpledgingofCompanyshares

Table of Contents

IQVIA2020PROXYSTATEMENT ProxyStatementSummary|9 SAY-ON-PAY

Stockholdersshowedstrongsupportofourexecutivecompensationprograminourlast“say-on-pay”voteatour2017annualmeetingofstockholders,whichourstockholderspreviouslyapprovedtoholdeverythreeyears,withapproximately88%ofvotescastinfavoroftheproposal.SeeProposalNo.2:Non-BindingVoteonExecutiveCompensationonpage39forfurtherdetailsonthisyear’ssay-on-payvote.

2019COMPENSATIONMIX

Ourexecutivecompensationprogramisfocusedoncreatinganalignmentbetweenexecutivecompensationandbusinessperformancebyrewardingourexecutiveofficersfortheachievementofstrategicgoalsthatareintendedtocontributetolong-termstockholdervalue.Weemphasizeperformance-based,variablecompensationoverfixedcompensation.ThefollowingchartsreflectthemixofpayforourChiefExecutiveOfficer(86.8%performance-linked)andtheaverageforourotherexecutiveofficerswhoarelistedinthe“SummaryCompensationTable”belowandtheothercompensationtablesincludedinthisProxyStatement(collectively,our“namedexecutiveofficers”)asagroup(74.5%performance-linked):

ChiefExecutiveOfficer

AverageofotherNamedExecutiveOfficers

Table of Contents

10|ProxyStatementSummary IQVIA2020PROXYSTATEMENT PAY-FOR-PERFORMANCE

TheLDCCommitteebelievesthatourexecutivecompensationprogramshouldaligntheinterestsofstockholdersandmanagementbyprovidingastrongalignmentbetweenexecutivecompensationandtotalstockholderreturn.ThegraphbelowshowstherelativealignmentofourChiefExecutiveOfficer’s(includinghispredecessor’scompensationfromJanuary1,2016untiltheclosingoftheMergeronOctober3,2016)historicpayagainstperformancewithrespecttototalstockholderreturnoverthethree-yearperiodendedDecember31,2018againstapeergroupdeterminedbyoneoftheleadingproxyadvisoryfirms.Thethree-yearperiodendedDecember31,2018isthelatestperiodforwhichinformationispubliclyavailablefromthepeergroup.

OurChiefExecutiveOfficer’scompensationduringthethree-yearperiodendedDecember31,2018includedaspecialretentiongrantofrestrictedstockprovidedbytheLDCCommitteefollowingtheMergerthatvestsoverafour-yearperiod.TheLDCCommitteegrantedtheawardtoourChiefExecutiveOfficertofurtherincentivizehiscontinuedengagementandlong-termcommitmenttoourbusinessandtorecognizethatourChiefExecutiveOfficer,post-Merger,assumedresponsibilityforamuchlargerandmorecomplexorganization.Whendecidingthetermsofthisspecialretentiongrant,theLDCCommitteeconsideredthefactthatapproximately90%ofthevalueassociatedwiththeoutstandingequityawardsheldbyourChiefExecutiveOfficerasofJanuary2017wouldbefullyvestedorexercisablewithinapproximately12months,makingitmucheasierforacompetitortorecruitourChiefExecutiveOfficerandprovidinghimwithlessofafinancialincentivetostayinthefaceofapotentialhigherofferfromanothercompany.Forthethree-yearperiodendedDecember31,2018,ourperformancewithrespecttototalstockholderreturnwasinthe88thpercentileandthetotalcompensation,includingthespecialretentionequitygrant,forourChiefExecutiveOfficerwasinthe88thpercentile,whichindicatesthatourChiefExecutiveOfficer’spayandourperformancearestronglyaligned.ExcludingourChiefExecutiveOfficer’sspecialretentionequitygrantin2017,histotalcompensationwasinthe69thpercentile.

FordetailsofourChiefExecutiveOfficer’s2019compensation,see“CompensationofNamedExecutiveOfficers”.

AlignmentofHistoricCEOPayJanuary1,2016-December31,2018

IQVIA(incudes2017RetentionGrant)IQVIA(excludes2017RetentionGrant)PeerCompaniesincludeAgilentTechnologies,Inc.,AutomaticDataProcessing,Inc.,BauschHealthCompaniesInc.,CognizantTechnologySolutionsCorp.,DaVita,Inc.,DXCTechnologyCo.,IHSMarkitLtd.,LaboratoryCorpofAmericaHoldings,LeidosHoldings,Inc.,ManpowerGroup,Inc.,MylanNV,NielsenHoldingsPLC,PerrigoCo.Plc,QuestDiagnostics,Inc.,SyneosHealth,Inc.,andThermoFisherScientific,Inc.

Table of Contents


Thisyear,ClassIdirectorsCarolJ.Burt

ColleenA.GogginsRonaldA.Rittenmeyer

willstandforelectionforanewterm.

AsJonathanJ.CosletandMichaelJ.Evanisko,bothClassIdirectors,willnotstandforreelectionatthe2020AnnualMeeting,theBoarddecidedtorebalancethedirectorclasses.Asaresult,ColleenA.Goggins,whowasservingasaClassIIdirector,andCarolJ.Burt,whowasservingasaClassIIIdirector,willeachstandforelectionthisyearasaClassIdirector.Followingour2020AnnualMeeting,assumingeachdirectornomineeiselectedtoanewtermbythestockholders,theBoardwillconsistofnine(9)directors,dividedintothefollowingthreeclasses:

Class Directors Year

TermExpires

ClassI

CarolJ.BurtColleenA.GogginsRonaldA.Rittenmeyer

2023

ClassII

AriBousbibJohnM.Leonard,M.D.ToddB.Sisitsky

2021

ClassIII

JohnP.ConnaughtonJohnG.DanhaklJamesA.Fasano

2022

ConsistentwiththerequirementsofourgovernancedocumentsandupontherecommendationoftheNominatingandGovernanceCommittee,theBoardhasnominatedCarolJ.Burt,ColleenA.GogginsandRonaldA.RittenmeyerforelectionforanewtermasaClassIdirectoratthe2020AnnualMeeting.Ifelectedtoanewtermatthe2020AnnualMeeting,eachClassIdirectornomineewillbeelectedforatermofthreeyearsandserveuntilhisorhersuccessorisdulyelectedandqualifiedoruntilhisorherearlierdeath,resignation,retirement,disqualificationorremoval.

TheBoardbelievesthateachofthenomineeshasarecordofintegrity,astrongprofessionalreputationandarecordofentrepreneurialormanagerialachievement.Thespecificexperience,qualifications,attributesandskillsofeachnomineethatledtheBoardtoconcludethattheindividualshouldserveasadirectoraredescribedineachnominee’sbiographybelow.

Sharesrepresentedbyexecutedproxieswillbevoted,ifauthoritytodosoisnotwithheld,fortheelectionofthethreenomineesnamedabove.Intheeventthatanynomineeshouldbeunavailableforelectionasaresultofanunexpectedoccurrence,andtheBoarddoesnot,inthatevent,choosetoreducethesizeoftheBoard,suchshareswillbevotedfortheelectionofsuchsubstitutenomineeastheBoardmaypropose.Eachpersonnominatedforelectionhasagreedtoserveifelected,andmanagementhasnoreasontobelievethatanynomineewillbeunabletoserve.Directorsareelectedbyapluralityofthevotescastatthe2020AnnualMeeting.

THEBOARDRECOMMENDSAVOTE“FOR”THEELECTIONOFEACHNAMEDNOMINEE

ProposalNo.1:ElectionofDirectors

OurCertificateofIncorporationprovidesforaboardofdirectorsdividedintothreeclasses,designatedClassI,ClassIIandClassIII.Eachyear,adifferentclassofdirectorsiselectedatourannualmeetingofstockholdersandeachelecteddirectorholdsofficefora3-yeartermoruntilhisorhersuccessorisdulyelectedoruntilhisorherearlierdeath,resignation,retirement,disqualificationorremoval.

Table of Contents

12|ProposalNo.1 IQVIA2020PROXYSTATEMENT Thefollowingtablesetsforth,fortheClassIdirectornomineesandeachpersonwhosetermofofficeasadirectorwillcontinueinofficeafterthe2020AnnualMeeting,certaininformationaboutthem,includingtheiragesasofthedateofthisProxyStatement:

Name Age PositionHeldwiththeCompany Audit(1) N&G(2) LDC(3) Director

SinceClassIDirectorstobeelectedtotermsthatwillexpireatthe2023AnnualMeetingofStockholders CarolJ.Burt 62 Director X 2019ColleenA.Goggins 65 Director X X 2017RonaldA.Rittenmeyer 71 Director X Chair 2016ClassIIDirectorswhosetermsexpireatthe2021AnnualMeetingofStockholders AriBousbib 58 ChairmanandChiefExecutiveOfficer 2016JohnM.Leonard,M.D. 62 LeadDirector X X 2015ToddB.Sisitsky 48 Director Chair X 2016ClassIIIDirectorswhosetermsexpireatthe2022AnnualMeetingofStockholders JohnP.Connaughton 54 Director X 2008JohnG.Danhakl 63 Director X X 2016JamesA.Fasano 49 Director Chair 2016

(1) MemberoftheAuditCommitteeoftheBoard(2) MemberoftheNominatingandGovernanceCommitteeoftheBoard(3) MemberoftheLDCCommitteeoftheBoard

BOARDCOMPOSITION

DiversityandTenure.ConsistentwithourCorporateGovernanceGuidelines,theBoardseeksamixofdirectorsthatenhancesthediversityofbackgrounds,skillsandexperiencesontheBoard,includingwithrespecttoprofessionalskills,relevantindustryexpertise,specializedexperience,internationalexperience,age,gender,raceandethnicity.TheBoardbelievesthatconsideringdiversityinourBoardcompositionisconsistentwiththegoalofcreatingaBoardthatbestservestheneedsoftheCompanyandtheinterestsofitsstockholders,anditisoneofthemanyfactorsconsideredwhenidentifyingindividualsforBoardservice.

Table of Contents

IQVIA2020PROXYSTATEMENT ProposalNo.1|13 SincetheMergerin2016,andasthedirectornominationrequirementsoftheShareholdersAgreement(asdefinedherein)havefallenaway,theBoardhasbeenfocusedonrefreshingthecompositionoftheBoardinordertoensuretheappropriatemixofbackgrounds,skillsandexperiencesinlightoftheCompany’spost-MergerstrategyandtoenhancethediversityoftheBoard.SincetheMerger,twodirectorshaveretiredfromtheBoardandtwodirectors,whoarebothwomen,havejoinedtheBoard.TheBoardexpectstocontinuetoseeknewdirectorswhowillfurtherenhancethemixofexperiencesandbackgroundsofthecurrentBoard.ThefollowingstatisticshighlightthediversityofthecompositionofourBoardfollowingthe2020AnnualMeeting. Gender

AgeDistribution SignificantBoardRefreshment

* 100%ofnew

directorappointmentssincetheMergerhavebeenfemaledirectors

59

AverageAgeofDirectors48-71–AgeRange

8

NewDirectorsoverPast5Years

Qualificationsandexperienceofdirectors.Webelieveourdirectorsbringawell-roundedvarietyofexperiences,qualifications,attributesandskills,andrepresentamixofdeepknowledgeoftheCompanyandfreshperspectives.Aswereviewourlong-termstrategy,wecontinuallyassesstheskillsofourdirectorsinevaluatingwhatcurrentandfutureskillsandexperienceswillberequiredandweighthoseskillswhenevaluatingourcurrentdirectorsaswellaspotentialdirectorcandidates.Thetablebelowsummarizescertainofthekeyexperiences,qualificationsandcorecompetenciesofourdirectors. Skill1 Totalof9

SeniorLeadershipExperience 9

PublicCompanyBoardExperience 6

HealthcareIndustryExperience 9

TechnologyIndustryExperience 4

FinancialExpertise 7

GlobalExperience 8

1 Thishigh-levelsummaryisnotintendedtobeanexhaustivelistofeachofourdirectors’skillsorcontributionstotheBoard.

Table of Contents

14|ProposalNo.1 IQVIA2020PROXYSTATEMENT BOARDOFDIRECTORS

SetforthbelowisbiographicalinformationfortheClassIdirectornomineesandeachpersonwhosetermofofficeasadirectorwillcontinueafterthe2020AnnualMeeting.

ClassIDirectorforElectiontoaThree-YearTermExpiringatthe2023AnnualMeetingofStockholders

CAROLJ.BURT

DirectorSince2019

Independent

62yearsold

AuditCommittee(Member)

AuditCommitteeFinancialExpert

Experience:Burt-HilliardInvestments(2008-present)• PrincipalConsonanceCapitalPartners(2013-present)• SeniorAdvisor• Member,OperatingCouncilWellPoint,Inc.(nowAnthem,Inc.)(1997-2007)• SVPCorporateFinanceandDevelopmentChaseSecurities(nowJ.P.Morgan)(1981-1996)• ManagingDirectorandHeadoftheHealthcareGroup(1992-1996)OtherU.S.publiccompanydirectorships:• ResMedInc.(AuditCommitteeandComplianceOversightCommittee)FormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• EnvisionHealthcareCorporation• WellCareHealthPlans,Inc.Otherpositions:• Member,BoardofDirectors,WellDyneRx,LLC;GlobalMedicalResponseInc.• Member,WomenCorporateDirectors• Chair,BoardofDirectors,ColoradoChapterofTheNatureConservancyEducation:• BachelorofArtsinBusinessAdministration,theUniversityofHouston

SpecificExperience:Becauseofherleadershipexperienceandover35yearsofbusinessexperienceinthehealthinsurance,healthcareservicesandfinancialservicesindustriesandherexperienceservingonpubliccompanyboards,webelieveMs.BurtiswellqualifiedtoserveontheBoard.

Table of Contents

IQVIA2020PROXYSTATEMENT ProposalNo.1|15

COLLEENA.GOGGINS

DirectorSince2017

Independent

65yearsold


NominatingandGovernanceCommittee(Member)


Experience:Johnson&Johnson(1981-2011)• Member,ExecutiveCommittee(2001-2011)• WorldwideChairman,ConsumerGroup(2001-2011)• CompanyGroupChairman,NorthAmerica(1998-2001)• PresidentConsumerProductsUS(1995-1998)OtherU.S.publiccompanydirectorships:• TheToronto-DominionBank(RiskCommittee)FormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• BauschHealthCompaniesInc.(f/k/aValeantPharmaceuticalsInternational)Otherpositions:• Member,BoardofDirectors,SIGCombiblocGroup;Citymeals-on-WheelsNewYorkCity;UniversityofWisconsinCenterforBrandandProductManagement

• Member,SupervisoryBoard,BayerAG• Member,UniversityofWisconsinFoundation• Member,BoardofTrustees,InstituteofInternationalEducationEducation:• MasterofArtsinManagement,KelloggSchoolofManagement• BachelorofScienceinFoodChemistry,UniversityofWisconsin-Madison

SpecificExperience:BecauseofMs.Goggins’sextensiveleadershipandhealthcareexperience,webelieveMs.GogginsiswellqualifiedtoserveontheBoard.Ms.GogginswasdesignatedfornominationtotheBoardpursuanttotheShareholdersAgreementdescribedherein.ThedesignationprovisionsintheShareholdersAgreementunderwhichMs.GogginswasdesignatedtotheBoardterminatedin2018.

Table of Contents

16|ProposalNo.1 IQVIA2020PROXYSTATEMENT

RONALDA.RITTENMEYER

DirectorSince2016

Independent

71yearsold


LDCCommittee(Chair)


Experience:TenetHealthcareCorporation(2017-present)• ExecutiveChairmanandChiefExecutiveOfficerMillenniumHealth(2016-2017)• ChairmanandChiefExecutiveOfficerElectronicDataSystemsCorporation(2005-2008)• ChairmanandChiefExecutiveOfficer(2007-2008)• President(2006-2007)• ChiefOperatingOfficer(2005-2007)• ExecutiveVicePresident,GlobalServiceDelivery(2005-2006)OtherU.S.publiccompanydirectorships:• TenetHealthcareCorporationFormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• AmericanInternationalGroup,Inc.• IMSHealth(predecessortoIQVIA)• MillenniumHealthEducation:• MasterofBusinessAdministration,RockhurstUniversity• BachelorofArtsinCommerceandEconomics(Finance),WilkesUniversity

SpecificExperience:Becauseofhisleadershipexperience,over30yearsofbusinessexperienceandextensiveexperienceservingonpubliccompanyboards,webelieveMr.RittenmeyeriswellqualifiedtoserveontheBoard.Forhiscurrenttermexpiringatthe2020AnnualMeeting,Mr.RittenmeyerwasdesignatedfornominationtotheBoardpursuanttotheShareholdersAgreementdescribedherein.ThedesignationprovisionsintheShareholdersAgreementunderwhichMr.RittenmeyerwasdesignatedtotheBoardterminatedin2018.

Table of Contents


ClassIIDirectorsContinuinginOfficeuntilthe2021AnnualMeetingofStockholders

ARIBOUSBIB

DirectorSince2016

ChairmanandCEO

58yearsold

Experience:IQVIAHoldingsInc.(2010-present)• ChairmanandChiefExecutiveOfficer(2016-present)• ChairmanandChiefExecutiveOfficerofIMSHealth(2010-2016)UnitedTechnologiesCorporation(1997-2010)• PresidentofUTC’scommercialcompanies(OtisElevatorCompany,CarrierCorporation,UTCFire&SecurityandUTCPowerInc.)(2008-2010)

• President,OtisElevatorCompany(2002-2008)• ChiefOperatingOfficer,OtisElevatorCompany(2000-2002)OtherU.S.publiccompanydirectorships:• TheHomeDepot,Inc.(FinanceCommitteeandAuditCommittee)FormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• IMSHealth(predecessortoIQVIA)Otherpositions:• Member,HarvardMedicalSchoolHealthCarePolicyAdvisoryCouncilEducation:• MasterofBusinessAdministration,ColumbiaUniversity• MasterofScienceinMathematicsandMechanicalEngineering,EcoleSuperieuredesTravauxPublics,Paris

SpecificExperience:BecauseofMr.Bousbib’sextensiveleadershipexperienceandserviceasourChiefExecutiveOfficer,webelieveMr.BousbibiswellqualifiedtoserveontheBoard.Mr.BousbibwasdesignatedfornominationtotheBoardpursuanttotheShareholdersAgreementdescribedherein.ThedesignationprovisionsintheShareholdersAgreementunderwhichMr.BousbibwasdesignatedtotheBoardterminatedin2018.

Table of Contents


JOHNM.LEONARD,M.D.

DirectorSince2015

Independent

LeadDirector

62yearsold




Experience:IntelliaTherapeutics,Inc.(2018-present)• Director,PresidentandChiefExecutiveOfficerAbbVieInc.(January2013-December2013)• ChiefScientificOfficerandSeniorVicePresidentofResearchandDevelopmentAbbottLaboratories(1992-2012)• SeniorVicePresidentofGlobalPharmaceuticalResearchandDevelopment(2008-2012)OtherU.S.publiccompanydirectorships:• IntelliaTherapeutics,Inc.Education:• DoctorateinMedicine,JohnsHopkinsUniversity• BachelorofArtsinBiochemistry,UniversityofWisconsin-Madison

SpecificExperience:Becauseofhisleadershipexperience,includinghisover30years’experienceinmedicine,researchandmanagement,webelieveDr.LeonardiswellqualifiedtoserveontheBoard.Dr.LeonardwasdesignatedfornominationtotheBoardpursuanttotheShareholdersAgreementdescribedherein.ThedesignationprovisionsintheShareholdersAgreementunderwhichDr.LeonardwasdesignatedtotheBoardterminatedin2018.

TODDB.SISITSKY

DirectorSince2016

Independent

48yearsold

LDCCommittee(Member)

NominatingandGovernanceCommittee(Chair)

Experience:TPGCapital(2003-present)• Co-ManagingPartnerOtherU.S.publiccompanydirectorships:• AllogeneTherapeutics,Inc.(AuditCommittee,NominatingandCorporateGovernanceCommittee)FormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• EndoInternationalplc• IASISHealthcareLLC• IMSHealth(predecessortoIQVIA)Otherpositions:• Chair,BoardofAdvisors,DartmouthMedicalSchool• Member,BoardofDirectors,ConveyHealthSolutions,Inc.;AdarePharmaceuticals,Inc.;ImmucorInc.Education:• MasterofBusinessAdministration,StanfordGraduateSchoolofBusiness• BachelorofArts,DartmouthCollege

SpecificExperience:Becauseofhisextensiveexperienceinleadership,businessandhealthcare,webelieveMr.SisitskyiswellqualifiedtoserveontheBoard.Mr.SisitskywasdesignatedfornominationtotheBoardbyTPGpursuanttotheShareholdersAgreementdescribedherein.TPG’sdesignationrightsundertheShareholdersAgreementceasedin2019.

Table of Contents


ClassIIIDirectorsContinuinginOfficeuntilthe2022AnnualMeetingofStockholders

JOHNP.CONNAUGHTON

DirectorSince2008

Independent

54yearsold


Experience:BainCapital(1989-present)• Co-ManagingPartnerFormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• iHeartMedia,Inc.Otherpositions:• Member,BoardofDirectors,TheBostonCeltics• Member,BoardofTrustees,TheBerkleeCollegeofMusic;UniversityofVirginiaMcIntireFoundationEducation:• MasterofBusinessAdministration,HarvardBusinessSchool• BachelorofScienceinCommerce,UniversityofVirginia

SpecificExperience:BecauseofhisextensiveexperienceasaManagingDirectorofBainCapital,serviceonotherpubliccompanyboardsandover15years’experienceintheprivateequityindustry,aswellasextensiveexperienceinthehealthcareindustry,webelieveMr.ConnaughtoniswellqualifiedtoserveontheBoard.

JOHNG.DANHAKL

DirectorSince2016

Independent

63yearsold



Experience:LeonardGreen&Partners,L.P.(1995-present)• ManagingPartnerFormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• IMSHealth(predecessortoIQVIA)Otherpositions:• Member,BoardofDirectors:LifeTimeFitness,Inc.;AdvantageSolutionsInc.;CharterNEX;GlobalCitizenCPAGlobal;GenaniCorporation;InsightGlobal,Inc.;MisterCarWashHoldings,Inc.;MultiPlan,Inc.;Savers,Inc.;SRSDistribution

Education:• MasterofBusinessAdministration,HarvardBusinessSchool• BachelorofArtsinEconomics,UniversityofCaliforniaatBerkeley

SpecificExperience:Becauseofhisextensiveexperienceservingasapubliccompanydirectorandhisextensiveexperienceinleadershipandbusiness,webelieveMr.DanhakliswellqualifiedtoserveontheBoard.

Table of Contents


JAMESA.FASANO

DirectorSince2016

Independent

49yearsold

AuditCommittee(Chair)

AuditCommittee

FinancialExpert

Experience:CanadaPensionPlanInvestmentBoard(2004-present)• ManagingDirectorFormerU.S.publiccompanydirectorshipsheldinthepastfiveyears:• IMSHealth(predecessortoIQVIA)Otherpositions:• Member,BoardofDirectors,NEWAsurionEducation:• MasterofBusinessAdministration,UniversityofChicagoGraduateSchoolofBusiness• BachelorofEngineering,RoyalMilitaryCollegeofCanada

SpecificExperience:BecauseofMr.Fasano’sextensiveexperienceasaManagingDirectoratCPPIBandexperienceinfinanceandleadershiproles,webelieveheiswellqualifiedtoserveontheBoard.

Table of Contents


IQVIA’sCorporateGovernanceTheBoardisresponsibleforsupervisionoftheoverallaffairsoftheCompany.TheBoardoverseesourseniormanagement,towhomithasdelegatedauthoritytomanagetheday-to-dayoperationsoftheCompany.MembersoftheBoardarekeptinformedofourbusinessthroughdiscussionswithourChiefExecutiveOfficerandotherofficers,byreviewingmaterialsprovidedtothemandbyparticipatinginregular,aswellasspecial,meetingsoftheBoardanditscommittees.Inaddition,topromoteopendiscussionamongournon-managementandindependentdirectors,thosedirectorsmeetinregularlyscheduledexecutivesessionswithouttheparticipationofourChiefExecutiveOfficer.TheBoardhasadoptedCorporateGovernanceGuidelines,which,togetherwithourCertificateofIncorporationandBylawsandtheotherdocumentslistedbelow,formthegovernanceframeworkfortheBoardanditscommittees.Thefollowingsectionsprovideanoverviewofourcorporategovernancestructure,includingdirectorindependenceandothercriteriaweuseinselectingdirectornominees,ourboardleadershipstructureandtheresponsibilitiesoftheBoardandeachofitscommittees.

DOCUMENTSESTABLISHINGOURCORPORATEGOVERNANCE

TheBoardhasalong-standingcommitmenttosoundandeffectivecorporategovernancepractices.ThefollowingkeydocumentsarethefoundationofcorporategovernanceattheCompany:

• CorporateGovernanceGuidelines

• AuditCommitteeCharter• CodeofConduct • LDCCommitteeCharter• CertificateofIncorporation

• NominatingandGovernanceCommitteeCharter• Bylaws

Thesedocumentsandotherimportantinformationonourcorporategovernancearepostedinthe“CorporateGovernance”sectionofthe“InvestorRelations”sectionofourwebsiteunder“GovernanceDocuments”and“CommitteeCharters”andmaybeviewedathttp://ir.iqvia.com.WewillalsoprovideprintedcopiesofthesedocumentsfreeofchargetoanystockholderwhosendsInvestorRelationsarequestat:IQVIAHoldingsInc.,100IMSDrive,Parsippany,NewJersey07054.

Table of Contents

22|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT CORPORATEGOVERNANCEPRACTICES

IQVIAbelievesthatastrongcorporategovernanceframeworkisessentialtoourlong-termsuccess.WearecommittedtoadoptingandfollowingstrongcorporategovernancepracticesbecausewebelievethatsuchpracticespromoteanenvironmentofaccountabilityfortheBoardandourseniormanagementandotherwisepromotethelong-terminterestsofourstockholders.Ourgovernancepracticesandpoliciesincludethefollowing:

IndependentBoard

AllourdirectorsareindependentexceptforourChairmanandChiefExecutiveOfficer

IndependentBoardcommittees

EachofourthreeBoardcommitteesiscomposedsolelyofindependentdirectors

IndependentLeadDirector;regularexecutivesessions

WehaveanindependentLeadDirector,whowaselectedbyourindependentdirectors,whohascomprehensivedutiessetforthinourCorporateGovernanceGuidelines,includingleadingregularexecutivesessionsoftheBoard,whereindependentdirectorsmeetwithoutmanagementpresent

AnnualBoardandcommitteeself-assessmentprocess

TheBoardandeachBoardcommittee,ledbytheirrespectivechairs,conductsaself-assessmentannuallytodeterminewhetheritisfunctioningefficientlyandmeetingitsgovernanceresponsibilities

Activestockholderengagement

Weregularlymeetwithourstockholderstobetterunderstandtheirperspectives,andweenhancedourstockholderengagementandoutreacheffortsin2019

RobustCodeofConduct

Ourcodeofconduct,DoingtheRightThing,appliestoourdirectors,officersandemployees,includingourprincipalexecutiveofficer,principalfinancialofficer,principalaccountingofficer,controllerorpersonsperformingsimilarfunctions.Thecodeofconductisaguidetotheresponsibilitiesweshareforethicalbusinessconductandpaintsaclearpictureofwhatwestandforasanorganization,whatweexpectfromourselves,andwhatwemustdotomaintainourreputation

ProhibitiononhedgingorpledgingofCompanystock

Oursecuritiestradingpolicyprohibitshedgingtransactionswithrespectto,andthepledgingof,oursecuritiesbyanyofourdirectors,officersorotheremployeesortheirimmediatefamilymembers,exceptwheretheindividualreceivespriorwrittenapprovalfromtheGeneralCounsel.In2019,theGeneralCounseldidnotapproveanystockhedgingorpledgingtransactionsandnoneofourcurrentexecutiveofficersordirectorshaveenteredintoanysuchhedgingorpledgingtransactions

Shareownershiprequirements

Wehaverobustshareownershipguidelines,whichrequireournamedexecutiveofficerstoholdbetween3timesand6timesbasesalary.Ourshareownershippolicyrequiresourexecutiveofficerstohold50%ofthenetsharesreceivedbythemasaresultoftheexercise,vestingorsettlementoflong-termincentiveawardsuntiltheymeettheirrequiredownershiplevels

ClawbackPolicy

Wemaintainaclawbackpolicythatappliestocurrentandformerexecutiveofficers,amongothers,thatprovidesfortherecoupmentofshort-andlong-termincentivecompensationintheeventofafinancialrestatementunderspecifiedcircumstances

DirectorResignationPolicy

Directorsarerequiredtotendertheirresignationiftheyreceiveanumberofwithholdvotesthatisgreaterthan50%ofallvotescast

Adoptedaproxyaccessright

Eligiblestockholdersmay,subjecttocertainrequirements,includetheirowndirectornomineesinourproxymaterials

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|23 LEADERSHIPSTRUCTURE

ChairmanandChiefExecutiveOfficerMr.BousbibbecameourChairmanandChiefExecutiveOfficeronOctober3,2016,inconnectionwiththeMerger.Webelievethatthecurrentboardleadershipstructure,withtheChairmanandChiefExecutiveOfficerrolescombined,isappropriateandinthebestinterestsofourstockholdersbecauseourChiefExecutiveOfficerhasauniquedepthofknowledgeabouttheCompanyandthevariedandcomplexopportunitiesandchallengesweface.TheroleoftheChairmanistosettheagendafortheboardmeetingsandtopresideovergeneralboardsessions.WhentheBoardmeetsinexecutivesessionwithoutmanagementpresenttoevaluatemanagement’sperformance,thesesessionsarepresidedbyourindependentLeadDirector.Independentdirectorsalsoevaluateourleadershipstructureregularlyandgarnerfeedbackfromstockholders.OurChairmanandChiefExecutiveOfficerandtheLeadDirectorcommunicateregularlyduringthecourseoftheyear.

Thecurrentboardleadershipstructureprovidesforeffectiveandefficientleadershipbecause,amongotherthings,itrecognizesthevalueofonepersonbothspeakingforandleadingtheCompanyandtheBoard.TheBoardrecognizesthattheremaybecircumstancesinthefuturethatwouldleadittoseparatetheseoffices,butitdoesnotbelievethereisanyreasontodosoatthistime.TheBoardbelievesthatthissubjectisprimarilyamatterofthesuccessionplanningprocessandthatitisinthebestinterestoftheCompanyfortheBoardtomakethisdeterminationwhenitelectsanewChiefExecutiveOfficerorundersuchothercircumstancesthatitbelievesarebestfortheCompanyatagivenpointintime.

LeadDirector;ExecutiveSessionsTheLeadDirectorhelpsensurethereisanappropriatebalancebetweenmanagementandtheindependentdirectorsandthattheindependentdirectorsarefullyinformedandabletodiscussanddebatetheissuesthattheydeemimportant.OurcurrentLeadDirectorisDr.Leonard.TheresponsibilitiesoftheLeadDirector,asoutlinedinourCorporateGovernanceGuidelinesinclude,amongothers: BoardMatter ResponsibilityCommunicatingwithdirectors Liaisingbetweennon-managementdirectorsandmanagementExecutivesessions Presidingatexecutivesessionsofnon-managementdirectorsBoardmeetings PresidingatallBoardmeetingswhentheChairmanisnotpresentAgendas

ConsultingwiththeChairmanonmatterspertinenttotheCompanyandtheBoard,includingmeetingagendas,schedulesandinformationsenttotheBoard

Communicatingwithstockholders Consultingwithmajorstockholders,asappropriate

TheBoardbelievesthatoneofthekeyelementsofeffective,independentoversightisthattheindependentdirectorsmeetinexecutivesessiononaregularbasiswithoutthepresenceofmanagement.Accordingly,ourindependentdirectorsmeetseparatelyinexecutivesessionateachregularlyscheduledin-personBoardmeeting.Ourindependentdirectorsheldfourexecutivesessionsduring2019,allofwhichwereledbytheLeadDirector.

BoardCommitteesToassistincarryingoutitsduties,theBoardhasdelegatedauthoritytothreecommittees:theAuditCommittee,theLDCCommitteeandtheNominatingandGovernanceCommittee.TheBoardheldsix(6)meetingsduringfiscal2019.Allofourcurrentdirectorsattendedatleast75%ofthetotal

Table of Contents

24|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT numberofmeetingsoftheBoardandBoardcommitteesonwhichtheyservedin2019.Eight(8)directorsattendedtheannualmeetingofthestockholdersin2019.

BOARDSTRUCTURE

TheBoardoverseesthemanagementofourbusinessbyourChiefExecutiveOfficerandseniormanagement.OurCertificateofIncorporationprovidesthattheBoardshallconsistofatleastfive(5)directorsbutnotmorethanseventeen(17)directorsandthatthenumberofdirectorsmaybefixedfromtimetotimebyresolutionoftheBoard.

TheBoardisdividedintothreeclasses.Upontheexpirationoftheinitialtermofofficeforeachclassofdirectors,eachdirectorinsuchclassshallbeelectedforatermofthreeyearsandserveuntilhisorhersuccessorisdulyelectedandqualifiedoruntilhisorherearlierdeath,resignation,retirement,disqualificationorremoval.Anyadditionaldirectorshipsresultingfromanincreaseinthenumberofdirectorsoravacancymaybefilledbythedirectorstheninoffice.

InconnectionwiththeMerger,theCompanyenteredintotheShareholdersAgreement,whichaddresses,amongotherthings,certainboarddesignationrights,registrationrightsandtransferrestrictions.TheBoarddesignationrightsforeachofthepartiestotheShareholdersAgreementhavesinceceased.

Followingour2020AnnualMeeting,theBoardwillbecomprisedofnine(9)directors,eachofwhomwasdesignatedfornominationasadirectorinaccordancewithourgovernancedocuments.

DIRECTORINDEPENDENCE

TheBoardconductedanassessmentoftheindependenceofeachdirectoranddeterminedthat,otherthanourChiefExecutiveOfficer,eachofourdirectorscontinuinginofficeafterthe2020AnnualMeetingiscurrentlyindependent:

8of9IQVIADirectorsareIndependent

›

• CarolJ.Burt

• JohnP.Connaughton

• JohnG.Danhakl

• JamesA.Fasano

• ColleenA.Goggins

• JohnM.Leonard,M.D.

• RonaldA.Rittenmeyer

• ToddB.Sisitsky

InaccordancewithourCorporateGovernanceGuidelinesandthecorporategovernancestandardsoftheNewYorkStockExchange(“NYSE”),thisdeterminationofindependencemeansthattheBoardfindsthatthedirectorhasnomaterialrelationshipwiththeCompany,directlyorindirectly,thatwouldinterferewithhisorherexerciseofindependentjudgmentasadirectoroftheCompany.WithrespecttodirectorswhoaremembersoftheAuditCommitteeandtheLDCCommittee,theBoardhasdeterminedthateachdirectormeetsanevenhigherstandardasrequiredbySecuritiesandExchangeCommission(the“SEC”)andNYSErules.

TheBoardhasalsodeterminedthatMs.Burt,Messrs.FasanoandRittenmeyerandDr.Leonardare“AuditCommitteeFinancialExperts”assuchtermalsoisdefinedinSECrulesandthateachmemberoftheAuditCommitteeisfinanciallyliterate.

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|25 COMMITTEESOFTHEBOARD

TheBoardhasthreestandingcommittees:

• AuditCommittee

• LeadershipDevelopmentandCompensationCommittee

• NominatingandGovernanceCommittee

Fromtimetotime,theBoardmayalsocreateadhocorspecialcommitteesforcertainpurposes.Eachcommitteeiscomprisedsolelyofindependent,non-employeedirectors.Thecharterofeachcommitteeprovidesthatnon-managementdirectorswhoarenotmembersofsuchcommitteemaynonethelessattendmeetingsofsuchcommittee,buttheymaynotvote.

Table of Contents

26|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT AUDITCOMMITTEE2019Meetings:TheAuditCommitteeheldeight(8)meetingsduringfiscal2019Membersin2019:

JamesA.Fasano(Chair)

MichaelJ.Evanisko

ColleenA.Goggins

JohnM.Leonard,M.D.

RonaldA.Rittenmeyer

Responsibilities:

• AssistingtheBoardinfulfillingitsoversightresponsibilitiesrelatingto:(i)theintegrityoftheCompany’sfinancialstatements,(ii)theCompany’scompliancewithlegalandregulatoryrequirements,includingitsqualityassurancefunctionoverseeingclinicaltrialservices,(iii)theindependentauditor’squalificationsandindependence,(iv)theperformanceoftheCompany’sinternalauditfunctionandtheindependentauditor,and(v)theperformanceoftheCompany’scomplianceandethicsprogram

• ReviewinganddiscussingwithmanagementandtheindependentauditortheannualandquarterlyfinancialstatementspriortothefilingoftheCompany’sAnnualReportonForm10-KandQuarterlyReportsonForm10-Q

• Discussingearningspressreleasesandthefinancialinformationandearningsguidanceincludedtherein

• OverseeingtherelationshipbetweentheCompanyandourindependentregisteredpublicaccountingfirm,including:

• Havingdirectresponsibilityforitsappointment,compensationandretention

• Reviewingthescopeofitsauditservices

• Approvingitsnon-auditservices

• Reviewingandevaluatingitsindependence

• Reviewingwithinternalauditorsandtheindependentauditortheoverallscopeandplansforaudits,includingauthorityandorganizationalreportinglinesandadequacyofstaffingandcompensation,andmonitortheprogressandresultsofsuchplansduringtheyear

• Reviewingwithinternalauditorsandtheindependentauditoranyauditproblemsordifficulties,includinganyrestrictionsonthescopeoftheindependentauditor’sactivitiesoronaccesstorequestedinformationandanysignificantdisagreementswithmanagement,andmanagement’sresponsetosuchproblemsordifficulties

• Overseeingmanagement’simplementationandmaintenanceofeffectivesystemsofinternalcontrolsoverfinancialreportinganddisclosurecontrols,andreviewinganddiscussingwithmanagement,internalauditorsandtheindependentauditortheCompany’ssystemofinternalcontrol,itsfinancialandcriticalaccountingpoliciesandpractices,policiesrelatingtoriskassessmentandriskmanagementandourmajorfinancialriskexposures

• Reviewingandapprovingallrelatedpartytransactionsandcorporateopportunitytransactions

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|27 LEADERSHIPDEVELOPMENTANDCOMPENSATIONCOMMITTEE2019Meetings:TheLDCCommitteeheldfive(5)meetingsduringfiscal2019Membersin2019:

RonaldA.Rittenmeyer(Chair)

JohnP.Connaughton

JohnG.Danhakl

ToddB.Sisitsky

Responsibilities:

• ReviewingandapprovingcorporategoalsandobjectivesrelevanttothecompensationofourChiefExecutiveOfficerandtheofficersoftheCompanywhoreportdirectlytoourChiefExecutiveOfficerandallofficerswhoare“insiders”subjecttoSection16oftheExchangeAct(“SeniorOfficers”)

• EvaluatingtheperformanceofourChiefExecutiveOfficerandotherSeniorOfficersinlightofthosegoalsandobjectivesand,eitherasacommitteeortogetherwiththeotherindependentdirectors(asdirectedbytheBoard),determiningandapproving,orrecommendingtotheBoardforapproval,thecompensationlevelsforourChiefExecutiveOfficerandotherSeniorOfficers

• MakingrecommendationstotheBoardaboutthecompensationofourdirectors

• Administeringourequity-basedplansandmanagementincentivecompensationplansandmakingrecommendationstotheBoardaboutamendmentstosuchplansandtheadoptionofanynewemployeeincentivecompensationplans

• RecommendingtotheBoardownershipguidelinesfortheSeniorOfficers,otherexecutivesandnon-employeedirectors,andperiodicallyassessingtheseguidelinesandrecommendingrevisionsasappropriate

• Establishingthetermsofcompensatoryarrangementsandpoliciestoprotectourbusiness,includingrestrictionsthatapplytocurrentandformerSeniorOfficers

• ReviewingandapprovingallSeniorOfficeremploymentcontractsandothercompensatory,severanceandchangeincontrolarrangementsforcurrentandformerSeniorOfficers,reviewingandestablishingouroverallmanagementcompensationandbenefitsphilosophyandpolicy,andreviewingandapprovingourpoliciesandproceduresforthegrantofequity-basedawards

• Establishingandreviewingperiodicallypoliciesandprocedureswithrespecttoperquisites

• Reviewingourincentivecompensationarrangementstodeterminewhethertheyencourageexcessiverisk-taking,reviewinganddiscussingatleastannuallytherelationshipbetweenriskmanagementpoliciesandpracticesandcompensation,andevaluatingcompensationpoliciesandpracticesthatcouldmitigateanysuchrisk

• Reviewingtheprocessesformanagingexecutivesuccessionandtheresultsofthoseprocesses

Table of Contents

28|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT NOMINATINGANDGOVERNANCECOMMITTEE2019Meetings:TheNominatingandGovernanceCommitteeheldfour(4)meetingsduringfiscal2019Membersin2019:

ToddB.Sisitsky(Chair)

JohnG.Danhakl

ColleenA.Goggins

JohnM.Leonard,M.D.

Responsibilities:

• IdentifyingindividualsqualifiedtobecomemembersoftheBoard,consistentwithcriteriaapprovedbytheBoard

• EstablishingprocessesforidentifyingandevaluatingBoardcandidates,includingnomineesrecommendedbystockholders

• RecommendingtotheBoardthepersonstobenominatedforelectionasdirectorsandtoeachoftheBoard’scommittees

• DevelopingandrecommendingtotheBoardasetofcorporategovernanceprinciples

• Articulatingtoeachdirectorwhatisexpected,includingreferencetothecorporategovernanceprinciplesanddirectors’dutiesandresponsibilities

• ReviewingandrecommendingtotheBoardpracticesandpolicieswithrespecttodirectors

• EvaluatingandmakingrecommendationstotheBoardregardingstockholderproposalsthatrelatetocorporategovernanceandothermattersrelatedtostockholders

• OverseeingtheevaluationoftheBoardTheNominatingandGovernanceCommitteewillconsiderstockholders’recommendationsofnomineesformembershipontheBoard.StockholdersmayrecommendcandidatesformembershipontheBoardtotheNominatingandGovernanceCommitteebysubmittingthenamesinwritingto:Secretary,IQVIAHoldingsInc.,100IMSDrive,Parsippany,NewJersey07054.TheBylawsspecifycertaintimelimitations,noticerequirementsandotherproceduresapplicabletothesubmissionofnominationsbeforeanannualorspecialmeeting.Theseproceduresaredescribedbelowunderthecaption“StockholderProposalsfor2021AnnualMeetingofStockholders.”

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|29 BOARD’SROLEINRISKOVERSIGHT

OurBoardactivelyoverseesourenterpriseriskmanagementprogramtoensurethatwemaintaineffectiveriskmanagement.OurBoard’sroleinriskoversightisconsistentwithouroverallleadershipstructure—managementisresponsibleforassessingandmanagingourriskexposures,andourBoardmaintainsanoversightrole,executedthroughopencommunicationwithmanagementandindependentoversightofstrategicrisks.OurBoardconsiderskeyrisktopicsinitsoversight,includingrisksassociatedwithourstrategicplan,ourcapitalstructure,ourbusinessactivities,andsocialandenvironmentalmatters.RisksareidentifiedbymanagementandreviewedwiththeappropriateBoardcommitteeorthefullBoardforoversight.

In2018,weestablishedanEnterpriseRiskCouncil,comprisedofleadersfromourprincipalfunctionalareasandbusinessunitsthatmeetonaquarterlybasis,toupdateourenterpriseriskframeworkusedtoidentifyandmanageourkeyrisks.Theframeworkconsidersexternalandinternalfactorsthatcouldimpedetheachievementofourbusinessobjectivesordamageourbrand,reputationorfinancialcondition.TheBoardreviewsthesekeyrisksandtherelatedframeworkannually,andtheBoardorappropriateBoardcommitteesdiscussselectedrisksinmoredetailthroughouttheyear,asdiscussedbelow.

WhileourBoardhastheultimateoversightresponsibilityfortheriskmanagementprocess,ourBoard’scommitteesassistitinfulfillingitsoversightresponsibilitiesincertainareasofrisk.Inparticular,ourAuditCommitteefocusesonrisksassociatedwithourfinancialstatements,internalaccountingandfinancialcontrols,internalandexternalaudits,cybersecurity,compliancewithlegalandregulatorymattersandperformanceofourcomplianceandethicsprograminconnectiontherewith,includingourguidelinesandpolicieswithrespecttoriskassessmentandriskmanagementandourmajorfinancialriskexposures.OurLDCCommitteefocusesonrisksassociatedwithourcompensationpoliciesandpractices,includingthoseforourexecutiveofficers.OurNominatingandGovernanceCommitteefocusesonrisksassociatedwithourcorporategovernancepoliciesandpractices.

EachofthesecommitteesreportstoourBoardwithrespecttotheriskcategoriesitoversees.TheseongoingdiscussionsenableourBoardtomonitorourriskexposureandevaluateourriskmitigationefforts.Inaddition,ourriskmanagementfunctionconductsregularinterviewsandsurveysofkeyemployeesrelatingtoenterpriseriskmanagementandreportstheresultsandanalysisofsuchinterviewsandsurveystoourBoard.

SUCCESSIONPLANNINGFORDIRECTORSANDEXECUTIVEOFFICERS

Directors.VacanciesontheBoardmayoccurfromtimetotime.TheBylawsprovidethatanyvacancycausedbythedeathorresignationofadirectormaybefilledbytheaffirmativevoteofamajorityofthedirectorstheninoffice.

SubjecttothetermsoftheBylaws,theNominatingandGovernanceCommitteeisresponsibleforrecommendingtotheBoardthepersonstobenominatedforelectionasdirectorsandtoeachoftheBoard’scommittees.ItistheBoard’spolicythatthecompositionoftheBoardatalltimesadheretothestandardsofindependencepromulgatedbytheNYSEasfurtherclarifiedhereinandreflectarangeoftalents,ages,skills,character,diversityandexpertise,particularlyintheareasofaccountingandfinance,management,domesticandinternationalmarkets,leadershipandcorporategovernance,ourindustryandthemarketsweservesufficienttoprovidesoundandprudentguidancewithrespecttoouroperationsandinterests.

AsprovidedinitsCorporateGovernanceGuidelines,theBoardalsoseekstoachieveamixofdirectorsthatenhancesthediversityofbackground,includingwithrespecttoprofessionalskills,relevant

Table of Contents

30|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT industryexperience,specializedexpertise,internationalexperience,gender,raceandethnicity,tomaintainadiversemembership.TheprocessofdeterminingtoaddanewBoardmemberandidentifyingqualifiedcandidatesbeginswellinadvanceofanticipatedvacancies.Underthisongoingprocess,theChairmanoftheNominatingandGovernanceCommitteeandourChiefExecutiveOfficermonitorandmaintainanopendialogue,andalsoconsultwiththeothermembersoftheBoard,includingourLeadDirector,regardingthesizeoftheBoard,futureretirementsanddirectorattributesdesiredforanynewdirectorships.Onceadecisionhasbeenmadetorecruitanewdirector,theNominatingandGovernanceCommitteemayretainanexecutiverecruitmentorganizationtoassistitinitssearchbyprovidingarangeofqualifiedcandidates.

TheBoardhasbeen,andwillcontinuetobe,focusedonarefreshmentprogramtoensurethecompositionoftheBoardhastheappropriatemixofdiversebackgrounds,skillsandexperiencestosupporttheCompany’sstrategy.

ExecutiveOfficers.Inaddition,theBoardalsoplansforsuccessiontothepositionsofChairmanoftheBoardandChiefExecutiveOfficeraswellascertainotherseniormanagementpositions.ToassisttheBoard,ourChiefExecutiveOfficerperiodicallyprovidestheLDCCommitteewithanassessmentofseniormanagersandoftheirpotentialtosucceedhim.HealsoprovidestheLDCCommitteewithanassessmentofpersonsconsideredpotentialsuccessorstocertainotherseniormanagementpositions.Thisassessmentresultsfromourleadershipdevelopmentandsuccessionplanningprocess,whichinvolvesthreeprincipalsteps:

• Regionalandglobalbusinessunitandcorporatestafffunctionassessmentstoidentifykeyemployeesandemployeeswithhighpotentialforincreasedresponsibilities

• ChiefExecutiveOfficerassessmentsoftheleadersoftheregionalandglobalbusinessunitsandcorporatestafffunctions,focusingonseniorexecutives’developmentandsuccession

• Boardreviewandapproval,focusingonChiefExecutiveOfficersuccession,keyseniorexecutives’developmentandsuccession,thepoolofhigh-potentialexecutivesandinitiativestoimproveretentionandpromotetheirdevelopmentascompanyleaders

Weusetoolsandprocesses,followedbyface-to-facereviews,toimplementourleadershipdevelopmentandsuccessionplanningprocess.Throughthisprocess,weidentifyapoolofhigh-potentialemployeeswhoareselectedfordevelopment.Ourdevelopmentprogramemphasizesskillstraining,educationandcareerplanning.

HOWTOCONTACTTHEBOARDANDITSCOMMITTEES

WehaveestablishedaprocessbywhichstockholdersandotherinterestedpartiescancontacttheBoard,oracommitteeoftheBoard.TocontacttheBoardoraBoardcommittee,[email protected],orwritetothefollowingaddress:

BoardofDirectorsc/oSecretary

IQVIAHoldingsInc.100IMSDrive

Parsippany,NewJersey07054

CommunicationswillbedistributedtotheChairmanoftheBoardortheothermembersoftheBoardasappropriatedependingonthefactsandcircumstancesoutlinedinthecommunicationreceived.

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|31 SUSTAINABILITYANDCORPORATECITIZENSHIP

SustainabilityandCorporatecitizenshipareessentialelementsofourcultureandvision.Afocusonwellnessandsafetyofouremployeesandcustomers,productinnovation,environmentalresponsibilityandethicalbusinesspracticesiscentraltooursuccess—andthiscultureofcaringextendstothecommunitieswhereweliveandwork.Westrivetomakeadifferencelocallyandglobally.

Wepaycloseattentiontoqualityandcompliancewhileembracingfreshideasandnewinnovations.Thisdualcommitmentempowersustoimprovehealthcare—enhancingandadvancingwellnessandsafety,strengtheningsupplierrelationships,andsupportingenvironmentalstewardship.

Wedemonstratethiscommitmentbyadoptingpoliciesandpracticesinspecificareasrelatedtosustainabledevelopment,includingenvironmentandhealthandsafety;corporatesocialgiving;workers’humanrights;protectingindividualprivacy;andethicalbusinesspractices.

People Public Planet

Creatingaworkplaceofhighlyengaged,safe,andhealthyemployeeswhofollowtheCodeofConduct

Engagingconsistentlyandtransparentlyinamannerthatinspiresparticipationanddemonstratesleadershipinsustainability

Makingapositiveimpactontheenvironmentsweworkin

People EveryoneatIQVIA,regardlessoftheirrole,contributestoagreaterpurpose.Ourcultureisbasedonfivecorevalues:Clientfocus,Results,Teamwork,Flawlessexecution,andIntegrity.Asateam,wearenotonlymovinghealthcareforward,weareleadingthechargetotakeitfurtherthaneverbefore.Westrivetogiveourbestineverythingwedo.Weembracethechallengebecauseweareuniquelypositionedtomakeatangible,meaningfuldifference.

DiversityandInclusion.Wearecommittedtomaintainingacultureofinclusioninwhichpeoplefromallbackgroundscanfullycontributetothegrowthandsuccessofourbusiness.Wecreatethiscultureofinclusionforemployeesregardlessofgender,race,color,creed,religion,maritalstatus,age,nationaloriginorancestry,physicalormentaldisability,medicalcondition,veteranstatus,citizenship,sexualorientation,genderidentity,oranyotherprotectedgroupstatus.Assuch,ourbusinessisfocusedonthreecoreareas:

1. Recruitment.IQVIAiscommittedtoconsideringarangeofqualifiedcandidatesforallpositionsandtohiringqualifiedindividualswithavarietyofbackgroundsandexperiencesfromwithinandoutsidetheorganizationforpositionsatalllevels.

2. Development&Progression.IQVIAisfocusedonhavingadiversepipelineoftalentmovingupinourorganizationandprovidingopportunitiesforallemployeestodevelopwithintheircurrentroleaswellastowardstheirnextrole.

3. Retention.Oncewehiretherightpeople,wewantthemtostay.Toincreaseemployeeengagementandretention,weconsistentlyseekfeedbackfromemployeesthroughsurveysandfocusgroups.Wewillcontinuetousethisfeedbackandreviewourprocessestoidentifyadditionalinitiativesaimedtofurtherincreaseemployeeretention.

PublicRecognition.WewerenamedtotheForbes2019listofAmerica’sBestEmployersforWomenandrecognizedagainbyFORTUNEasoneoftheWorld’sMostAdmiredCompaniesin2019.

EmployeeEngagementSurvey.Inlate2018,wedeployedourfirstcompany-wideemployeeengagementsurveyfollowingtheMerger.Wereceivedvaluablefeedbackregardingemployeeroles,teamenvironments,relationshipswithmanagementandcareerprogression.Usingthisfeedback,

Table of Contents

32|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT actionplansweredevelopedatbothglobalandlocallevelsin2019.Wecontinuetoharmonizeoursystemsaswellasimplementtoolsandprogramstoequipemployeeswiththeresourcestheyneedfortheirjobsandhelpthemtakeownershipoftheircareers.In2020,wewillcontinuetoprogressouremployeeengagementsurveyactionplans.

Public AtIQVIA,weareinspiredtoadvancehealthoutcomes.Throughcollaboration,wehopetoovercomesomeofthebiggestchallengesfacingglobalhealth.AfewexamplesofinitiativesthatIQVIAisengagedininclude:

• Facilitatingsharinginsightsonanti-cancermedicines.WeestablishedtheOncologyDataNetwork,whichdeliversinsightsinto

howanti-cancermedicinesarebeingusedinEuropeinreal-timetoparticipatingcentersacrossEuropewithin24hourstoacceleratetheirclinicalresearchefforts.

• Supportingprogressagainstantimicrobialresistance.IQVIAispartoftheCentersforDiseaseControlandUnitedNations’AntimicrobialResistanceChallenge,anefforttoacceleratethefightagainstantimicrobialresistanceacrosstheglobe.

• LeadingtheWayinDrugSafety:IQVIAformedanovelalliancewiththeFDACenterforBiologicsEvaluationandResearchtomonitorandevaluatethesafetyandeffectivenessofvariousvaccines,bloodproducts,andotherbiologics.

• FightingtheOpioidEpidemic:IQVIApartneredwiththeAmericanMedicalAssociation’sOpioidTaskForcetosupportstrategiesthat

targetthenation’sopioidepidemicandcontinuestoprovidevaluableinsightsintotheongoingeffortstocombatthispublichealthissue.

• CollaboratingwithCancerResearcherstoAdvanceRealWorldEvidence:IQVIAcollaborateswithFriendsofCancerResearchinacross-industryefforttoadvanceacceptanceanddrivefutureusesofrealworldevidence.

• ProvidingthePublicwithKeyPublicHealthInformation.Weprovidekeyhealthcaremeasurementsforflu,allergy,andcoughand

coldseasonatthezipcodelevelintheUSthroughFluSTAR.comanditsmobileapp,givingconsumersuniqueinsightsintothespreadoffluandcoldsintheUS.

Planet Wecomplywithhealthandsafetyregulationsforworkersgloballypursuanttolocallawsandregulations.Environmentallawsandregulationsareincorporatedintoourpoliciesandprocedurestoensurecompliance.SelectlocationsarecertifiedtoISO14001:2004andOHSAS18001,includinggroupcertificationsatthecorporateleveltobothstandards.IQVIAhasanEnvironmental,Health&SafetyPolicyandsupportingstandardoperatingproceduresinplace.Weexpectallstafftoactivelyparticipateinhelpingtoensureasafe,healthy,andsecureworkenvironment.

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|33

IndustryStandards

IQVIAholdsaratingofAintheMSCIESGRatingsassessment.MSCIratescompaniesaccordingtotheirexposuretoindustry-significantESG(Environment,Social&Governance)risksandtheirabilitytomanagethoserisksrelativetoindustrypeers.

IQVIAhasbeenawardedaBronzeRatingbyEcoVadisinrecognitionofourachievementsasatop65%performeracrossmorethan55,000companiesassessedbyEcoVadis.EcoVadisisaglobalproviderofbusinesssustainabilityratings.IQVIAisinthetop11%ofcompaniesassessedbyEcoVadisinthescientificresearchanddevelopmentindustry.WearetargetingachievementofSilverRatingbyendof2020.

IQVIAisanactivememberofCDP(formerlyCarbonDisclosureProject),globallyrecognizedassessorsofcorporatesustainabilitymetrics.WeprovidedatatoCDPannuallyonourenergyuse,wastemanagementandourgreenhousegasemissions.CDPisatoolthathelpsuskeeptrackofprogressandprovidesinsightofkeyperformancemetricstodriveimprovementstoreduceourcorporatecarbonfootprint.

Our2019SustainabilityandCorporateCitizenReport,whichprovidesincreasedvisibilityintoourgovernanceprograms,commitmenttoandsupportforthecommunitiesinwhichweliveandworkisavailableonourwebsiteathttps://ir.iqvia.com/corporate-responsibility-and-sustainability.

Wearenotamanufacturerofproductsandhavearelativelylightphysicalfootprintthroughourofficesandlaboratoryfacilities.OurprimaryGHGemissionsimpactisassociatedwithourbusinesstravel,whenprovidingservicestoourcustomers.Ourreportedemissionsfor2017and2018indicatea3.3%reductionyearoveryear,oranequivalentof7,914tonsacrossScope1-3,whichisnotablegiventhesignificantincreaseofournumberofemployeesoverthesameperiod.Wesimilarlyreducedourrealestatefootprintbyapproximately110,000squarefeetduringthistime,whichcontributedtoourGHGreduction.

Weareacutelyawareofourenergyconsumptionassociatedwithbusinesstravelandouroperationsandareactivelypursuingfurtherreductionsthroughmoreefficientuseofenergyinourbuildings,requiringvirtualmeetingswherepossibleandraisingawarenessoftheimpactoftraveltoouremployeesinordertoreduceimpactontheclimate.

GreenhouseGasEmissions(GHG)MetricTonsEquivalent

Table of Contents

34|IQVIA’sCorporateGovernance IQVIA2020PROXYSTATEMENT STOCKHOLDERENGAGEMENT

OurBoardandmanagementarecommittedtoregularengagementwithourstockholdersandsolicitingtheirviewsandinputonmattersrelatedtoperformance,corporategovernance,environmentalandsocialimpacts,humancapitalmanagementandexecutivecompensation,amongothertopics. OurApproach

Who When&How EngagementApproach• Stockholders

• ResearchAnalysts

• ProxyAdvisoryFirms

• Year-Around

• Targetedoutreachaheadofannualmeetingsandasneeded

• In-personmeetings

• Teleconferencesandphonecalls

• Industryconferences

• IQVIAFinancialAnalystandInvestorConference

Board Engagement

• LedbyourLeadDirectorandChairofourNominatingandGovernanceCommittee

• LeadDirectorprovidesfeedbacktotherestoftheBoardManagement Engagement

• LedbyourChiefExecutiveOfficer,ChiefFinancialOfficer,GeneralCounselandSVP,InvestorRelationsandTreasurer

• Targetedoutreachandinboundinquiries

• FeedbackprovidedtoseniormanagementandtheBoard

DepthofEngagement

In2019,weconductedsignificantproactiveengagementwithourstockholders.Asummaryofourengagementprogramisincludedbelow.

• Seniorexecutivesmetthroughouttheyearwith70%ofourtop100stockholders,representingapproximately55%ofourcommonstock,todiscussCompanyperformanceandstrategy,amongothertopics.ParticipantstypicallyincludedacombinationofourChiefExecutiveOfficer,ChiefFinancialOfficerandourSeniorVicePresident,InvestorRelationsandTreasurer

• Wealsorequestedmeetingswithstockholdersrepresentingapproximately39%ofouroutstandingcommonstocktodiscussandsolicitfeedbackonourpracticesrelatingtocorporategovernance,executivecompensation,andsustainabilityandcorporatecitizenshipmatters,amongothertopics

• Seniorexecutives,includingourChiefFinancialOfficer,GeneralCounselandSeniorVicePresident,InvestorRelationsandTreasurer,

meteachstockholderwhorespondedtoouroutreachefforts,whichincludedtenstockholders,representingapproximately25%ofourcommonstock

• OurLeadDirectorandtheChairoftheNominatingandGovernanceCommitteealsoparticipatedinasubsetofmeetingswithfivestockholders,representingapproximately16%ofouroutstandingcommonstock

• WehostedaFinancialAnalystandInvestorConferenceduringwhich20ofourseniorexecutivesgaveacomprehensiveoverviewofourbusinesses.OurChiefExecutiveOfficerlaidoutourstrategyoverthenextthreeyearsandourChiefFinancialOfficerprovidedmedium-termfinancialguidance.Over200investors,analystsandotherstakeholdersattendedtheConferenceinpersonandalmost400investorslistenedtothelivewebcast

Table of Contents

IQVIA2020PROXYSTATEMENT IQVIA’sCorporateGovernance|35 Whatwelearnedfromourmeetingswithstockholders:

• StockholdersgreatlyappreciatedtheopportunitytomeetwithourseniorexecutivesandmembersofourBoardandexpressedtheirsatisfactionwithourfinancialresults,management’sachievementofitsstatedobjectivesandoursuccessinthemarketwithnewofferings

• Stockholdersexpressedaninterestinamorereadableandfocusedproxystatementthatprovidesgreaterclarityandtransparencyonourgovernanceprograms,andexecutivecompensationprogram

• Stockholderswereinterestedinhowwemanagehumancapital,howwesolicitfeedbackfromemployeesandhowwerespondtothatfeedback

• Stockholderscommentedapprovinglyonouroverallcompensationprogramandleadershipteamandwereinterestedinbetterunderstandingourshort-termincentiveprogramandtherelationshipamongtargetobjectives,achievementandexecutivecompensationdeterminations

• StockholdersexpressedaninterestintheCompanyadoptingaproxyaccessbylaw

• Stockholdersrequestedenhanceddisclosureonsustainabilityandcorporatecitizenshipmatters

Ourresponsestostockholderinput:

• CommittedtocontinuingandenhancingourstockholderengagementprogrambymeetingwithstockholdersonaregularbasistodiscusstheCompany’sstrategy,progressagainststrategic,financialandoperationalobjectivesandcorporategovernancematters

• EnhancedourProxyStatementbyenhancingthestyleofpresentationofthefilingthroughout,addingamorecomprehensivestockholderletterfromourChiefExecutiveOfficer,addingnewsummarysectionsandsectionsonstockholderengagementandsustainabilityandcorporatecitizenship,anddeepeningourdisclosureoncorporategovernancemattersandourexecutivecompensationprogram,amongotherareas

• DescribedinthisProxyStatementouremployeeengagementsurveythatweconductedinlate2018andourfocusedeffortsin2019toimplementactionplanstoaddressemployeefeedback

• EnhancedourCompensationDiscussionandAnalysisbymakingthedisclosureeasiertofollowandenhancingdisclosureaboutourcompensationphilosophywithregardtoourshort-termincentiveplan,includingthesettingofobjectivesanddeterminationofshort-termannualincentiveawardsforournamedexecutiveofficers

• Adoptedaproxyaccessbylawtoallowqualifyingstockholders/stockholdergroupstoincludedirectornomineeinformationinourproxystatements

• EnhancedourSustainabilityandCorporateCitizenshipDisclosurebypublishinganupdatedversionofourSustainabilityandCorporateCitizenshipReportfor2019andincludingadditionalsustainabilityandcorporatecitizenshipinformationandhighlightsinthisProxyStatement

Table of Contents

36| IQVIA2020PROXYSTATEMENT

DirectorCompensationNON-EMPLOYEEDIRECTORCOMPENSATIONPROGRAM

Non-employeedirectorcompensationisassessedeachyearbytheLDCCommittee,basedoninputfromStevenHall&Partners,anindependentcompensationconsultingfirm(our“externalcompensationconsultant”),andtakingintoaccountcompensationpaidtonon-employeedirectorsatcompaniesinthesamepeergroupusedforexecutivecompensationpurposes,asdescribedbelowintheCompensationDiscussionandAnalysisunder“OverviewofourExecutiveCompensationProgram—Benchmarking”beginningonpage44.TheBoardreviewsrecommendationsmadebytheLDCCommitteeasaresultofitsannualassessmentofnon-employeedirectorcompensationandmakesafinaldeterminationonthecompensationofournon-employeedirectors.Forcompensationpaidin2019,thisassessmenttookplaceinJuly2018.Basedonitsassessment,theLDCCommitteedidnotrecommendtotheBoardanychangestonon-employeedirectorcompensationfor2019.

Underournon-employeedirectorcompensationprogram,eachmemberoftheBoardwhoisnotanemployeeandwhoisnotaffiliatedwiththeSHAParties(asdefinedandidentifiedunder“CertainRelationshipsandRelatedPartyTransactions—ShareholdersAgreement”below)iseligibletoreceivecompensationconsistingofanannualretainerof$100,000paidincashinquarterlyinstallmentsandanannualgrantoffullyvestedrestrictedstockunitswithagrantdatefairvalueofapproximately$200,000.Inaddition,undertheprogram,eligibledirectorsreceiveadditionalpayments,paidincashonaquarterlybasis,forserviceonthecommitteesoftheBoard.Wealsoreimburseourdirectorsforreasonabletravelexpensesandotherout-of-pocketcostsincurredinconnectionwithattendanceatBoardmeetings.

Thenon-employeedirectorcompensationprogramfordirectorswhoarenotaffiliatedwiththeSHAPartiesisasfollows: Payment AnnualCompensation($)Cashretainer 100,000Equityretainerfairvalue(payableinfullyvestedrestrictedstockunits) 200,000CommitteeChairFees: Audit 30,000LeadershipDevelopmentandCompensation 25,000NominatingandGovernance 20,000LeadDirectorFee 42,500CommitteeMember(otherthanChairs)Fees: Audit 10,000LeadershipDevelopmentandCompensation 5,000NominatingandGovernance 5,000

Committeemembershipfeesarenotpaidtothechairpersonofacommittee.TheBoardhastheauthoritytosetthetermsofournon-employeedirectorcompensationprogramandmaychangethosetermsatanytime.

Table of Contents

IQVIA2020PROXYSTATEMENT DirectorCompensation|37 Non-employeedirectorcompensationfor2019.Thefollowingtableshowsinformationregardingthecompensationearnedbyournon-employeedirectorsduring2019.ThecompensationreceivedbyourChiefExecutiveOfficerduring2019isincludedinthe“SummaryCompensationTable”below.OurChiefExecutiveOfficerdidnotreceiveanyadditionalcompensationforhisserviceontheBoard.Onlyournon-employeedirectorsnotaffiliatedwiththecurrentSHAPartiesreceivecompensationfortheirserviceontheBoard.

2019DIRECTORCOMPENSATION

Name FeesEarnedorPaidinCash($) StockAwards($)(1) Total($)

CarolJ.Burt(2) 75,000 199,885 274,885JohnP.Connaughton — — —JonathanJ.Coslet — — —JohnG.Danhakl(3) 82,500 199,885 282,385MichaelJ.Evanisko(4) 110,000 199,885 309,885JamesA.Fasano — — —ColleenA.Goggins(5) 115,000 199,885 314,885JackM.Greenberg(6) 31,250 — 31,250JohnM.Leonard,M.D. 157,500 199,885 357,385RonaldA.Rittenmeyer 135,000 199,885 334,885ToddB.Sisitsky — — —

(1) Inaccordancewithournon-employeedirectorcompensationprogram,restrictedstockunitsweregrantedtoeachofMses.BurtandGoggins,Messrs.Danhakl,EvaniskoandRittenmeyerandDr.LeonardonMay16,2019(1,478restrictedstockunitseach).Theserestrictedstockunitswerefullyvestedwhengranted.AmountsreflecttheaggregategrantdatefairvalueoftherestrictedstockunitsatMay16,2019($135.24pershare)computedinaccordancewithAccountingStandardsCodificationTopic718,orASC718,excludingtheimpactofestimatedforfeitures.Assumptionsusedinthecalculationoftheseamountsin2019areincludedinNotes1and17toourconsolidatedauditedfinancialstatementsfortheyearendedDecember31,2019includedinPartIIofourannualreportonForm10-K.

(2) Ms.BurtwaselectedasadirectoroftheBoardonFebruary21,2019,andhercashretainerandfeeswereearnedbasedonherservicecommencingonFebruary21,2019.

(3) Mr.DanhaklbeganearninghiscashretainerandfeesbasedonhisservicecommencingApril9,2019,followinghisreelectiontotheBoard.Mr.DanhaklwasnotdesignatedfornominationtotheBoardbyoneoftheSHAPartiesinconnectionwithhisreelection.

(4) TheaggregatenumberofsharesthatweresubjecttooutstandingstockoptionsasofDecember31,2019is92,600forMr.Evanisko.

(5) Ms.Gogginsdeferred100%ofherannualcashBoardretainersandcommitteefeesunderourDirectorDeferralPlan,describedbelow,whichamountswereconvertedintodeferredsharesthatarepayableinsharesofCompanycommonstockfollowingaterminationofthedirector’sBoardserviceorthedirector’sdeath,oruponachangeincontroloftheCompany.AsofDecember31,2019,Ms.Gogginshas815deferredsharesoutstandingundertheDirectorDeferralPlan.

(6) Mr.GreenbergretiredfromtheBoardonApril9,2019followingour2019annualmeetingofstockholders.

Directorshareownershipguidelines.UndertheCompany’sshareownershipguidelinesestablishedbytheLDCCommittee,eachmemberoftheBoardwhoisnotanemployeeandisnotaffiliatedwiththeSHAPartiesisexpectedtoholdsharesofourcommonstockthathaveavalueequaltofive(5)timeshisorherannualcashretainerforserviceasadirector.Whilethereisnosetperiodinwhichthisownershiplevelmustbemet,eachnon-employeedirectornotaffiliatedwiththeSHAPartiesisrequiredtoretainownershipofatleast50%ofthesharesreceivedbyhimorherasaresultoftheexercise,vestingorsettlementofequityawards,untiltheshareownershipguidelineismet.TheLDCCommitteeisresponsibleforsettingandperiodicallyreviewingtheseguidelines.TheLDCCommitteeoverseescompliancewiththeseguidelines,andreviewsdirectorholdingsannually.OtherthanMs.Burt,whojoinedtheBoardinFebruary2019,eachnon-employeedirectornotaffiliatedwiththeSHAPartieshasalreadysatisfiedhisorhershareownershiprequirement.

Table of Contents

38|DirectorCompensation IQVIA2020PROXYSTATEMENT Non-EmployeeDirectorDeferralPlan.PursuanttotheIQVIAHoldingsInc.Non-EmployeeDirectorDeferralPlan(the“DirectorDeferralPlan”),non-employeedirectorsmayelecttodeferreceiptoftheircashretainers.Ifadirectorelectstodeferhisorherretainer,heorshewillinsteadbecreditedwiththatvalueindeferredsharesundertheDirectorDeferralPlan.DeferredsharesbecomepayableinCompanycommonstockfollowingaterminationofthedirector’sBoardserviceorthedirector’sdeath,oruponachangeincontroloftheCompany.

Table of Contents


ProposalNo.2:Non-BindingVoteonExecutiveCompensation

AsrequiredpursuanttoSection14AoftheExchangeAct,theBoardispleasedtoprovidestockholderswiththeopportunitytocastanadvisory,non-bindingvoteoncompensationofournamedexecutiveofficers(“say-on-pay”),asdisclosedinthisProxyStatementpursuanttoItem402ofRegulationS-K,includingtheCompensationDiscussionandAnalysis,compensationtablesandrelatednarrativedisclosure.

Ourcompensationstrategyfocusesonprovidingatotalcompensationpackagethatisdesignedtoattractandretainhigh-caliberexecutivesbyincentivizingthemtoachieveCompanyandindividualperformancegoalsandcloselyaligningthesegoalswithstockholderinterests.Ourphilosophyreflectsouremphasisonpayforperformanceandonlong-termvaluecreationforourstockholders.TheLDCCommitteebelievesthattheCompany’sexecutivecompensationprogramandthecompensationdecisionsfor2019describedinthisProxyStatement,includingtheCompensationDiscussionandAnalysis,appropriatelyrewardournamedexecutiveofficersfortheirandourperformanceandthattheseprogramsandpolicieswillassisttheCompanyinretainingourseniorleadershipteam.

Inconsideringtheirvote,weurgestockholderstoreviewthefulldetailsofourexecutivecompensationprogramanddecisionspresentedintheCompensationDiscussionandAnalysisandthediscussionsregardingtheLDCCommitteeincludedelsewhereinthisProxyStatement.

Becauseyourvoteisadvisory,itwillnotbebindingontheBoardandwillnotoverruleanydecisionbytheBoardorrequiretheBoardtotakeanyaction.However,theBoardandtheLDCCommitteevaluetheviewsofstockholdersandwillconsidertheoutcomeofthesay-on-payvotewhenmakingfutureexecutivecompensationdecisionsforournamedexecutiveofficers.Wewillholdanon-binding,advisoryvoteofstockholdersonthecompensationofournamedexecutiveofficerseverythreeyearsuntilthenextrequiredstockholdervoteonthefrequencyofsuchadvisoryvote.Thenextstockholdervoteonthefrequencyofsuchadvisoryvoteisexpectedtobeheldatour2023annualmeeting.

ThetextoftheresolutioninrespectofProposalNo.2,asrequiredbyproxyrules,isasfollows:

“RESOLVED,thatthecompensationpaidtotheCompany’snamedexecutiveofficers,asdisclosedintheCompany’sProxyStatementforthe2020annualmeetingofstockholderspursuanttoItem402ofRegulationS-K,includingtheCompensationDiscussionandAnalysis,compensationtablesandnarrativediscussion,isherebyAPPROVED.”

THEBOARDRECOMMENDSAVOTE“FOR”THEAPPROVALOFOUREXECUTIVECOMPENSATIONASDESCRIBEDINTHISPROXYSTATEMENT

Table of Contents

40| IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysisThefollowingCompensationDiscussionandAnalysis(“CD&A”)isorganizedaroundfivekeyfactorswebelieveareimportantforourstockholdersandanevaluationandunderstandingofourexecutivecompensationprogram.

Summaryoffactorsforstockholderconsideration

1. Strongperformance

2019BusinessResults

$11.1BnRevenue

$2.4BnAdjustedEBITDA

$6.39AdjustedDilutedEPS

h6.5%h7.9%

h15.1%

BusinessHighlights

• Contractedbusinesswithover250newR&DScustomersin2019,with13ofthetop20pharmaceuticalcompaniesusingCORE-poweredsmarttrials

• 50OCEcustomerwinsin2019,versus30in2018,thefirstfullyearsinceproductlaunch

CapitalDeployment

• $945Minsharerepurchasesin2019,resultingin$6.0BnsinceMerger

• $1.2Bninvestmentsinsoftwaredevelopment,capabilitybuildingM&A,technologyinfrastructure,E360enhancements,amongothers

2. Soundpaypractices

Alignmentofnamedexecutivepaywithperformance

Settingofchallengingindividualperformanceobjectives

Appropriatebalanceofshort-andlong-termincentives

Alignmentofexecutivecompensationwithstockholderreturnsthroughperformance-basedlong-termincentiveawards

Nocontractswithguaranteedsalaryincreaseornon-performancebonusarrangements

3. Disciplinedassessmenttodeterminepay

BalancedIndividualPerformanceEvaluationGrantsofannualawardsbasedinpartonfourkeyperformanceareas:

• BusinessResults

• StrategicInitiatives

• OperationalExcellence

• PeopleManagement&LeadershipShort-TermIncentiveAwardsIfactualRevenueorAdjustedEBITDAachievement,againstpre-establishedtargets,islessthanthethresholdamount,ourAnnualPlandoesnotallowshort-termincentiveawardstobepaidtoournamedexecutiveofficers.Long-TermIncentiveAwardsPerformanceshareslinkultimatepayouttopre-establishedRelativeTSRandAdjustedDilutedEPSgoals.Thisdiscussionandanalysisofourexecutivecompensationprogramshouldbereadinconjunctionwiththeaccompanyingtablesbelowandtextdisclosingthecompensationawardedto,earnedbyorpaidtoournamedexecutiveofficers.

4. Payisalignedwithperformance

• 86.8%ofourChiefExecutiveOfficer’stotal2019compensationwasperformance-linked.


ShareholderFeedbackInresponseto88%say-on-paysupportin2017andthepositivestockholderfeedbackwereceivedinconnectionwithourstockholderengagementdescribedabove,theLDCCommitteemaintainedthekeyfeaturesofourexecutivecompensationprogramsfor2019.

5. Rigorousaccountability,risk-mitigationandrecoveryprovisions • Significantstockownershiprequirements • Conductanannualcompensationriskreviewandassessmenttoensureour

executivecompensationprogrampromotesourlong-termbusinesssuccesswithoutencouragingexcessiverisktaking

• Strongforfeitureandclawbackprovisionscoverbothcash-andequity-based

awards

Trigger Vested UnvestedRestatement

BreachofRestrictiveCovenants

Compensationofournamedexecutiveofficersisdeterminedunderourexecutivecompensationprogram.ThisprogramisoverseenbytheLDCCommittee.TheLDCCommittee,togetherwiththeBoardwithrespecttocertainmatters,determinesthecompensationandbenefitsofourexecutiveofficersandadministersourequity-basedandothercompensationplans.Asageneralmatter,weregularlycommunicatewithourlargeandmid-sizeinvestorstodiscusscorporategovernance,executivecompensationandsustainabilitymattersandseektheirfeedbackonourpractices.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|41 1.STRONGPERFORMANCE

In2019,wecontinuedtomakesignificantprogresscombiningtheQuintilesandIMSHealthbusinessesduringthefinalyearofourthree-yearMergerintegrationperiod.Highlightsofourperformancein2019include:

2019KeyFinancialMetrics

Year-over-YearGrowth

Revenue

$11.1Bn 6.5%AdjustedEBITDA1

$2.4Bn 7.9%AdjustedDilutedEPS1

$6.39 15.1%

TotalStockholderReturn

33%

1 Seereconciliationofnon-GAAPitemsintheAppendix.

2019AccomplishmentSummary.2019wasayearofmajormilestonesandaccomplishmentsforourorganization,includingthefollowing:

• NamedtoFORTUNE’slistofWorld’sMostAdmiredCompanies

• RecognizedasoneofAmerica’sBestEmployersforWomenbyForbes

• EarnedtophonorsastheBestContractResearchOrganizationFull-serviceProviderbyScripAwards

• Closedtheyearwith$19billionofResearch&DevelopmentSolutionsbacklog,andnexttwelvemonthrevenuefrombacklogincreasedapproximately$400millionto$5.2billion,showingpromisingsignsofcontinuedrevenueacceleration

• GainedsignificanttractionwithourcommercialOrchestratedCustomerEngagementSaaS-basedplatform,whichisbuiltonbest-in-classtechnologiessuchasSalesforce,Mulesoft,Herokuandothers,with50newlifesciencesclientsdecidingtostandardizeonoursuperiortechnology,includingfourtop-15pharmaceuticalcompanies

• ContinuedourpartnershipwithSalesforcetodevelopasuiteofclinicaltrialtechnology,investingconsiderableresourcesandexpertiseintoourinnovativetechnologyplatformstoaddresscriticalclientneedsintheclinicalareaandintheregulatory,compliance,safetyandqualityspace

• Continuedinvestmentsinrichclinicaldataassetswhichnowstandsat800millionnon-identifiedpatientsglobally

• Deployedtotalinvestmentof$1.2billioninnetcash,includingnewproductandtechnologydevelopmentaswellasstrategicacquisitions

• Returnedapproximately$945milliontostockholdersintheformofsharerepurchases

Webelievethattheeffortsofournamedexecutiveofficerswerecriticaltoachievingtheseresultsandsignificantmilestones.Weconsideredanumberoffactorsinassessingeachnamedexecutiveofficer’sindividualperformance,includingcontributiontothesebusinessresultsandstrategicobjectivesandtheachievementofpre-establishedcorporateandindividualobjectives,amongotherthings,indeterminingeachnamedexecutiveofficer’sannualincentiveunderourannualshort-termincentiveplanawardfor2019.

Table of Contents

42|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT AmountsexpressedinconstantcurrencytermsinthisProxyStatementexcludetheeffectofchangesinforeigncurrencyexchangeratesonthetranslationofforeigncurrencyresultsintoU.S.dollars.Foradditionalinformationregardingforeigncurrencytranslation,see“Management’sDiscussionandAnalysisofFinancialConditionandResultsofOperations”includedinour2019AnnualReport.ThedefinitionsofAdjustedEBITDAandAdjustedDilutedEPSfiguresarethesame,andreconciledbacktothenearestcomparableGAAPfinancialmeasureintheexactsamemanner,asintheCompany’searningsreleases.Foradditionalinformationregarding“AdjustedEBITDA,”and“AdjustedDilutedEPS,”includingareconciliationofthesenon-GAAPfinancialmeasurestonetincome,see“AppendixA—FinancialReconciliations”.

TotalStockholderReturn.AsdiscussedearlierinthisProxyStatement,wesuccessfullydeliveredonourthree-yearMergerintegrationcommitments,deliveringacceleratedtoplinegrowth,withtotalrevenuegrowthacceleratingbyover200basispointsentering2019andachievingrun-ratecostsavingsofover$200millionexiting2019.Wedeliveredfinancialperformanceatoraboveexpectationseveryoneofthe13quarterssincetheMerger,andin2019wesetnewthree-yeartargetsforthe2020-2022three-yearperiod.Thefollowinggraphshowsacomparisonofthetotalcumulativestockholderreturnforourcommonstock,theStandard&Poor’s500StockIndex(“S&P500”)andaselectpeergroupforthethree-yearperiodfromtheendof2016through2019.December31,2019markstheendofourthree-yearmergerintegrationperiod.Thebelowgraphassumesthat$100wasinvestedinIQVIAHoldingsInc.,theS&P500andthestockperformancepeergroupdescribedbelowasofthecloseofmarketonDecember31,2016andassumesthereinvestmentsofdividends,ifany.

TotalStockholderReturnOverthePastThreeYears(December31,2016toDecember31,2019)

(1) PeergroupconsistsofCernerCorporation,CharlesRiverLaboratories,Inc.,EquifaxInc.,ICONplc,IHSMarkitLtd.,LaboratoryCorporationofAmericaHoldings,NielsenN.V.,PRAHealthSciences,Inc.,SyneosHealth,Inc.,ThomsonReutersCorporationandVeriskAnalytics,Inc.

Totalstockholderreturnwas29%in2017,19%in2018and33%in2019,resultinginacumulativethree-yearreturnof103%,morethandoubletheS&P500andpeergroupperformance,whichdeliveredcumulativethree-yearreturnsof44%and45%,respectively.Ourthree-yearperformanceyieldedsignificantstockholdervaluecreation,asourstockpriceincreasedfrom$76.05pershareonDecember31,2016,representingamarketcapitalizationofapproximately$18billion,to$154.51pershareonDecember31,2019,representingamarketcapitalizationofapproximately$30billion.

Thecompaniesinthestockperformancepeergrouparepubliclytradedinformationservices,informationtechnologyorcontractresearchcompanies,andthussharesimilarbusinessmodelcharacteristicstoIQVIA,orprovideservicestosimilarcustomersasIQVIA.

TheS&P500andthestockperformancepeergroupwereincludedforcomparativepurposesonly.Theydonotnecessarilyreflectmanagement’sopinionthattheS&P500andthispeergrouparean

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|43 appropriatemeasureoftherelativeperformanceofthestockinvolved,andtheyarenotintendedtoforecastorbeindicativeofpossiblefutureperformanceofourcommonstock.

Thisperformancegraphshallnotbedeemed“filed”forpurposesofSection18oftheExchangeActorincorporatedbyreferenceintoanyfilingofIQVIAHoldingsInc.undertheExchangeActorundertheSecuritiesAct,exceptasshallbeexpresslysetforthbyspecificreferenceinsuchfiling.

2.SOUNDPAYPRACTICES

COMPENSATIONPHILOSOPHY

OurcompensationphilosophyfortheCompanycontinuestobeprimarilyfocusedoncreatinganalignmentbetweenexecutivecompensationandbusinessperformancebyrewardingourexecutiveofficersfortheachievementofstrategicgoalsthatareintendedtocontributetolong-termstockholdervalue.Weemphasizeperformance-based,variablecompensationoverfixedcompensation.

PrincipalObjectives.Ourexecutiveteamiscriticaltooursuccessandtobuildingvalueforourstockholders.Ourexecutivecompensationprogramisdesignedto:

• Attractandretainexperiencedandwell-qualifiedexecutivestoserveinleadershippositionsandtoleadourorganizationoverthelongterm

• Motivateourexecutivestosucceedbyprovidingcompensationthatisdirectlylinkedtobothourshort-andlong-termperformance

• Aligntheinterestsofourexecutiveofficerswiththoseofourstockholdersbydeliveringasubstantialportionoftheexecutiveofficer’scompensationthroughtime-andperformance-basedequityawardsandthroughtheuseofshareownershipguidelines

• Ensurethatourexecutivecompensationprogramisdesignedandadministeredinamannerthatappropriatelymanagesrisktosafeguardtheinterestofourstockholders,aswellasouremployees

Wehavedesignedourexecutivecompensationprogramwithspecificfeaturestohelpachievethesegoalsandtopromoterelatedobjectivesthatareimportanttoourlong-termsuccess.

Compensationandgovernancepractices. Belowwehighlightcertainofourkeypracticesthatweconsidergoodgovernancefeaturesofourexecutivecompensationprogram.

WHATWEDO

Alignexecutivepaywithperformance

Setchallengingperformanceobjectivesforournamedexecutiveofficers

Appropriatelybalanceshort-andlong-termincentives

Alignexecutivecompensationwithstockholderreturnsthroughperformance-basedlong-termincentiveawards

Usemulti-yearvestingrequirementsforlong-termincentiveawards

Implementmeaningfulshareownershipguidelines

AnnualnamedexecutiveofficerperformanceevaluationbytheLDCCommittee

Robustclawbackpolicyinplaceforourcashandequityincentivecompensationforfinancialrestatements

Includenon-solicitationandnon-competitionprovisionsinawardsagreements

Conductanannualcompensationriskreviewandassessment

Utilizeexpertiseofanindependentcompensationconsultant

Table of Contents

44|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT

WHATWEDON’TDO

Performancemetrics.Ourexecutivecompensationprogramtiesasubstantialportionofeachnamedexecutiveofficer’scompensationtotheachievementofperformanceobjectivesoverboththeshort-andlong-term,asdescribedinfurtherdetailbelow.For2019,86.8%ofourChiefExecutiveOfficer’stotalcompensationwasperformance-linkedand,onaverage,74.5%ofourothernamedexecutivesofficers’compensationwasperformance-linked.Webelievethisapproachtocompensationdemonstratesour“payforperformance”philosophyaswellasourfocusoncreatinglonger-termvalueforourstockholders.

OVERVIEWOFOUREXECUTIVECOMPENSATIONPROGRAM

RolesoftheLDCCommittee,theBoardandmanagementincompensationdecisions.OurexecutivecompensationprogramisdevelopedandoverseenbytheLDCCommittee.TheLDCCommitteeconsultswithandtakesintoaccounttheviewsandrecommendationsofmanagement,includingthoseofourChiefExecutiveOfficerandourChiefHumanResourcesOfficer,inmakingdecisionsregardingourexecutivecompensationprogram.OurChiefExecutiveOfficermakesrecommendationsaboutannualbasesalaryincreases,annualcashincentivetargetsandpaymentsandlong-termincentivegrantsforournamedexecutiveofficers(otherthanforhimself).TheLDCCommitteeisresponsibleforapproving(orrecommendingforapprovaltotheBoard,inthecaseofthecompensationofourChiefExecutiveOfficer)thelong-termincentiveawardsandthecompensationofournamedexecutiveofficers.

Useofcompensationconsultants.TheLDCCommitteeusesanexternalcompensationconsultanttoprovideitwithobjectiveanalysis,adviceandinformation,includingcompetitivemarketdataandcompensationrecommendationsrelatedtothecompensationofournamedexecutiveofficers.Whiletheexternalcompensationconsultantmaymakerecommendationsontheformandamountofcompensationdelivered,theLDCCommittee(ortheBoardasdescribedabove)makesalldecisionsregardingthecompensationofournamedexecutiveofficers.

TheLDCCommitteeissolelyresponsibleforapprovingpaymentstotheexternalcompensationconsultantandforsettingthetermsandscopeoftheexternalcompensationconsultant’sengagementandtheterminationofthisengagement.TheexternalcompensationconsultantreportsdirectlytotheLDCCommittee.Theexternalcompensationconsultantprovidesonlyexecutiveandnon-employeedirectorcompensationconsultingservicestousanddoesnotprovideotherservicessuchasbenefitsadministrationoractuarialservices.

AfterconsiderationoftheindependenceassessmentfactorsprovidedunderthelistingrulesoftheNYSE,theLDCCommitteedeterminedthattheexternalcompensationconsultantwasindependentandthattheworkitperformedduring2019didnotraiseanyconflictsofinterest.

Benchmarking.TheLDCCommitteeworkswithourexternalcompensationconsultanttobetterunderstandandcontinuallymonitormarketcompetitivepaypractices,whichitthenconsiderswhendeterminingcompensationadjustmentsandchangesforthecomingyear.Thisannualprocessincludesreviewingouridentifiedpeergroupandconductingacompetitivemarketbenchmarkanalysisofseniorofficerroles.

Nocontractswithmulti-yearguaranteedsalaryincreasesornon-performancebonusarrangements

Noexcisetaxgross-ups

Nosingletriggerequityvesting

NorepricingofunderwaterstockoptionsorSARswithoutstockholderapproval

Nopaymentofunearneddividendspriortovesting

NohedgingorpledgingofCompanyshares

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|45 ReviewofPeerCompanies.TheLDCCommitteetargetstotalcompensationopportunitiesforournamedexecutiveofficers,otherthanourChiefExecutiveOfficer,atornearthemedianofourpeergroupand/ormarketsurveygroup.WhenreviewingthecompensationopportunitiesforourChiefExecutiveOfficer,theLDCCommitteeconsidersthecompensationofchiefexecutiveofficersatpubliccompaniesoutsideofthepeergroupdescribedbelow,includingsignificantlylargercompanies,whichtheLDCCommitteebelievesarerealisticcompetitorsforhisservices.TheLDCCommitteeconsiderscomparisonstocompensationlevelsatothercompaniestobehelpfulinassessingtheoverallcompetitivenessofourcompensationpracticesbutplacesagreateremphasisonoverallcompensationopportunitiesratherthanonsettingeachelementofcompensationatornearthemedianforthatelement.

Thecompositionofourpeergroupreflectsamixofbothindustryandnon-industrypeers.Thesecompaniesareoneswithwhomwecompeteforexecutivetalent,orwhicharebroadlysimilartousbasedoncertaincharacteristics,suchas:financialsizeandperformanceasmeasuredbyrevenue,capitalization,returns,growthand/orprofitability;industryfocus;scopeofoperations;employeebaseandmarketpresenceoutsidetheUnitedStates;andorganizationalcomplexity.Thepeercompanies,whenselected,hadannualrevenuesrangingfrom0.5timesto2.5timesourrevenues.TheLDCCommitteeworkedwiththeexternalcompensationconsultantin2019toreviewourpeergroupforitscontinuedappropriateness.Basedondiscussionswith,andrecommendationsfrom,ourexternalcompensationconsultant,theLDCCommitteedecided,afterafullevaluation,toupdatethepeergroupasfollowsin2019:

Added Removed

BauschHealthCompaniesInc.

AgilentTechnologies,Inc.

BostonScientificCorporation

CernerCorp.

RegeneronPharmaceuticals,Inc.

PerrigoCo.Plc.

ScienceApplicationsInternationalCorp.

Thecomparatorcompaniesthatwereremovedweredonesobecausetheirrevenuesfallbelowthetargetedrangeofourrevenue.Theupdatedpeergroupisasfollows:

Allerganplc BauschHealthCompaniesInc.

BostonScientificCorporation

CognizantTechnologySolutionsCorp. Fiserv,Inc.

LaboratoryCorpofAmericaHoldings

NielsenHoldingsPLC QuestDiagnostics,Inc.

RegeneronPharmaceuticals,Inc.

salesforce.com,inc. S&PGlobal,Inc.

ThomsonReutersCorp.

ReviewofMarketSurveyData.TheLDCCommitteealsoconsideredmarketsurveydatawhendeterminingtheelementsandamountoftotaldirectcompensationforournamedexecutiveofficers,otherthanourChiefExecutiveOfficer,whosebasesalaryandannualincentivetargetwereestablishedpursuanttohisemploymentagreement.

Themarketsurveydatareviewedconsistedofsurveysofexecutivecompensationdatafrompublicandprivatecompaniesacrossallsectorswithsimilarqualificationsasweusetodeterminepeercompanies.TheexternalcompensationconsultantpreparedanalysesofthissurveydataatthedirectionoftheLDCCommitteeforitsreviewandconsideration.Forpositionswherepeergroupandmarketsurveydatawereavailable,thepeergroupandmarketsurveydatawereaveragedtoprovideamarketcompositeperspectiveofcompensationlevelsofsuchpositions.Wealsoreviewedpeergroupdatatoassesscompetitiveexecutiveincentivecompensationprograms,practicesandlong-termincentiveawardlevels.

Non-BindingCompanyGrantGuidelines.For2019,long-termincentiveawardsweredeterminedinpartbasedonnon-bindingCompanygrantguidelinesdevelopedusingpeergroupandmarketsurvey

Table of Contents

46|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT dataofthetypedescribedabove.Theseguidelines,whicharereviewedonanannualbasis,coveremployeesateachofourseniorexecutivelevels,includingournamedexecutiveofficers,otherthanourChiefExecutiveOfficer,andsetforthproposedlong-termtargetawardvaluesforeachjoblevel,whichwereestablishedtakingintoaccountpeergroupandmarketsurveydataontargetequityawardvaluesforemployeeswithsimilarsalariesandpositions.

ELEMENTSOFCOMPENSATION

Asdescribedinmoredetailbelow,theprimaryelementsofour2019executivecompensationprograminclude:

Together,theseitemsareintendedtobecomplementaryandservethegoalsdescribedabove.TheLDCCommittee,however,doesnothaveanyformalpoliciesorguidelinesforallocatingcompensationbetweenshort-andlong-termcompensation,betweencashandnon-cashcompensationoramongdifferentformsofcashandnon-cashcompensation.Thefollowingisadiscussionoftheprimaryelementsofcompensationforeachofournamedexecutiveofficers.

BaseSalary.Thepurposeofbasesalaryisto:

• providefinancialpredictabilityandstabilitythroughfixedcompensationthatislessthanamajorityoftotaldirectcompensationattargetforthenamedexecutiveofficers

• providefixedcompensationthatwillattractnewexecutivesandretainourexistingexecutiveswithmarketcompetitivesalaries

• providefixedcompensationthatreflectsthescope,scaleandcomplexityoftheexecutiverole

AnnualbasesalariesofournamedexecutiveofficersmaybeadjustedbytheLDCCommitteebasedupontherecommendationsofourChiefExecutiveOfficer(exceptwithrespecttohisownsalary)aswellasmarketbenchmarkingdataandanalysisprovidedbytheexternalcompensationconsultant.Therecommendationsmadewithrespecttoanamedexecutiveofficeraregenerallybasedupontheexecutive’sindividualannualperformancereviewfortheprioryear’sperformance,leadershipandcontributiontoCompanyperformance,aswellasmarketconditions,peergroupand/ormarketsurveydataandouroverallbudgetaryguidelines.

TheLDCCommitteetakesallofthesefactorsintoaccountwhenmakingitsdecisionsbutdoesnotassignaspecificorpre-determinedweighttoanyonefactor.Inadditiontotheannualsalaryreview,theLDCCommitteemayalsoadjustbasesalariesduringtheyearinconnectionwithpromotions,increasesinresponsibilitiesortomaintaincompetitivenessinthemarket.

Short-TermIncentiveAwards.General.Wedonotfollowaformulaicapproachindeterminingtheshort-termincentiveawardspaidtoournamedexecutiveofficersunderourannualincentiveplan(the“AnnualPlan”).OverthelastseveralyearssincetheMerger,wehavebeenengagedinastrategictransformationofourbusinesstoaleadingglobalproviderofadvancedanalytics,technologysolutions,andcontractresearchservicestothelifesciencesindustry.Toachieveourshort-andlong-termfinancial,operationalandstrategicobjectivesandtocontinueourgrowthtrajectory,webelieveitisnecessarytoevaluateavarietyofqualitativeandquantitativefactorstoassessachievement.WebelievepayoutsunderourAnnualPlanarecloselyalignedwithCompanyperformanceandthattheLDCCommitteeshouldhaveflexibilityinmakingcompensationdecisionsforournamedexecutiveofficersbasedontheirindividualcontributionstotheCompany’sperformance.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|47 FinancialPerformanceTargets.TheLDCCommitteereviewsandestablishesperformancetargetstomotivateournamedexecutiveofficerstodeliverahighdegreeoffinancialandoperationalperformancewithoutencouragingexcessiverisk-taking.Earlyeachyear,theLDCCommitteeestablishesthresholdperformancegoalsundertheAnnualPlan.Aftertheendofthefiscalyear,theLDCCommitteedetermineswhetherCompanyperformancemeritspayoutsofshort-termincentiveawardsundertheAnnualPlanbasedonitsreviewoftheCompany’sachievementagainstpre-determinedRevenueandAdjustedEBITDAgoalsfortheCompanyasawhole.IfactualRevenueorAdjustedEBITDAachievementislessthanthethresholdamount,theAnnualPlandoesnotallowshort-termincentiveawardstobepaidtoournamedexecutiveofficers.Therelativecontributionofeachfinancialperformancemetricisasfollows: FinancialPerformanceMetric DescriptionandReasonSelected

“Revenue”

• “Revenue”isdefinedastheCompany’srevenuefromitsConsolidatedStatementsofIncome

• TheLDCCommitteebelievesthatRevenueisakeydriverofstockholdervalueandearningsgrowthovertime,andbasesaportionofitsdeterminationonmakingshort-termincentiveawardstoournamedexecutiveofficersontheachievementofRevenuegoals

“AdjustedEBITDA”

• “AdjustedEBITDA”isdefinedastheCompany’snetincomeorlossfromourConsolidatedStatementsofIncomebeforeinterestincomeandexpense,incometaxes,depreciationandamortization,andasfurtheradjustedtoeliminaterestructuringandrelatedcharges,incomefromnon-controllinginterests,stock-basedcompensation,acquisitionrelatedcharges,deferredrevenuepurchaseaccountingadjustments,lossonextinguishmentofdebt,integrationrelatedcostsandotherexpense.Thisdefinitionisthesame,andreconciledbacktothenearestcomparableGAAPfinancialmeasureintheexactsamemanner,asAdjustedEBITDAincludedintheCompany’searningsreleases

• TheLDCCommitteebelievesthatAdjustedEBITDAisanimportantmeasureoffinancialperformanceandtheabilitytoservicedebtandreflectsournear-andlonger-termgoalofincreasingprofitability,andbasesaportionofitsdeterminationonmakingshort-termincentiveawardstoournamedexecutiveofficersontheachievementofAdjustedEBITDAgoals

IndividualPerformanceEvaluation.Atthebeginningofeachfiscalyear,eachnamedexecutiveofficermeetswithourChiefExecutiveOfficer(or,inthecaseofourChiefExecutiveOfficer,withtheLDCCommittee)todiscusshisindividualperformancegoalsfortheyear.Eachnamedexecutiveofficer’sindividualperformancegoalsaredevelopedinconsultationwithourChiefExecutiveOfficerforreviewwiththeLDCCommitteeandconsistofaseriesofkeypre-establishedstrategic,financial,operationaland/orleadershipobjectives,amongothers,thatrelatetothedutiesofthenamedexecutiveofficerinsupportofthebusinessobjectivesforthefiscalyear.

IfamountsareallocatedtotheAnnualPlan,foreachnamedexecutiveofficer,theLDCCommitteeandourChiefExecutiveOfficer(exceptwithrespecttohisownindividualperformancegoals)evaluatethenamedexecutiveofficer’sactualindividualperformance,includingachievementagainstasubstantialnumberofpre-establishedquantitativefactorsaswellassustainabilityandcorporatecitizenshipfactors,includingthosesetforthinthetablebelow,indetermininganamedexecutiveofficer’sannualshort-termincentiveawardundertheAnnualPlan.Dependingonthenamedexecutiveofficer’sindividualperformancelevel,hisannualshort-termincentivepayoutrangewillbefrom0%to200%ofhistargetannualshort-termincentivebasedonassessmentofperformanceversusindividualobjectives.

Table of Contents

48|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT

FactorsConsideredforIndividualShort-TermIncentiveCompensationAwardsforourNamedExecutiveOfficers MeasuredAchievementsAgainstGoals OtherFactors• Netnewbusiness

• Customersatisfactionscores

• Customerwins/losses

• QualityScores

• Marketgains/losses

• Freecashflowperformance

• Contributiontoourbusinessresultsandstrategicobjectives

• Contributiontotheindividual’srespectivebusinessunitorfunction

• Contributiontosustainabilityandcorporatecitizenshipgoals

• Performanceoftheindividual’srespectivebusinessunitorfunction

• Marketcompensationlevelsfortherespectiveindividual’srole

Thekeyindividualperformancegoalsforeachofournamedexecutiveofficersin2019,alongwithanassessmentofthelevelofachievementforeachofournamedexecutiveofficers,arediscussedbelowunderthesectionentitled“—2019Short-TermIncentiveAwards—GoalAchievement”.Weconsiderthespecificmetricsusedtodetermineeachofournamedexecutiveofficer’sannualincentiveawardstobeconfidential,commercially-sensitiveinformation,andthattheirdisclosurewouldresultincompetitiveharmtotheCompany.

Long-TermIncentiveAwards.Webelievethatsubstantiallong-termreturnsforourstockholdersareachievedthroughaculturethatfocusesonlong-termperformancebyournamedexecutiveofficersandotherseniormanagement.ByprovidingourseniormanagementwithameaningfulequitystakeintheCompany,wearebetterabletoaligntheirinterestswithandcreatevalueforourstockholders.

In2019,ourannualgrantoflong-termincentiveawardstoournamedexecutiveofficersunderour2017IncentiveandStockAwardPlan(the“2017Plan”)consistedofacombinationofstockappreciationrights(“SARs”),whichonlyhavevalueifourstockpriceincreasesfromthedateofgrantandvestbasedoncontinuedservice,andperformanceshares,whichareearnedbasedonCompanyachievementofRelativeTSRandAdjustedDilutedEPSperformancegoals,asdescribedinthetablebelow.

TheLDCCommitteebelievesthatSARsreinforceourgoalofretainingkeyexecutiveswhileincentivizingthecreationofvalueforourstockholders.TheSARsgrantedtoournamedexecutiveofficersin2019willvestastoone-thirdoftheunderlyingsharesoneachofthefirstthreeanniversariesofthegrantdate,generallysubjecttothenamedexecutiveofficer’scontinuedservicewiththeCompanythroughtheapplicablevestingdates.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|49 Webelievethatperformancesharesencourageournamedexecutiveofficerstoachievekeystrategicobjectivesandmaximizevaluecreationforourstockholders.Theperformancesharesgrantedtoournamedexecutiveofficersin2019willbeearnedbasedonourfinancialresultsoverthethree-yearperiodfromJanuary1,2019throughDecember31,2021usingaweightedcombinationofthefollowingperformancemetrics: PerformanceMetric DescriptionandReasonSelected

Relative“TotalStockholderReturn”or“TSR”

• “RelativeTSR”or“TSR”isameasureoftheCompany’sstockholdervaluecreationrelativetoapeergroupovertime.Itcombinessharepriceappreciationanddividends,ifany,paidtoshowthetotalreturntotheshareholderexpressedasanannualizedpercentage

• TheLDCCommitteeviewsthismetricascloselycorrelatedwithlong-termreturnstostockholdersandties25%ofthevestingofperformancesharestoachievementofRelativeTSRgoals

“AdjustedDilutedEPS”

• “AdjustedDilutedEPS”means,withrespecttoeachfiscalyearduringtheperformanceperiod,ourearningspershare,asreported,excluding,alladjustmentsmadetoNetincomeorlossfromourConsolidatedStatementsofIncometoarriveatAdjustedEBITDAwiththeexceptionofinterestexpenseanddepreciationandamortizationaswellasincrementaladjustmentsforpurchaseaccountingamortizationandroyaltyhedgegain(loss)andanyextraordinarynonrecurringitems.Thisdefinitionisthesame,andreconciledbacktothenearestcomparableGAAPfinancialmeasureintheexactsamemanner,asAdjustedDilutedEPSincludedintheCompany’searningsreleases

• TheLDCCommitteebelievesitisanimportantmeasureofourgoalofincreasingprofitabilityandties75%ofthevestingofperformancesharestoachievementofAdjustedDilutedEPSgoals

TheAdjustedDilutedEPSgoalisbasedonourthree-yearAdjustedDilutedEPSgrowthandissubjecttoadjustmentbasedupontheoccurrenceofcertaincorporateeventsinaccordancewiththe2017Planandmaybesubjecttosuchotheradjustmentsformaterialornon-recurringeventsoccurringduringtherelevantfiscalyearasdeterminedbytheLDCCommitteeinitssolediscretion.OurRelativeTSRgoalforthe2019performancesharesisbasedonourthree-yeartotalstockholderreturnperformanceascomparedtothetotalstockholderreturnperformanceoftheS&P500Index.

TheLDCCommitteeconsidersanumberoffactorsindeterminingthelong-termincentiveawardgrantstoournamedexecutiveofficers,includingtheCompany’snon-bindinggrantguidelines,includingareviewofmarketsurveydataasdescribedabove,theretentivevalueofremainingunvestedlong-termincentiveawards,individualperformanceevaluations,andtheperformanceobjectivesofeachnamedexecutiveofficer.Thenumberofperformancesharesthatmaybeearnedrangesfrom0%ofthenamedexecutiveofficer’stargetaward,ifthethresholdlevelsofperformancearenotachieved,to200%ofthetargetaward,ifthemaximumlevelsareachievedorexceeded.

Eachearnedandvestedperformancesharewillbesettledbydeliveryofoneshareofourcommonstock.

Underthetermsoftheapplicableawardagreements,ournamedexecutiveofficersmustremainemployedthroughtheendoftheperformanceperiodinordertoreceivepaymentfromanyearnedperformanceshares.

TheLDCCommittee’sdeterminationswithrespecttolong-termincentiveawardgrantstoournamedexecutiveofficersduring2019arediscussedbelowunderthesectionentitled“—2019Long-TermIncentiveAwards”.

Table of Contents

50|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT RETIREMENT,PERQUISITESANDTERMINATIONBENEFITS

RetirementPlans.Webelievethatourretirementplansserveasanimportanttooltoattractandretainournamedexecutiveofficersandotherkeyemployees,andthatwewouldbeatacompetitivedisadvantageifwedidnotofferattractiveretirementplans.Wealsobelievethatofferingabaselineofstableretirementbenefitsencouragesournamedexecutiveofficerstomakealong-termcommitmenttous.Consistentwithourunderstandingofcompetitivemarketpractice,wedonotadjustthelevelofretirementplanbenefitsbasedonthevalueofanamedexecutiveofficer’slong-termincentiveawardsnordoweadjustthelevelofanamedexecutiveofficer’stotaldirectcompensationforagivenyearinlightofthevalueofretirementbenefits.

Thesummariesbelowofeachofourretirementplansshouldbereadinconjunctionwiththetables,andrelatedfootnotes,underthesectionsentitled“CompensationofNamedExecutiveOfficers—PensionBenefits,”“—DefinedBenefitRetirementPlans”and“—Non-qualifiedDeferredCompensation,”whichprovidemoredetailontheretirementbenefitsanddeferredcompensationvalues,ifany,foreachofournamedexecutiveofficers. Plan Description

IMSHealthRetirementPlan

U.S.-basedlegacyIMSHealthemployees,includingourChiefExecutiveOfficerandMr.Knightly,areeligibletoparticipateinthistax-qualifieddefinedbenefitpensionplanwithacashbalanceformula.EffectiveDecember31,2016,thisplanwasclosedtonewparticipants.

IMSHealthRetirementExcessPlan

CertainU.S.-basedlegacyIMSHealthemployees,includingourChiefExecutiveOfficerandMr.Knightly,areeligibletoparticipateinthisunfunded,non-qualifiedretirementplanutilizingthesamebenefitformula,compensationrecognition,retirementeligibilityandvestingprovisionsasthetax-qualifiedIMSHealthRetirementPlan.ItprovidespensionbenefitsnotprovidedbytheIMSHealthRetirementPlanduetoInternalRevenueCodelimits.EffectiveDecember31,2016,thisplanwasclosedtonewparticipants.

IMSHealthDefinedContributionExecutiveRetirementPlan

CertainU.S.-basedlegacyIMSHealthemployeesareeligibletoparticipateintheunfunded,non-qualifieddefinedcontributionplanthatwasfrozentonewparticipantsandaccrualsasofJune30,2012.Mr.Knightlyistheonlynamedexecutiveofficerwhoparticipatesinthisplan.

IQVIA401(k)Plan

U.S.-basedemployees,includingournamedexecutiveofficers,areeligibletoparticipateinthistax-qualified,definedcontributionplan.EmployeesmaycontributeaportionoftheircompensationtothisplanandreceiveamatchingCompanycontribution.UndertheIQVIA401(k)Plan,for2019,ourdiscretionarymatchingcontributionmatchedthefirst3%ofemployeecontributionsat100%andthenext3%ofcontributionsat50%(subjecttoInternalRevenueCodelimitations);however,forthoseemployeeseligibletoparticipateintheIMSHealthRetirementPlan,ourdiscretionarymatchingcontributionmatched50%ofemployeecontributionsupto6%ofcompensation(subjecttoInternalRevenueCodelimitations).

IQVIASavingsEqualizationPlan

CertainU.S.-basedemployees,includingournamedexecutiveofficers,areeligibletoparticipateinthisunfunded,non-qualifieddefinedcontributionplanusingthesamebenefitformulaasintheIQVIA401(k)Plan.ItprovidesaCompanymatchingcontributionnotprovidedbythetax-qualifiedIQVIA401(k)PlanduetoInternalRevenueCodelimits.

IQVIAElectiveDeferredCompensationPlan

CertainU.S.basedemployees,includingournamedexecutiveofficers,areeligibletoparticipateinthiselectivenon-qualifieddeferredcompensationplan.Theplanallowseligibleemployeestodeferupto80%oftheirbasesalariesasofthefirstdayofthecalendaryearorpartialyearandupto100%ofshort-termincentiveawardsearnedundertheAnnualPlanpayabletotheparticipantwithrespecttothatyear.Contributionsconsistsolelyofparticipants’electivedeferralcontributionswithnomatchingorotheremployercontributions.Noneofournamedexecutiveofficersparticipatedinthisplanin2019.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|51 TerminationBenefits.Weprovideseverance,changeofcontrolandretirementprotectionstoourChiefExecutiveOfficerpursuanttohisemploymentagreement.Messrs.McDonnellandStaubhaveseveranceprotectionintheirrespectiveemploymentarrangements.Messrs.Knightly,SherbetandMr.McDonnellexceptforsalarycontinuationbenefits,haveseveranceprotectionthroughourEmployeeProtectionPlan.Theseemploymentagreementsandplansaresummarizedbelowunder“—PotentialPaymentsuponTerminationorChangeinControl”below.Ourseveranceandchangeincontrolprotectionsaredesignedtobefairandcompetitivetoaidinattractingandretainingexperiencedexecutives,includingournamedexecutiveofficers.Webelievetheprotectionweprovide,includingthelevelofseverancepayments,post-terminationbenefitsandourlimitedchangeincontrolbenefits,isappropriateandwithintherangeofcompetitivepractice.

Theprovisionsofouremploymentagreements,plansandothercompensationarrangementsdonotprovideforanyexcisetaxgross-uppaymenttoournamedexecutiveofficers.Anytaxes,includinggoldenparachuteexcisetaxes,resultingfromseveranceoranyotherchangeincontrolrelatedcompensationaretheresponsibilityoftheexecutive.

Perquisites.Forotherelementsofcompensationprovidedtoournamedexecutiveofficers,suchasperquisitesandhealthandwelfarebenefits,theLDCCommitteeprovidescompetitivebenefits.TheLDCCommitteeconsiderstheviewsandexperiencesoftheexternalcompensationconsultantonthesematters.TheLDCCommitteebelievesthatperquisitesshouldnotconstituteasignificantpartofourexecutivecompensationprogrambutdoesprovidecertainperquisitestoournamedexecutiveofficersonanindividualbasisasdeemedappropriateandreasonablebytheLDCCommittee.Theperquisitesprovidedtoournamedexecutiveofficersin2019aresummarizedbelowunder“—Perquisites”andreportedinthe“SummaryCompensationTable”.

Table of Contents

52|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT 3.DISCIPLINEDASSESSMENTTODETERMINEPAY

2019NAMEDEXECUTIVEOFFICERS

ThroughoutthisCompensationDiscussionandAnalysis,wefocusonournamedexecutiveofficers,whicharelistedinthe“SummaryCompensationTable”belowandtheothercompensationtablesincludedinthisProxyStatement.For2019,thefollowingindividualswereournamedexecutiveofficers: Name Age CurrentPosition

AriBousbib

58

Chairman,ChiefExecutiveOfficerandPresident

MichaelR.McDonnell

56

ExecutiveVicePresidentandChiefFinancialOfficer

W.RichardStaub,III

57

President,Research&DevelopmentSolutions

KevinC.Knightly

59

President,Technology&CommercialSolutions

EricM.Sherbet

55

ExecutiveVicePresident,GeneralCounselandSecretary

2019COMPENSATIONDETERMINATIONS

BelowwediscusstheLDCCommittee’skeycompensationdecisionsinsetting2019salary,short-andlong-termincentives,whichweremadebasedontheprocessandevaluationdescribedunder“SoundPayPractices”andwithadvicefromourChiefExecutiveOfficer(exceptwithrespecttohisowncompensation)andourexternalcompensationconsultant(see“—OverviewofourExecutiveCompensationProgram—Useofcompensationconsultants”).Whenmakingcompensationdecisions,theLDCCommitteeconsideredsuchfactorsasrelevantbenchmarkingdata,theexperienceandlengthofserviceofthenamedexecutiveofficer,relativeresponsibilitiesamongmembersofourexecutiveteam,contributionsbythenamedexecutiveofficeragainstaseriesofestablishedstrategic,financial,operationaland/orleadershipobjectivesthatrelatetothedutiesofthenamedexecutiveofficerandbusinessconditions.

2019AMENDMENTTOCHIEFEXECUTIVEOFFICER’SEMPLOYMENTAGREEMENT

InFebruary2019,theLDCCommitteerecommended,andtheBoardapproved,anamendmentandrestatementtoourChiefExecutiveOfficer’semploymentagreement,replacingandsupersedinghisexistingemploymentagreement,whichhadlastbeenamendedandrestatedinJuly2018.Thenew

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|53 employmentagreementincreasedourChiefExecutiveOfficer’sannualbasesalary,whichhadnotbeenincreasedsince2014,to$1.7millionperyearfrom$1.6millionperyear,subjecttoannualreview,providedforanyoutstandinglong-termincentiveawardsgrantedtohimafterJuly2018toremainoutstandingandeligibleforcontinuedvesting,subjecttocertainlimitations,intheeventofhispermanentretirementfromtheCompany,andotherwisepreservedthetermsandconditionsunderhisexistingemploymentagreement.ThesechangestoourChiefExecutiveOfficer’semploymentagreementweremadebytheLDCCommitteebasedonfeedbackfromtheexternalcompensationconsultantonmarketpractices.Thelong-termincentiveawardsgrantedtotheChiefExecutiveOfficerin2019includedvestingtermsconsistentwiththetermsprovidedinhisemploymentagreement,includingtheamendmentsmadein2019.ThematerialtermsofourChiefExecutiveOfficer’semploymentagreementaresetforthinthenarrativedisclosurethatfollowsthe“SummaryCompensationTable”andunderthesectionentitled“—PotentialPaymentsUponTerminationorChangeinControl”below.

2019BASESALARY

TheamountofourChiefExecutiveOfficer’sannualbasesalaryissetforthinhisemploymentagreement,butitremainssubjecttoincreasebasedonthesamefactorsasdescribedabovefortheothernamedexecutiveofficers.

Asdiscussedabove,LDCCommitteeapprovedanamendmentandrestatementoftheChiefExecutiveOfficer’semploymentagreementin2019,whichprovidedfor,amongotherthings,anincreasetohisannualbasesalaryinFebruary2019,thefirstsuchincreasetohisannualbasesalarysince2014.TheLDCCommitteealsoapprovedanincreasetoourothernamedexecutiveofficer’sbasesalariesfor2019basedoninternalpayequityconsiderations,includingnamedexecutiveofficerperformance,leadershipandscopeofresponsibility,andareviewofthecompetitivemarketdata.Thefollowingtablesetsforththeannualbasesalariesforeachnamedexecutiveofficer. NamedExecutiveOfficer 2019BaseSalary1AriBousbib $1,700,000MichaelR.McDonnell $ 670,000W.RichardStaub,III $ 605,000KevinC.Knightly $ 550,000EricM.Sherbet $ 525,000

1 OurChiefExecutiveOfficer’sbasesalaryincrease,whichwasthefirstincreaseinhisbasesalarysince2014,waseffectiveFebruary13,2019upontheexecutionofourChiefExecutiveOfficer’samendedandrestatedemploymentagreement.Theothernamedexecutiveofficer’sbasesalaryincreaseswereeffectiveJuly1,2019followingtheannualmeritreviewcycle.BasesalariesreflecttheannualizedsalariesapprovedbytheLDCCommittee.

2019SHORT-TERMINCENTIVEAWARDS

KeyFactorsinDeterminingLevelofAchievement.Assetforthabove,earlyeachyear,theLDCCommitteeestablishesthresholdperformance-basedgoalsundertheAnnualPlan.Ifthethresholdlevelofperformanceisachieved,payoutsofshort-termincentiveawardswillbeeligibleundertheAnnualPlan.Thepre-establishedRevenueandAdjustedEBITDAthresholdtargetsfor2019were$9.361billionand$2.040billion,respectively.

TheLDCCommitteereviewedtheCompany’sachievementagainstthesepre-establishedRevenueandAdjustedEBITDAgoalsanditwasdeterminedthattheCompanyhadexceededthethresholdlevelofperformance,whichsupportedthepaymentofshort-termincentiveawards.2019Revenuewas$11.088billionandAdjustedEBITDAwas$2.400billionagainstthresholdperformancegoalsof

Table of Contents

54|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT $9.361billionand$2.040billion,respectively.TheLDCCommitteethenevaluatedseveralotherquantitativeandnon-quantitativefactors,alsodescribedabove,todetermineindividualawardsundertheAnnualPlan.

TheLDCCommitteethenconductedadetailedreviewconsistentwiththeprocessandfactorssetforthunder“SoundPayPractices—IndividualPerformanceEvaluation,”includingareviewofeachnamedexecutiveofficer’sachievementagainsthispre-establishedobjectivestodetermineeachnamedexecutiveofficers’annualshort-termincentiveaward.

GoalAchievement.Thefollowingtablelistscertainkeypre-established2019strategic,financial,operationaland/orleadershipgoalsforeachofournamedexecutiveofficersanddetailedachievementagainstthosegoalsusedtodeterminetheirannualincentiveawards.Weconsiderthespecificmetricsusedtodetermineournamedexecutiveofficer’sannualincentiveawardstobeconfidential,commercially-sensitiveinformation,andtheirdisclosurewouldresultincompetitiveharmtotheCompany.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|55 AriBousbibChairmanandChiefExecutiveOfficerGoals Achievements

Achievementofcertainkeyfinancialtargetsfor:

• Revenue

• AdjustedEBITDA

• AdjustedDilutedEPStargets

Strongoverallfinancialperformancefor2019thatsignificantlyexceededthetargetforeachgoalandresultedinmeetingorexceedingguidanceandconsensusresultsforRevenue,AdjustedEBITDAandAdjustedDilutedEPSeachquarterandforthefiscalyear,includingfollowinganincreaseinfull-yearrevenueconstantcurrencyrevenuegrowthguidanceinJuly2019

Executecapitalallocationstrategy,includingachievingcertaintargetsfor:

• Cashrepatriation

• Sharerepurchase

• Acquisitions

• Decreaseaverageinterestexpense

Successfullyexecutedcapitalallocationstrategy,whichincluded:

• Repatriationof$1.1billionincashtotheU.S.,whichsignificantlyexceededthetargetforthisgoal

• Therepurchaseof6.6millionsharesofcommonstock,whichsignificantlyexceededthetargetforthisgoal

• Executionofouracquisitionandinvestmentstrategy,withatotalof$1.2billioninnetcashdeployedin2019,whichexceededthetargetforthisgoal

• Twonoteissuances,toextendmaturitiesandreduceourcostofdebt,andtherepricingofcertaincreditfacilityindebtedness,resultinginareducedafter-taxaveragecostofdebtof3.1%exiting2019,comparedto3.5%exiting2018,whichsignificantlyexceededthetargetforthisgoal

Delivercontinuedvaluetostockholdersthrough:

• Achievementofcertaintotalstockholderreturngoalsand

• EffectiverepresentationoftheCompanywiththeinvestorcommunity

Strongstockpriceperformancein2019,achieving33%totalstockholderreturnfortheCompanyversus28.9%fortheS&P500(assumingthereinvestmentsofdividends,ifany),whichsignificantlyexceededthetargetforthisgoal

HostedFinancialAnalystandInvestorConferenceandclearlycommunicatedtheCompany’sVision2022strategyinitiativeandnewthree-yearsavingstargets

Metwith95uniqueinvestorfundstoprovideupdatesontheCompany’sprogress

Achievedfoursell-sideanalystupgrades/initiations,allto“Buy”ratings;nodowngrades

RecognizedbyInstitutionalInvestoras2019BestCEOinHealthcareTechnologyandDistribution(buy-side)

ExecutestrategytodrivetransformationoftheCompanytoananalytics-andtechnology-drivenservicesfocusedcompany,includingachievingspecifictargetsfor:

• OCEcustomerwins

• Growthinourtechnologybusiness

Executedtechnologyproductstrategyresultingin50customerawardsfortheOCEplatform,versus30in2018,thefirstfullyearsinceproductlaunch,whichsignificantlyexceededthetargetforthisgoal

TechnologyandAnalyticsSolutionsgrowthof10.7%atconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoal

CreatedArtificialIntelligence/MachineLearningGlobalCounciltogovernuseofAI/MLinexternalfacingofferingsandinternaluse;received2019FierceInnovationAwardforuseofNaturalLanguageProcessingPlatforminAI/MLsolutions

LaunchedHumanDataScienceCloudprovidingasingleplatformfortheaggregationandtransformationofdataforeffectiveandefficientapplicationofartificialintelligencecapabilities

Table of Contents

56|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT Goals Achievements

AchievecertaingrowthandnewbusinesstargetsforResearchandDevelopmentSolutions:

• Revenue

• Contractedservicesnetnewbusiness

• Newcustomers

• Newpreferredproviders

ResearchandDevelopmentSolutionsrevenueof$5.8billion,representing6.9%year-overyeargrowthatconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoal

Achievedgrowthofclinicalresearchcontractedservicesnetnewbusinessthatsignificantlyexceededthetargetforthisgoalandresultedinyear-endbacklogof$19billion,whichwasanall-timehigh

Contractedbusinesswithover250newcustomersintheclinicalresearchservicesspace,includingwith13ofthetop20pharmaceuticalcompaniesusingCORE-poweredsmarttrials,whichsignificantlyexceededthetargetforthisgoal

Enteredintoanumberofnewpreferredproviderrelationships,whichsignificantlyexceededthetargetforthisgoal

EnablegrowththroughRealWorldSolutions:

• Continuedataexpansion

• MarketleadershiproleinArtificialIntelligence

• Developinnovativeofferings

Double-digitgrowthofourRealWorldSolutionsbusiness,whichsignificantlyexceededthetargetforthisgoal

RecognizedastheleaderinRealWorldDataandRealWorldEvidenceServicesin2019LifeScienceStrategyGroupreport

Offeringdevelopmentsfocusedonpatientengagementthroughconnectedheathandpatientengagementportal,whichexceedednewbusinesstargets

AchievespecificgrowthtargetsforourContractSales&MedicalSolutionsbusiness

StabilizationofourContractSales&MedicalSolutionsbusiness,whichhadbeendecliningfor9consecutivequarters,resultingingrowthinrevenueof1.6%atconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoal

DirectourMergerandinvestmentstrategyandachieveMerger-relatedsynergygoalof$200millioninannualrun-ratesavingsattheendof2019

Achievedgoalofover$200millioninannualrun-ratesavings,aheadofscheduledtimeline

EstablishVision2022frameworkandexecutegloballaunchofprogramtodrivefurthercost-savings

OversawstrategicplanningandimplementationprocessforourVision2022,three-yearstrategyinitiative,establishingobjectivesatenterpriseandbusinessunitleveltargeting$200millioninannualsavings;programsuccessfullylaunchedinternallyandexternally

Demonstratecommitmenttocorporatecitizenship

SponsoroftheCompany’sSustainabilityandCorporateCitizenshipprogram

GlobalimplementationofIQVIAdayencouragingemployeestodonateover28,000hourstolocalcommunities

Promoteddiversityandinclusionforeveryemployee

RecognizedbyForbesasoneof2019America’sBestEmployersforWomen

RecognizedbyFORTUNEasoneof2019World’sMostAdmiredCompanies

Strengthentheworkforcethroughnewdevelopmentinitiativesandrecruitnewtalenttosupportgrowth

LaunchedCareerSiteportal,harmonizedonboardingprogram,andimplementeduniformrewardsandrecognitionprogram

Talentdevelopmentandleadershipassessmentsthroughoperatingreviewsandleadershipmeetings

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|57 MichaelR.McDonnellExecutiveVicePresidentandChiefFinancialOfficerGoals Achievements


• Revenue

• AdjustedEBITDA

• AdjustedDilutedEPStargets

Strongoverallfinancialperformancefor2019thatsignificantlyexceededthetargetforeachgoalandresultedinmeetingorexceedingguidanceandconsensusresultsforRevenue,AdjustedEBITDAandAdjustedDilutedEPSeachquarterandforthefiscalyear,includingfollowinganincreaseinfull-yearrevenueconstantcurrencyrevenuegrowthguidanceinJuly2019

Oversawthefinancialplanningandreportingprocessinclusiveofthecontrolenvironment

Executecapitalallocationstrategy,includingachievingcertaintargetsfor:

• Cashrepatriation

• Sharerepurchase

• Acquisitions

• Decreaseaverageinterestexpense

Successfullyexecutedcapitalallocationstrategy,whichincluded:

• Repatriationof$1.1billionincashtotheU.S.,whichsignificantlyexceededthetargetforthisgoal

• Therepurchaseof6.6millionsharesofcommonstock,whichsignificantlyexceededthetargetforthisgoal

• Executionofouracquisitionandinvestmentstrategy,withatotalof$1.2billioninnetcashdeployedin2019,whichexceededthetargetforthisgoal

• Twonoteissuances,toextendmaturitiesandreduceourcostofdebt,andtherepricingofcertaincreditfacilityindebtedness,resultinginareducedafter-taxaveragecostofdebtof3.1%exiting2019,comparedto3.5%exiting2018,whichsignificantlyexceededthetargetforthisgoal

Delivercontinuedvaluetostockholdersthrough

• achievementofcertaintotalstockholderreturngoalsand

• effectiverepresentationoftheCompanywiththeinvestorcommunity

Strongstockpriceperformancein2019,achieving33%totalstockholderreturnfortheCompanyversus28.9%fortheS&P500(assumingthereinvestmentsofdividends,ifany),whichsignificantlyexceededthetargetforthisgoal

HostedFinancialAnalystandInvestorConferenceandclearlycommunicatedtheCompany’sVision2022strategyinitiativeandnewthree-yearsavingstargets

Achievedfoursell-sideanalystupgrades/initiations,allto“Buy”ratings;nodowngrades

Leadourenhancedstockholderengagementprogram

ManageourMergerandinvestmentstrategyandachieveMerger-relatedsynergygoalof$200millioninannualrun-ratesavingsattheendof2019

Achievedgoalofover$200millioninannualrun-ratesavings,aheadofscheduledtimeline

Developandretainkeytalent

Launchedafinanceteamspecificmentoringprogram

Retained100%ofidentifiedkeytalent,whichsignificantlyexceededthetargetforthisgoal

Table of Contents

58|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT W.RichardStaub,IIIPresident,Research&DevelopmentSolutionsGoals Achievements


• Revenue

• Profitability

DemonstratedstrongleadershipofResearch&DevelopmentSolutionsglobalbusinessunitresultinginsolidfinancialperformance,includingRevenueof$5.8billion,representing6.9%year-overyeargrowthatconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoalandalsoresultedinprofitabilitythatexceededthetargetforthatgoal

Createdifferentiationintheclinicalresearchservicesspaceandachievecertaintargetsfor:

• Contractedservicesnetnewbusinesstargets

• newandexistingcustomerrelationships

• newpreferredprovidertargets

Continuedtobuildonmergerthesisbycreatingdifferentiationofclinicalresearchserviceswithtechnology-enabledofferings

Achievedgrowthofclinicalresearchcontractedservicesnetnewbusinessthatsignificantlyexceededthetargetforthisgoalandresultedinyear-endbacklogof$19billion,whichwasanall-timehigh

Contractedbusinesswithover250newcustomersintheclinicalresearchservicesspace,includingwith13ofthetop20pharmaceuticalcompaniesusingCORE-poweredsmarttrials,whichsignificantlyexceededthetargetforthisgoal

Enteredintoanumberofnewpreferredproviderrelationships,whichsignificantlyexceededthetargetforthisgoal

Developnewofferingsandpursuebusinessdevelopmentareasforexpansion

Oversawofferingdevelopmentsfocusedonpatientengagementviaconnectedheathandpatientengagementportal,whichexceedednewbusinesstargetsfortheseofferings

ContinueddevelopmentofOrchestratedClinicalTrialplatformwithmobileCRA,centralizedmonitoringanddocumentrepository

Demonstrateimprovementinqualityanddeliverymetricsbyachievingseveralspecifictargets

Achievedsignificantimprovementinoperationaldeliveryandqualitymetrics,whichexceededtargetsforthisgoalinmanycases


Launchedcareerpathsandmentoringprogramsforkeyareas

Improvedoverallattritionrateswithhigherthantargetretentionofidentifiedkeytalent

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|59 KevinC.KnightlyPresident,TechnologyandCommercialSolutionsGoals Achievements


• Revenue

• Profitability

DemonstratedstrongleadershipofTechnology&CommercialSolutionsglobalbusinessunitresultinginsolidfinancialperformance,includingrevenuegrowthandprofitabilitythatexceededthetargetforeachgoal

Executecommercialtechnologygrowthstrategy,includingspecifictargetsfor:

• OCECustomerwins

• Growthinourtechnologybusiness

• Developmentofnewproducts

Executedtechnologyproductstrategyresultingin50customerawardsfortheOCEplatform,versus30in2018,thefirstfullyearsinceproductlaunch,whichsignificantlyexceededthetargetforthisgoal

TechnologyandAnalyticsSolutionsgrowthof10.7%atconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoal

LaunchofHumanDataScienceCloudprovidingasingleplatformfortheaggregationandtransformationofdataforeffectiveandefficientapplicationofartificialintelligencecapabilities

Managedthecontinueddevelopmentofnewtechnologyofferingssuchasaregulatoryandinformationsystem,commercialanalyticsandpatientengagementportal

LeadthestabilizationoftheContractSales&MedicalSolutionsbusiness

DemonstratedexcellentleadershipinthestabilizationofourContractSales&MedicalSolutionsbusiness,whichhadbeendecliningfor9consecutivequarters,resultingingrowthinrevenueof1.6%atconstantforeigncurrencyexchangerates,whichsignificantlyexceededthetargetforthisgoal

Pursuebusinessdevelopmentactionsforexpansion

SuccessfullyexecutedtheTechnology&CommercialSolutionsacquisitionstrategy,resultingintheexpansionofourtechnologyofferingsandcapabilities


Launchedcareerpathsandmentoringprogramsforkeyareas

Improvedoverallattritionrateswithhigherthantargetretentionofidentifiedkeytalent

EricM.SherbetExecutiveVicePresident,GeneralCounselandSecretaryGoals Achievements

Achievementofcertainbudgetgoals

Exceededfinancialtargetsforlegalfunction

LegalguidanceandsupportforMergers&Acquisitions,securitiesofferingsandlitigationmatters

Providedstronglegalguidanceandsupportinexecutingouracquisitionandinvestmentstrategy,withatotalof$1.2billioninnetcashdeployedin2019,allowingustoenhanceourcapabilitiesandofferings

Oversawtwonoteissuances,toextendmaturitiesandreduceourcostofdebt,andtherepricingofcertaincreditfacilityindebtedness,resultinginareducedafter-taxaveragecostofdebtof3.1%exiting2019,comparedto3.5%exiting2018

Effectiveoversightofourethicsandcomplianceprogram

Demonstratedexcellentleadershipofourethicsandcomplianceprogram,enterpriseriskmanagementprogram,andourSustainabilityandCorporateCitizenshipprogram

SupportappropriateBoardofDirectorgovernance

ContinuedserviceasatrustedadvisortotheBoardandChiefExecutiveOfficer,withparticularfocusoncorporategovernancematters

Leadourenhancedstockholderengagementprogram

Oversawsuccessfulonboardingofnewboardmember


Establishedlegalspecificcommunicationforums

Retained100%ofidentifiedkeytalent,whichsignificantlyexceededthetargetforthisgoal

Table of Contents

60|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT TargetIncentive.Eachofournamedexecutiveofficerswaseligibleforanannualshort-termincentiveawardin2019rangingfrom0%to200%ofhistargetincentive.Thetargetshort-termincentiveamounts(expressedasapercentageofbasesalary)forournamedexecutiveofficersdidnotchangefrom2018.Thetargetshort-termincentiveamountforeachofournamedexecutiveofficersfor2019undertheAnnualPlanwasasfollows:

NamedExecutiveOfficer

TargetAnnualIncentiveasaPercentageofAnnualBaseSalary

AriBousbib 200%MichaelR.McDonnell 85%W.RichardStaub,III 85%KevinC.Knightly 85%EricM.Sherbet 75%

ChiefExecutiveOfficerShort-TermIncentiveAwardDetermination.WithrespecttothedeterminationofourChiefExecutiveOfficer’sannualshort-termincentiveaward,theLDCCommitteeconsideredhisexceptionalperformanceindefiningourstrategyandleadingthetransformationofourbusinessthroughthenowlargely-completeMergerintegrationprocessandpositioningusforfuturegrowth,hiscriticalroleintheCompany’s2019performanceandthesignificantprogressinexecutingourtechnologystrategy,whenawardinghimtheshort-termincentiveawardspecifiedinthetablebelow.

Morespecifically,andasfurtherdetailedintheachievementsummaryofourChiefExecutiveOfficer’sgoalsabove,theBoardandtheLDCCommitteebelievethatourChiefExecutiveOfficerisexceptionalandwascriticaltothehighlysuccessfulintegrationofQuintilesandIMSHealthandtransformationofourCompanysincetheMerger.ThesuccessoftheMergerisevidencedbytheCompany’sachievementand,inmanycases,earlyachievementofitsMergerobjectives,includingachievingourtargetrevenueaccelerationofover200basispointsentering2019andachievingover$200millionofrun-ratecostsavingsexiting2019,andtheoutstandingfinancialandtotalstockholderperformanceoftheCompanysincetheMerger.TheLDCCommitteebelievesthissuccessisespeciallynoteworthygivenitwasnotassuredatthetimeoftheMerger,asQuintilesandIMSHealthwerenotviewedasnaturalmergerpartnersandtherewassignificantskepticismoftheMergerinsomecornersoftheanalystandinvestmentcommunity.OurChiefExecutiveOfficerhasalsobeenessentialinourevolutiontobecometheleadingglobalproviderofadvancedanalytics,technologysolutions,andcontractresearchservicestothelifesciencesindustry.TheBoardandtheLDCCommitteebelievesthatthisevolution,whichisstillinprocess,isfundamentaltothelong-termsuccessofourCompany.

TheBoardandtheLDCCommitteebelievestronglythatourChiefExecutiveOfficerishighlytalentedandthatmanylargercompanieswouldhaveakeeninterestinrecruitinghimtoserveaschiefexecutiveofficer,especiallyinlightofthesuccessoftheMergerandoursubsequentstrategictransformation.Accordingly,theBoardandtheLDCCommitteebelievethat,whilecompensationofourChiefExecutiveOfficerandothernamedexecutiveofficersisstronglyalignedwithperformance(2019compensationofourChiefExecutiveOfficerwas86.8%performance-linked),retentionofourChiefExecutiveOfficerisimperativetooursuccessasacompanyandinformsthedecisionsoftheBoardandourLDCCommitteeregardingbothhisannualshort-termincentiveandlong-termincentiveawards.Ourdirectorswhometwithstockholdersaspartofour2019stockholderengagementprogramcommunicatedthismessagewhenreviewingourexecutivecompensationprogramduringthesemeetings.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|61 NamedExecutiveOfficerShort-TermIncentiveAwardDeterminations.TheLDCCommitteeandourChiefExecutiveOfficer(exceptwithrespecttohisownindividualperformance)evaluatedtheperformanceofeachofournamedexecutiveofficersasdescribedaboveanddeterminedtheirrelativelevelsofachievementatthelevelsspecifiedbelow.

NamedExecutiveOfficer Short-Term

IncentiveAward PercentageofTarget

AriBousbib $6,600,000 195.5%MichaelR.McDonnell $ 645,000 115.0%W.RichardStaub,III $ 720,000 142.1%KevinC.Knightly $ 600,000 130.1%EricM.Sherbet $ 550,000 142.4%

2019LONG-TERMINCENTIVEAWARDS

Consistentwiththeprocesssetforthunder“SoundPayPractices,”weprovideournamedexecutiveofficerswithlong-termincentiveawardstopromoteretention,toincentivizesustainablegrowthandlong-termvaluecreation,andtofurtheraligntheinterestsofourexecutiveswiththoseofourstockholdersduringthevestingperiods.Thegrantdatevalueoflong-termincentiveawardsgrantedtoeachnamedexecutiveofficerforagivenyearisbasedonanassessmentoftheindividual’sposition,roleandresponsibilitieswithintheCompany,theoverallcompetitivenessofhistotaldirectcompensationopportunity,internalequityconsiderationsandthecurrentretentivevalueofthelong-termincentiveawardsthatremainedunvestedforeachnamedexecutiveofficer.TheLDCCommitteealsoconsiderscompensationpeergroupandothermarketdataforageneralunderstandingofcompetitiveequitycompensationpracticesandconsiderstheimpactofthegrantsonlong-termincentiveplanusageandsharedilution.Additionalinformationontheequityawardsgrantedtoournamedexecutiveofficersin2019issetforthinthetables,andrelatedfootnotes,under“CompensationofourNamedExecutiveOfficers—2019GrantsofPlan-BasedAwards”.

Whenmakinglong-termincentiveawardsforfiscal2019,theLDCCommitteefirstdeterminedthetotalgrantdatevalueoftheawardstobegrantedtoeachnamedexecutiveofficerandthendeliveredthatvalueintwocomponents:performancesharesrepresenting50%andSARsrepresentingtheremaining50%ofthetotalgrantdatevalueoftheaward,assumingtargetlevelachievementofapplicableperformancegoalsforperformanceshares,assetforthinthetablebelow.Thetermsofeachtypeoflong-termincentiveawardaresetforthaboveunder“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Long-TermIncentiveAwards”,whichtermsaregenerallyapplicabletolong-termincentiveawardsgrantedinfiscal2019andinpreviousfiscalyears. NamedExecutiveOfficer PerformanceShares SARsAriBousbib $6,599,377 $6,026,709MichaelR.McDonnell $ 824,866 $ 753,325W.RichardStaub,III $ 659,961 $ 602,661KevinC.Knightly $ 659,961 $ 602,661EricM.Sherbet $ 659,961 $ 602,661

Table of Contents

62|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT Fiscal2019short-termvs.long-termincentivecompensation

PerformanceShareDeterminations.PerformanceshareawardsgrantedtoournamedexecutiveofficersonFebruary2,2017eachprovidedforthegrantofsharesofourcommonstockattheendoftheirperformanceperiodbasedonIQVIA’sachievementofAdjustedDilutedEPSgrowthandRelativeTSRgoals,asdescribedabove.Thethree-yearperformanceperiodforthe2017-2019performancesharesendedonDecember31,2019.Thenumberofperformancesharesthatmaybeearnedrangesfrom0%ofthenamedexecutiveofficer’stargetaward,ifthethresholdlevelsofperformancearenotachieved,to200%ofthetargetaward,ifthemaximumlevelsareachievedorexceeded.Forresultsbetweentheselevels,thenumberofshareswouldbedeterminedbyinterpolation.Theperformancegoalsandresultsusedtodeterminethefinalpayoutfactorforthe2017-2019performanceperiodwereasfollows:

PerformanceMetric Weight Threshold Target Maximum Actual PerformancePayoutFactor

3-YearAdjustedDilutedEPSGrowth 75% 6.2% 10.0% 13.5% 17.8% 200% 150%3-YearTSRvs.S&P500(percentile) 25% 25 50 75 88 200% 50% FinalPayout 200%

Additionalinformationonthevestedvalueoftheperformanceshareawardsearnedbyournamedexecutiveofficersissetforthinthetableandrelatedfootnotesbelowunder“CompensationofNamedExecutiveOfficers—2019OptionExercisesandStockVested”.

PERQUISITES

WeprovidecertainperquisitestoourChiefExecutiveOfficereachyearpursuanttohisemploymentagreement,allofwhichareconsideredcompensationandsubjecttotaxes.OurChiefExecutiveOfficerreceivesreimbursementofreasonableexpensesrelatedtohomesecurity,financialandestateplanning,taxpreparationservices,andexecutivephysicalexamsinanannualamountnottoexceed$50,000intheaggregate;useofaCompany-leasedautomobileandreimbursementofallrelatedoperatingexpenses;andpersonaluseofcorporateaircraft,subjecttothebusinessneedsoftheCompany.Wedonotprovideanytaxgross-upstoourChiefExecutiveOfficerinconnectionwithanyofthesebenefits.

Inaddition,ourChiefFinancialOfficerisentitledtoreceivereimbursementforthecostofphysicalexamsandrelatedtaxes.

Webelievethecostofprovidingsuchperquisitesin2019wasreasonableandrepresentsarelativelysmallpercentageoftheexecutives’overallcompensationpackages.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|63 4.PAYISALIGNEDWITHPERFORMANCE

ConsiderationofMostRecentsay-on-payvote

Stockholdersshowedstrongsupportofourexecutivecompensationprograminourlast“say-on-pay”voteatour2017annualmeetingofstockholderswithapproximately88%ofvotescastinfavoroftheproposalandelectedtoholda“say-on-pay”voteeverythreeyears.Thenextsuchvotewilloccuratthe2020AnnualMeeting.

TheLDCCommitteeconsideredtheoutcomeofthemostrecentsay-on-payvotewhenmakingdecisionsrelatingtothe2019compensationofournamedexecutiveofficersandourexecutivecompensationprogram.Stockholdersshowedstrongsupportforourexecutivecompensationprogram,withapproximately88%ofthevotescastforapprovalofthe“say-on-pay”proposalatour2017annualmeetingofstockholders.TheLDCCommitteebelievesthattheresultsofourlastsay-on-payvotereflectedourstockholder’ssatisfactionwiththealignmentofournamedexecutiveofficers’compensationwiththeCompany’sperformanceanddeterminednottoimplementanysignificantchangestoourexecutivecompensationprogramin2019asaresultofthisvote.

Proposal2(page39)givesourstockholderstheopportunitytocastanadvisoryvoteonourexecutivecompensationprogramasdescribedinthisProxyStatement.Althoughthisvoteisnon-binding,theLDCCommitteewillreviewtheresultsofthevoteasitdidin2017andtakethoseresultsintoaccountwhenmakingfuturedeterminationsconcerningtheexecutivecompensationprogramandpolicies.

ExecutivePayMixfor2019.Asillustratedinthechartsbelow,thevastmajorityofthetargetedmixofcompensationforourChiefExecutiveOfficerandothernamedexecutiveofficersfor2019consistedofvariablepayelements.Thisbreakdowndirectlytiesexecutivepaytoourperformance,includingfinancialresults,strategicinitiativesandstockperformance.Inaddition,theLDCCommitteebelievesthatasignificantpercentageofourChiefExecutiveOfficer’stargetcompensationpackageshouldconsistofcompensationthatalignswithourcompensationphilosophyofappropriatelybalancingriskandmotivatingourexecutiveofficerstoachieveCompanyperformanceobjectivesintheshorttermandtogrowthebusinesstocreatevalueforourstockholdersoverthelongterm.


AverageofotherNamedExecutiveOfficers

Table of Contents

64|CompensationDiscussionandAnalysis IQVIA2020PROXYSTATEMENT KeyFeaturestoAlignExecutivePaywithStockholderInterests.Asillustratedbelow,wetieourexecutivecompensationprogramtoourlong-termbusinessstrategybykeepingourexecutivesfocusedon,andrewardingthemfor,theirachievementofshort-andlong-termgoalsthatareintegraltoourstrategy.

AnnualPlan

• Asignificantportionofournamedexecutiveofficer’sindividualperformancegoals,uponwhichAnnualPlanpayoutsaredetermined,aretiedtooneormoreofourstrategicgoals

• WelinkasubstantialportionofcompensationtocorporateperformancethroughouruseofachievementofspecifiedRevenueandAdjustedEBITDAgoalstodeterminewhetherornotannualcashincentiveawardswillbepaid

Alignsnamedexecutiveofficerswithstockholders’interestsby:

• Rewardingindividualperformanceforachievementofstrategicgoals,whichareincreasedeachyearanddesignedtopositiontheCompanyasanindustryleader

• IncentivizingbehaviorconsistentwithstrongannualRevenueandAdjustedEBITDAgrowth

Long-TermIncentiveAwards

• Weconsiderindividualperformance(whichistiedtoourstrategicgoals)insettingthevalueofournamedexecutiveofficer’slong-termequitygrants

• Welinkasubstantialportionofcompensationtolong-termcorporateperformancethroughtheuseoflong-termincentives,includingperformancesharesthatuseRelativeTSRandAdjustedDilutedEPSasfinancialmetrics

Furtheralignsnamedexecutiveofficer’sinterestswithstockholders’interestsby:

• Takingindividualperformance(whichistiedtoourstrategicgoals)intoaccountinmakinggrants

• Linkingasubstantialportionoflong-termcompensationtolong-termcorporateandstockperformance

5.RIGOROUSACCOUNTABILITY,RISK-MITIGATIONANDRECOVERYPROVISIONS

Shareownershipguidelines.UnderourshareownershipguidelinesestablishedbytheLDCCommittee,ournamedexecutiveofficersareexpectedtoownsharesofourstockwithavalueequaltoatleastthefollowingmultiplesoftheirannualbasesalaries:

NamedExecutiveOfficer

ShareOwnershipGuideline1

OwnershipLevelasofFebruary12,20201

AriBousbib 6x 110xMichaelR.McDonnell 3x 5xW.RichardStaub,III 3x 5xKevinC.Knightly 3x 8xEricM.Sherbet2 3x —

1 Representstheapplicablemultipleofthenamedexecutiveofficer’sannualbasesalary.2 Mr.SherbetjoinedIQVIAinMarch2018.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationDiscussionandAnalysis|65 Ourshareownershipguidelinesaredesignedtoincreaseeachnamedexecutiveofficer’sownershipstakeinusandaligntheirinterestswiththeinterestsofourstockholders.

Forpurposesofthepolicy,sharesaretreatedasownediftheyareowneddirectly,heldthroughthenamedexecutiveofficer’saccountunderourretirementplans,oriftheyareunderlyingunvestedtime-basedrestrictedstockunitawardsorunvestedtime-basedrestrictedstockawards.Sharesarenotcountedasownedforpurposesofourshareownershipguidelinesiftheyareunderlyinganyunvestedperformancesharesorotherperformance-basedawardsorunderlyinganystockoptionawardorstockappreciationrightsaward,whetherornotvested.Whilethereisnosetperiodinwhichtheseownershiplevelsmustbemet,individualscoveredbytheguidelines,includingournamedexecutiveofficers,arerequiredtoretainatleast50%oftheshares,netofapplicabletaxwithholdingandpaymentofexerciseprice(ifapplicable),receiveduponthevestingoflong-termincentiveawards,ortheexerciseofstockoptionsorstockappreciationrights,untiltheseshareownershipguidelinesaremet.

Clawbackpolicy.Wemaintainaformalrecoupment,or“clawback,”policyfortherecoveryofincentive-basedcompensationpaidtocurrentandformerexecutiveofficers,amongothers,onthebasisoffinancialresultsthataresubsequentlyrestatedasaresultofmisconduct,materialnoncompliancewithfinancialreportingrequirementsunderGAAPandSECrulesandintheeventofabreachofrestrictivecovenants.TheBoardadministersthispolicywithrespecttoexecutiveofficersandhasthesolediscretiontoinvokethepolicyanddirecttheCompanytorecoverincentive-basedcompensationreceivedbysuchpersonsonthebasisoftherestatementormisconductevent.

RISKASSESSMENT

Indesigningexecutivecompensation,theLDCCommitteeseekstocreateincentivestopromoteourlong-termbusinesssuccesswithoutencouragingunduerisktaking.TheLDCCommitteehasreviewedourcompensationprogramsandhasconcludedthattherisksarisingfromthemarenotreasonablylikelytohaveamaterialadverseeffectonus.Wedonotbelievethatourcompensationprogramsgenerally,includingtheexecutivecompensationprogram,encourageexcessiveorinappropriaterisk-taking.Whileappropriaterisk-takingisanecessarycomponentofgrowingabusiness,theLDCCommitteeandmanagementhavefocusedonaligningourcompensationpolicieswithourlong-terminterestsandavoidingshort-termrewardsformanagementandemployeedecisionsthatcouldposeunduelong-termrisks.

TAXDEDUCTIBILITY

Section162(m)oftheInternalRevenueCodelimitsthedeductibilityofcompensationpaidtocertainindividuals,includingcertaincurrentandformerexecutiveofficers,to$1millionperyear.Priortoachangeinthetaxlawinlate2017,certainperformance-basedcompensationawardedorpaidbytheCompany,suchasstockappreciationrightsand,insomecases,performancesharesandannualincentiveplanawards,hadbeeneligibletonotbelimitedastodeductibilityundersuchSection162(m)(ifcertainrequirementshadbeenmet).Afterthechangeintaxlaw,asageneralmatter,allsuchcompensationandothercompensationpaidtoindividualscoveredbySection162(m)willbesubjecttothelimitationondeductibility,subjecttolimitedgrandfatheringexceptionsforcertaincompensationpaidpursuanttowrittenbindingcontractsineffectonNovember2,2017andnotmateriallymodifiedaftersuchdate.TheLDCCommitteebelievesthatitsprimaryresponsibilityistoprovideanexecutivecompensationprogramthatmeetstheobjectivesdescribedabove,andthatstockholderinterestsarebestservedifitretainsflexibilityanddiscretiontoapprovecompensationarrangementseveniftheymaynotqualifyforfullorpartialtaxdeductibilityandtoamendexistingarrangementsevenifsuchamendmentcouldresultinalossorlimitationofdeductibility.Therefore,theLDCCommitteehasapprovedcompensationarrangementsforexecutiveofficersthatdidnotqualifyforfulltaxdeductibilityduetoSection162(m)andwillcontinuetodosointhefuture.

Table of Contents


CompensationCommitteeReportTheLDCCommitteehasreviewedanddiscussedwithmanagementtheforegoingCompensationDiscussionandAnalysis.Basedonsuchreviewanddiscussions,theLDCCommitteerecommendedtotheBoardthattheCompensationDiscussionandAnalysisbeincludedinthisProxyStatementandincorporatedbyreferenceintoour2019AnnualReportforfilingwiththeSEC.

TheLeadershipDevelopmentandCompensationCommitteeRonaldA.Rittenmeyer,ChairJohnP.ConnaughtonJohnG.DanhaklToddB.Sisitsky

Table of Contents


CompensationofNamedExecutiveOfficers2019SUMMARYCOMPENSATIONTABLE

Thefollowingtablepresentssummaryinformationregardingthecompensationawardedto,earnedby,orpaidtoeachofournamedexecutiveofficersforservicesrenderedtousinallcapacitiesforthefiscalyearsendedDecember31,2019,2018,and2017,ifthenamedexecutiveofficerwasanexecutiveofficerinthatfiscalyear.

Year Salary(1)

($) Bonus

($)

StockAwards(2)

($)

OptionAwards(3)

($)

Non-EquityIncentivePlan

Compensation(4)($)

ChangeinPensionValue

andNon-QualifiedDeferred

CompensationEarnings(5)

($)

AllOtherCompensation(6)

($) Total($)

AriBousbib ChairmanandChiefExecutiveOfficer

2019

1,684,470

—

6,599,377

6,026,709

6,600,000

583,877

645,343

22,139,776

2018 1,600,000 — 3,911,254 3,637,456 6,300,000 476,553 536,516 16,461,7792017

1,600,000

—

26,391,942

2,984,594

6,000,000

529,625

523,356

38,029,517

MichaelR.McDonnell ExecutiveVicePresident,ChiefFinancialOfficer

2019

660,000

—

824,866

753,325

645,000

—

64,852

2,948,043

2018 650,000 — 651,772 606,223 600,000 — 58,560 2,566,5552017

650,000

—

2,039,988

497,426

600,000

—

475,276

4,262,690

W.RichardStaub,III President,Research&DevelopmentSolutions

2019

596,050

—

659,961

602,661

720,000

—

62,487

2,641,159

2018 578,550 — 521,475 484,991 615,000 — 43,041 2,243,0572017

555,000

—

378,058

348,205

550,000

—

35,821

1,867,084

KevinC.Knightly President,Technology&CommercialSolutions

2019

542,500

—

659,961

602,661

600,000

173,261

35,366

2,613,749

2018 517,500 — 521,475 484,991 575,000 57,865 33,351 2,190,1822017

487,500

—

378,058

348,205

600,000

144,918

30,532

1,989,213

EricM.Sherbet ExecutiveVicePresident,GeneralCounselandSecretary

2019

515,000

—

659,961

602,661

550,000

—

41,537

2,369,159

2018

415,833

—

294,676

275,003

350,000

—

63,939

1,399,451

(1) SalaryinformationforMr.Sherbetin2018reflectsamountspaidsincehisemploymentcommencedwithusonMarch1,2018.

(2) Amountsreflecttheaggregategrantdatefairvalueofperformanceshares(therestrictedstockorrestrictedstockunits,asapplicable)grantedintherelevantfiscalyearcomputedinaccordancewithAccountingStandardsCodificationTopic718,“Compensation—StockCompensation,”orASC718,excludingtheimpactofestimatedforfeitures.Assumptionsusedinthecalculationoftheseamountsin2019areincludedinNote17toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2019includedinPartIIofourannualreportonForm10-K.Assumptionsusedinthecalculationoftheseamountsfor2017and2018areincludedinNote19toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2017andNote17toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2018,respectively.Forperformancesharesgrantedtoournamedexecutiveofficersin2019,theamountreportedinthetableaboveisbasedontheprobableoutcomeoftheperformanceconditionsassociatedwiththeawardsasofthegrantdate.Thegrantdatefairvalueoftheperformanceshares,madeintheformofrestrictedstockunits,grantedtoeachofournamedexecutiveofficersin2019assumingthehighestlevelofachievementoftheperformanceconditions,was$13,198,755forMr.Bousbib,$1,649,732forMr.McDonnell,$1,319,922forMr.Staub,$1,319,922forMr.Knightlyand$1,319,922forMr.Sherbet.Forperformancesharesgrantedtoournamedexecutiveofficersin2018,theamountreportedin

Table of Contents

68|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT

thetableaboveisbasedontheprobableoutcomeoftheperformanceconditionsassociatedwiththeawardsasofthegrantdate.Thegrantdatefairvalueoftheperformanceshares,madeintheformofrestrictedstockunits,grantedtoeachofournamedexecutiveofficersin2018assumingthehighestlevelofachievementoftheperformanceconditions,was$7,822,508forMr.Bousbib,$1,303,545forMr.McDonnell,$1,042,950forMr.Staub,$1,042,950forMr.Knightlyand$589,352forMr.Sherbet.TheperformanceshareawardgrantedtoourChiefExecutiveOfficerin2017wasmadeintheformofrestrictedstockandisreportedinthetableaboveassumingmaximumperformanceisachieved,withagrantdatefairvalueof$6,481,084.ForperformancesharesgrantedtoournamedexecutiveofficersotherthanourChiefExecutiveOfficerin2017,theamountreportedinthetableaboveisbasedontheprobableoutcomeoftheperformanceconditionsassociatedwiththeawardsasofthegrantdate.Thegrantdatefairvalueoftheperformanceshares,madeintheformofrestrictedstockunits,grantedtoeachofournamedexecutiveofficersin2017,otherthanourChiefExecutiveOfficer,assumingthehighestlevelofachievementoftheperformanceconditions,was$1,080,098forMr.McDonnell,$756,116forMr.Staub,and$756,116forMr.Knightly.

(3) AmountsreflecttheaggregategrantdatefairvalueforeachSARawardgrantedintherelevantfiscalyearascomputedinaccordancewithASC718,excludingtheimpactofestimatedforfeitures.Assumptionsusedinthecalculationoftheseamountsin2019areincludedinNote17toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2019includedinPartIIofourannualreportonForm10-K.Assumptionsusedinthecalculationoftheseamountsfor2017and2018areincludedinNote19toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2017andNote17toourconsolidatedauditedfinancialstatementsforthefiscalyearendedDecember31,2018,respectively.

(4) Amountsfor2019reflectamountstobepaidinMarch2020undertheAnnualPlan,asapplicabletothenamedexecutiveofficer,asapprovedbytheLDCCommitteeinFebruary2020.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Short-TermIncentiveAwards.”Amountsfor2017and2018representannualbonusespaidundertheannualbonusplaninwhichthenamedexecutiveofficerwasaparticipantduringtheapplicablefiscalyear.

(5) 2019valuesrepresent(i)theaggregatechangeinthepresentvalueofeachnamedexecutiveofficer’saccumulatedbenefitundertheIMSHealthRetirementPlanandRetirementExcessPlanfromDecember31,2018toDecember31,2019and(ii)interestearnedfromDecember31,2018toDecember31,2019ondeferredcompensationthatisconsidered“above-marketinterest”underSECrules.Thechangeinpensionvalueisbrokendownbelowtoshowtheeffectofanadditionalyearofservicebythenamedexecutiveofficeronthepresentvaluesversuschangesinpresentvalueattributabletoactuarialassumptions.“Abovemarketinterest”isequaltothedifferencebetweentheinterestcreditedtothecashportionofMr.Knightly’saccountundertheIMSHealthDefinedContributionExecutiveRetirementPlanfromDecember31,2018toDecember31,2019usingtheinterestratedeterminedundertheplan’sprovisions(3.44%)andtheinterestthatwouldhavebeencreditedusing120%ofthelong-termapplicablefederalrateforDecember2019(or2.52%usingannualcompounding).Eachofthesecomponentsisshowninthefollowingtable:

ChangeinPresentValueofPensionBenefit

Name

Duetoadditionalaccruals

($)

Duetochangeinactuarialassumptions

($) Total($)

AboveMarketInterestonDeferred

Compensation($)

AriBousbib 533,916 49,961 583,877 —KevinC.Knightly 99,879 63,776 163,655 9,606

(6) Seebelowforadditionalinformationregardingtheamountsdisclosedinthe“AllOtherCompensation”column.

2019ALLOTHERCOMPENSATION

Thefollowingtabledetailsthecomponentsoftheamountsreflectedinthe“AllOtherCompensation”columnoftheSummaryCompensationTableforeachofournamedexecutiveofficersforthefiscalyearendedDecember31,2019.

Name

LifeInsurancePremiums/

OtherBenefits

($)

MatchingContributionsto401(k)(1)

($)

SavingsEqualization

PlanMatchingContribution(2)

($)

OtherPerquisites(3)

($) Total($)

AriBousbib 672 8,400 248,169 388,102 645,343MichaelR.McDonnell 4,902 12,600 47,350 — 64,852W.RichardStaub,III 4,902 12,600 44,985 — 62,487KevinC.Knightly 672 7,717 26,977 — 35,366EricM.Sherbet 672 12,600 28,265 — 41,537

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|69 (1) RepresentsourmatchingcontributionstotheIQVIA401(k)Planonbehalfofournamedexecutiveofficers.

(2) Representscertainmake-wholeplancontributionstotheIQVIASavingsEqualizationPlanonbehalfofournamedexecutiveofficersequaltotheamountsthatwouldhavebeencontributedbyusonbehalfofeachofthenamedexecutiveofficerstotheapplicabletax-qualified401(k)planundertheplan’smatchingcontributionformulaifnotforcertainlimitsapplicabletotax-qualifiedplansundertheInternalRevenueCode.

(3) AmountsinthiscolumnforMr.Bousbibrepresentreimbursementofestateplanningservices($50,000)andthecosttotheCompanytoleaseanautomobileforMr.Bousbibandtoreimbursehimforalloperatingexpensesrelatedtouseoftheautomobile($30,710).Italsoincludestheaggregateincrementalcostforpersonalaircraftusage($307,392).Forsafety,securityandproductivityreasons,westronglyencourageMr.BousbibtousetheCompany’saircraftforpersonaltravel.Mr.Bousbibisentitledtouseofthecorporateaircraftforpersonaluseupto150hoursperannum,subjecttothebusinessneedsoftheCompany.Theamountofincrementalcostforpersonalaircraftusageisdeterminedbycalculatingthehourlyvariablecosts(i.e.,fuel,catering,aircraftmaintenance,landingandparkingfees,crewcostsandothermiscellaneouscosts)fortheaircraft,andthenmultiplyingtheresultbythehoursflownforpersonaluseduringtheyear.Incrementalcost,ifany,oftravelbytheexecutive’sfamilywhenaccompanyingtheexecutiveisalsoincluded.

2019GRANTSOFPLAN-BASEDAWARDS

Thefollowingtablesetsforthinformationregardingplan-basedawardsmadetoeachofournamedexecutiveofficersduring2019.

EstimatedFuturePayoutsUnderNon-EquityIncentivePlanAwards(1)

EstimatedFuturePayoutsUnderEquityIncentivePlan

Awards(4)

AllOtherStock

Awards:NumberofSharesof

StockorUnits

(#)

AllOtherOption

Awards:NumberofSecuritiesUnderlyingOptions(5)

(#)

ExerciseorBasePriceofOption

Awards(6)($)

GrantDateFairValueof

StockandOption

Awards(7)($)Name GrantDate

Threshold(2)($)

Target($)

Maximum(3)($)

Threshold(#)

Target(#)

Maximum(#)

AriBousbib

—

—

3,400,000

6,800,000

—

—

—

—

—

—

—

2/13/2019 — — — 22,785 45,571 91,142 — — — 6,599,377

2/13/2019

—

—

—

—

—

—

—

184,364

131.82

6,026,709

MichaelR.McDonnell

—

—

569,500

1,139,000

—

—

—

—

—

—

—

2/13/2019 — — — 2,848 5,696 11,392 — — — 824,866

2/13/2019

—

—

—

—

—

—

—

23,045

131.82

753,325

W.RichardStaub,III

—

—

514,250

1,028,500

—

—

—

—

—

—

—

2/13/2019 — — — 2,278 4,557 9,114 — — — 659,961

2/13/2019

—

—

—

—

—

—

—

18,436

131.82

602,661

KevinC.Knightly

—

—

467,500

935,000

—

—

—

—

—

—

—

2/13/2019 — — — 2,278 4,557 9,114 — — — 659,961

2/13/2019

—

—

—

—

—

—

—

18,436

131.82

602,661

EricSherbet

—

—

393,750

787,500

—

—

—

—

—

—

—

2/13/2019 — — — 2,278 4,557 9,114 — — — 659,961

2/13/2019

—

—

—

—

—

—

—

18,436

131.82

602,661

(1) RepresentsannualcashincentiveawardopportunitiesgrantedundertheAnnualPlan.Asdescribedin“CompensationDiscussionandAnalysis—2019Short-TermIncentiveAwards”above,eachnamedexecutiveofficerwaseligibletoreceiveatargetannualincentiveequaltoapercentageofhisannualbasesalary.TheactualamountpaidtoournamedexecutiveofficersundertheAnnualPlanfor2019isincludedintheSummaryCompensationTableabove,inthecolumnlabeled“Non-EquityIncentivePlanCompensation.”

(2) UndertheAnnualPlan,amountsshowninthe“threshold”columnassumeourLDCCommitteeexercisesitsdiscretiontoauthorizethelowestpossibleaward(or$0)foreachnamedexecutiveofficer.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Short-TermIncentiveAwards.”

(3) UndertheAnnualPlan,amountsshowninthe“Maximum”columnrepresent200%ofthenamedexecutiveofficers’targetawardamount.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Short-TermIncentiveAwards.”

(4) Representsperformancesharesgrantedin2019.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Long-TermIncentiveAwards.”

(5) Consistsofthenumberoftime-basedSARsgrantedin2019,whichvestoverthreeyears,inthreeequalinstallmentsbeginningonthefirstanniversaryofthegrantdate.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Long-TermIncentiveAwards.”

(6) Theexercisepriceisequaltotheclosingpricepershareofourcommonstockonthegrantdate,asreportedontheNYSE.

(7) Reflectsthegrantdatefairvalueofequityawardsgrantedin2019determinedinaccordancewithFASBASCTopic718.Seefootnotes(2)and(3)tothe“SummaryCompensationTable.”

Table of Contents

70|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT Narrativedisclosuretosummarycompensationtableand2019grantsofplan-basedawardstable.WehaveenteredintoagreementswithMessrs.Bousbib,McDonnell,StaubandSherbetgoverningthetermsoftheiremployment.Thematerialtermsofeachoftheagreementswiththesenamedexecutiveofficersaredescribedbelow.Eachoftheagreementsalsoprovidesforcertainpaymentsandbenefitstowhichthenamedexecutiveofficermaybeentitledinconnectionwithaterminationofemploymentoruponachangeincontrol,whicharedescribedbelowunder“—PotentialPaymentsUponTerminationorChangeinControl”.

EmploymentAgreementwithourChiefExecutiveOfficerInFebruary2019,weamendedandrestatedtheemploymentagreementwithourChiefExecutiveOfficer,replacingandsupersedinghisprioremploymentagreement,whichwasmostrecentlyamendedandrestatedinJuly2018.Asdiscussedabove,theamendedandrestatedagreementincreasedourChiefExecutiveOfficer’sbasesalaryandprovidedthathisoutstandinglong-termincentiveawardswouldremainoutstandingandeligibleforvesting,subjecttocertainlimitations,intheeventofhisretirementfromtheCompany,butotherwisepreservedthetermsandconditionsofhisexistingagreement.OurChiefExecutiveOfficer’semploymentagreementhasathree-yearterm,commencingJuly26,2018,withautomaticone-yearrenewalsthereafterunlesseitherpartygivesanoticeofnon-renewalatleastsixtydaysinadvance.Undertheamendedemploymentagreement,ourChiefExecutiveOfficer’sannualbasesalaryis$1.7millionperyear,subjecttoannualreview,andheremainseligibletoreceiveanannualbonuswithatargetamountof200%ofhisannualbasesalary.Pursuanttohisemploymentagreement,ourChiefExecutiveOfficerisentitledtoparticipateinoursavings,retirementandhealthandwelfareplansandcertaindeferredcompensationplansinaccordancewiththeirterms,andheisalsoentitledtocertainperquisitesasdescribedmorefullyunder“CompensationDiscussionandAnalysis—Retirement,PerquisitesandTerminationBenefits—Perquisites”,andinnote6tothe“2019SummaryCompensationTable”,above.TheemploymentagreementalsoincludescertainrestrictivecovenantsinfavoroftheCompany,includingacovenantnottocompetewithusortosolicitourclientsoremployeesduringandfor24monthsfollowinghisemploymentwithus.

AgreementswithMr.McDonnellInOctober2015,theCompanyenteredintoaletteragreementwithMr.McDonnellinconnectionwithhisappointmentasChiefFinancialOfficer.ThetermoftheletteragreementwithMr.McDonnellwillcontinueuntilitisterminatedpursuanttoitsterms.Eitherpartytotheletteragreementmayterminatetheemploymentrelationshipwithoutcauseatanytimeupongivingtheotherparty90days’advancewrittennotice.Undertheletteragreement,Mr.McDonnell’sinitialannualbasesalarywas$650,000,whichhassincebeenincreasedto$670,000,histargetannualcashincentiveis85%ofhisannualbasesalaryandheisentitledtoparticipateinoursavings,retirementandwelfareplansinaccordancewiththeirterms.Theletteragreementalsoprovidedforaone-timeequityawardintheformoftime-basedrestrictedstockunitswithanaggregategrantdatedollarvalueequalto$2,500,000.Mr.McDonnellisalsosubjecttoaNon-Competition,Non-Solicitation,ConfidentialityandIntellectualPropertyAgreement(a“Non-CompetitionAgreement”)thatincludes,amongotherthings,provisionsregardingnon-competitionandnon-solicitationofcustomersandemployeesfor12monthsfollowinghisterminationofemploymentforanyreason.

AgreementswithMr.StaubInNovember2016,weenteredintoaletteragreementwithMr.StaubinconnectionwithhisappointmentasPresident,Research&DevelopmentSolutions.TheletteragreementdoesnotspecifyatermofemploymentandeitherweorMr.Staubmayterminatetheemploymentrelationshipatanytimeforanyreason.Underhisletteragreement,Mr.Staub’sinitialannualbasesalarywas$540,000,whichhassincebeenincreasedto$605,000,histargetannualbonusis85%of

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|71

hisannualbasesalary,andheisentitledtoparticipateinoursavings,retirementandwelfareplansinaccordancewiththeirterms.Mr.StaubisalsosubjecttoaNon-CompetitionAgreementthatincludes,amongotherthings,provisionsregardingnon-competitionandnon-solicitationofcustomersandemployeesfor24monthsfollowinghisterminationofemploymentforanyreason.

AgreementswithMr.SherbetInJanuary2018,weenteredintoaletteragreementwithMr.SherbetinconnectionwithhisappointmentasourExecutiveVicePresident,GeneralCounselandSecretary,effectiveMarch1,2018.TheletteragreementdoesnotspecifyatermofemploymentandeitherweorMr.Sherbetmayterminatetheemploymentrelationshipatanytimeforanyreason.Underhisletteragreement,Mr.Sherbet’sinitialannualbasesalarywas$490,000,whichhassincebeenincreasedto$525,000,histargetannualbonusis75%ofhisannualbasesalaryandheisalsoentitledtoparticipateinoursavings,retirementandwelfareplansinaccordancewiththeirterms.Underhisletteragreement,Mr.Sherbetwasalsoentitledtoalong-termincentiveawardwithagrantdatevalueof$550,000andaone-timerelocationallowanceof$25,000,eachofwhichhereceivedin2018.Inaddition,weagreedtoprovideMr.SherbetwithcertainadditionalrelocationbenefitsifherelocatestotheParsippany,NewJerseyareawithinthreeyearsofhishiredate.Mr.SherbetisalsosubjecttoaNon-CompetitionAgreementthatincludes,amongotherthings,provisionsregardingnon-competitionandnon-solicitationofcustomersandemployeesfor12monthsfollowinghisterminationofemploymentforanyreason.

Table of Contents

72|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT OUTSTANDINGEQUITYAWARDSATFISCALYEAR-ENDFOR2019

Thefollowingtablesetsforthinformationregardinglong-termincentiveawardsheldbyournamedexecutiveofficersasofDecember31,2019.

Option/SARAwards

StockAwards

Name GrantDate

NumberofSecuritiesUnderlyingUnexercised

Options/SARs

(exercisable)(#)

NumberofSecuritiesUnderlying

UnexercisedOptions/SARs(unexercisable)

(#)(3)

EquityIncentiveAwards:

NumberofSecuritiesUnderlyingUnexercisedUnearnedOptions/

SARs(#)

Option/SARs

ExercisePrice

($)

Option/SARs

ExpirationDate

NumberofSharesorUnitsofStockThat

HaveNotVested(#)(3)

MarketValueof

SharesorUnitsof

StockThatHaveNotVested(1)

($)

EquityIncentive

PlanAwards:

NumberofUnearnedShares,UnitsorOther

RightsThatHaveNotVested(2)

(#)(3)

EquityIncentive

PlanAwards:

MarketorPayoutValueof

UnearnedUnitsorOther

RightsThatHaveNotVested(1)

(2)($)

AriBousbib

12/1/2010

276,480

-

-

8.34

12/1/2020

-

-

-

-

12/1/2010 138,240 - - 15.11 12/1/2020 - - - - 2/10/2015 82,847 - - 65.16 2/10/2025 - - - - 2/2/2016 95,694 31,898 - 59.90 2/2/2026 - - - - 2/2/2017 104,137 52,069 - 78.21 2/2/2027 - - - - 2/8/2018 53,485 106,972 - 95.23 2/8/2028 - - - - 2/13/2019 - 184,364 - 131.82 2/13/2029 - - - - 2/2/2017 - - - - - 190,937 29,501,676 - - 2/8/2018 - - - - - - - 38,183 5,899,655

2/13/2019

-

-

-

-

-

-

-

45,571

7,041,175

MichaelR.McDonnell

3/3/2016

23,400

-

-

64.67

3/3/2026

-

-

-

-

2/2/2017 17,356 8,678 - 78.21 2/2/2027 - - - - 2/8/2018 8,914 17,828 - 95.23 2/8/2028 - - - - 2/13/2019 - 23,045 - 131.82 2/13/2029 - - - - 7/5/2017 - - - - - 5,608 866,492 - - 2/8/2018 - - - - - - - 6,363 983,147

2/13/2019

-

-

-

-

-

-

-

5,696

880,089

W.RichardStaub,III

2/25/2014

7,508

-

-

53.26

2/25/2024

-

-

-

-

3/4/2015 2,475 - - 64.93 3/4/2025 - - - - 3/3/2016 1,750 1,750 - 64.67 3/3/2026 - - - - 2/2/2017 12,149 6,075 - 78.21 2/2/2027 - - - - 2/8/2018 7,131 14,263 - 95.23 2/8/2028 - - - - 2/13/2019 - 18,436 - 131.82 2/13/2029 - - - - 3/3/2016 - - - - - 579 89,461 - - 2/8/2018 - - - - - - - 5,091 786,610

2/13/2019

-

-

-

-

-

-

-

4,557

704,102

KevinC.Knightly

2/10/2015

8,284

-

-

65.16

2/10/2025

-

-

-

-

2/2/2016 7,655 2,552 - 59.90 2/2/2026 - - - - 2/2/2017 12,149 6,075 - 78.21 2/2/2027 - - - - 2/8/2018 7,131 14,263 - 95.23 2/8/2028 - - - - 2/13/2019 - 18,436 - 131.82 2/13/2029 - - - - 2/8/2018 - - - - - - - 5,091 786,610

2/13/2019

-

-

-

-

-

-

-

4,557

704,102

EricM.Sherbet

3/1/2018

3,956

7,914

-

97.20

3/1/2028

-

-

-

-

2/13/2019 - 18,436 - 131.82 2/13/2029 - - - - 3/1/2018 - - - - - - - 2,829 437,109

2/13/2019

-

-

-

-

-

-

-

4,557

704,102

(1) Thevaluesshownequalthenumberofsharesorunitsmultipliedby$154.51,theclosingpriceofashareofourcommonstockonDecember31,2019,thelastbusinessdayoffiscalyear2019,asreportedontheNYSE.

(2) Thenumberofsharesandthepayoutvaluereportedreflectpayoutassumingtargetperformanceisachieved.

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|73 (3) ThefollowingtableshowsthevestingdatesoftheoutstandingandunvestedawardsheldbyournamedexecutiveofficersasofDecember31,2019.Vestingis

generallysubjecttothenamedexecutiveofficer’scontinuedservicewithusthroughtheapplicablevestingdate.AllunvestedequityawardsheldbyourChiefExecutiveOfficeraresubjecttoaccelerationand/orcontinuedvestingincertaincases(discussedbelowinthesectionentitled“—PotentialPaymentsuponTerminationorChangeinControl”).

Name

GrantDate

NumberofSecuritiesUnderlying

UnexercisedOptions/SARs(unexercisable)

(#)

VestingDate

Schedule

NumberofSharesorUnitsof

StockThatHaveNot

Vested(#)

VestingDate

Schedule

EquityIncentive

PlanAwards:NumberofUnearned

Shares,UnitsorOther

RightsThatHaveNot

Vested(#)

VestingDate

Schedule

AriBousbib

2/2/2016

31,898

02/02/2020

-

-

-

-

2/2/2017 52,069 02/02/2020 - - - - 2/8/2018 53,486 02/08/2020 - - - - 2/8/2018 53,486 02/08/2021 - - - - 2/13/2019 61,454 02/13/2020 - - - - 2/13/2019 61,455 02/13/2021 - - - - 2/13/2019 61,455 02/13/2022 - - - - 2/2/2017 - - 63,645 02/02/2020 - - 2/2/2017 - - 127,292 02/02/2021 - - 2/8/2018 - - - - 38,183 12/31/2020

2/13/2019

-

-

-

-

45,571

12/31/2021

MichaelR.McDonnell

2/2/2017

8,678

02/02/2020

-

-

-

- 2/8/2018 8,914 02/08/2020 - - - - 2/8/2018 8,914 02/08/2021 - - - - 2/13/2019 7,681 02/13/2020 - - - - 2/13/2019 7,682 02/13/2021 - - - - 2/13/2019 7,682 02/13/2022 - - - - 7/5/2017 - - 5,608 07/05/2020 - - 2/8/2018 - - - - 6,363 12/31/2020

2/13/2019

-

-

-

-

5,696

12/31/2021

W.RichardStaub,III

3/3/2016

1,750

03/03/2020

-

-

-

-

2/2/2017 6,075 02/02/2020 - - - - 2/8/2018 7,131 02/08/2020 - - - - 2/8/2018 7,132 02/08/2021 - - - - 2/13/2019 6,145 02/13/2020 - - - - 2/13/2019 6,145 02/13/2021 - - - - 2/13/2019 6,146 02/13/2022 - - - - 3/3/2016 - - 579 03/03/2020 - - 2/8/2018 - - - - 5,091 12/31/2020

2/13/2019

-

-

-

-

4,557

12/31/2021

KevinC.Knightly

2/2/2016

2,552

02/02/2020

-

-

-

-

2/2/2017 6,075 02/02/2020 - - - - 2/8/2018 7,131 02/08/2020 - - - - 2/8/2018 7,132 02/08/2021 - - - - 2/13/2019 6,145 02/13/2020 - - - - 2/13/2019 6,145 02/13/2021 - - - - 2/13/2019 6,146 02/13/2022 - - - - 2/8/2018 - - - - 5,091 12/31/2020

2/13/2019

-

-

-

-

4,557

12/31/2021

EricM.Sherbet

3/1/2018

3,957

03/01/2020

-

-

-

- 3/1/2018 3,957 03/01/2021 - - - - 2/13/2019 6,145 02/13/2020 - - - - 2/13/2019 6,145 02/13/2021 - - - - 2/13/2019 6,146 02/13/2022 - - - - 3/1/2018 - - - - 2,829 12/31/2020

2/13/2019

-

-

-

-

4,557

12/31/2021

Table of Contents

74|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT 2019OPTIONEXERCISESANDSTOCKVESTED

Thefollowingtablesetsforthinformationregardingstockoptionsand/orSARsexercisedandvestingofrestrictedstock,restrictedstockunitsand/orperformancesharesbyournamedexecutiveofficersduring2019.

Option/SARAwards StockAwards(2)

Name

NumberofSharesAcquired

onExercise(#)

ValueRealizedOn

Exercise($)(1)

NumberofSharesAcquired

onVesting(3)(#)

ValueRealizedOn

Vesting($)

AriBousbib 384,000 47,230,390 317,420 47,456,622MichaelR.McDonnell - - 18,336 2,868,930W.RichardStaub,III 30,617 2,636,232 12,831 1,956,633KevinC.Knightly 46,080 5,161,300 12,994 1,986,752EricM.Sherbet - - - -

(1) Calculatedbymultiplyingthenumberofsharesofourcommonstockacquireduponexercisebythedifferencebetweentheexercisepriceandthemarketpriceofourcommonstockontheexercisedate.

(2) Amountsshowninthesecolumnsreflectrestrictedstock,restrictedstockunitsand/orperformanceshareawardsthatvestedduring2019.Theperformanceshareawardsforthe2017-2019performanceperiodvestedonDecember31,2019andwereearnedbyeachnamedexecutiveofficerbasedontheLDCCommittee’scertificationonFebruary11,2020.See“CompensationDiscussionandAnalysis—DisciplinedAssessmenttoDeterminePay—2019Long-TermIncentiveAwards—PerformanceShareDetermination”.Thevaluerealizeduponthevestingofrestrictedstock,restrictedstockunitsand/orperformanceshareswascalculated,asrequiredbySECrules,usingtheclosingpriceofourcommonstockasquotedontheNYSE,onthedatesuchrestrictedstock,restrictedstockunitsand/orperformancesharesbecamevested.

(3) Afterwithholdingsharessufficienttocoverapplicabletaxesandfeesdueuponthevestingofrestrictedstock,restrictedstockunitsand/orperformanceshares,thenamedexecutiveofficersretainedatotalof189,564netsharesinaggregatewithindividualsharesretainedasfollows:

Name

TotalNetSharesRetained

AriBousbib 163,136MichaelR.McDonnell 10,551W.RichardStaub,III 7,998KevinC.Knightly 7,879EricM.Sherbet -

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|75 2019PENSIONBENEFITS

ThefollowingtablesetsforthinformationregardingthepresentvalueoftheaccumulatedbenefitsofournamedexecutiveofficersunderourpensionplansassumedfromIMSHealthintheMergerasofDecember31,2019.OnlyourChiefExecutiveOfficerandMr.Knightly,aslegacyIMSHealthemployees,areeligibletoparticipateinsuchplans.Noamountswerepaidtoanyofournamedexecutiveofficersunderourpensionplansduringour2019fiscalyear.

Name PlanName

NumberofYearsofCreditedService(1)

PresentValueof

AccumulatedBenefit($)(2)

PaymentsDuringLastFiscalYear

PresentValueofLumpSum

PayableifTerminatedon12/31/19

($)

AriBousbib IMSHealthRetirementPlan 8.33 153,920 — — IMSHealthRetirementExcessPlan 8.33 2,791,219 — 3,279,100(3)MichaelR.McDonnell — — — — —W.RichardStaub,III — — — — —KevinC.Knightly IMSHealthRetirementPlan 36.42 536,271 — — IMSHealthRetirementExcessPlan 36.42 605,392 — 710,290(3)EricM.Sherbet — — — — —

(1) Yearsarecreditedbasedonservicefromthedatetheindividualbecameaparticipantineachplan.IndividualsbecomeparticipantsintheRetirementPlanandtheRetirementExcessPlanonthefirstdayofthemonthcoincidentwithornextfollowingtheattainmentofage21andcompletionofoneyearofservice.

(2) Theseamountsrepresenttheactuarialpresentvalue,asofDecember31,2019,ofthetotalretirementbenefitthatwouldbepayabletoeachofournamedexecutiveofficersinaccordancewiththetermsoftheRetirementPlanandRetirementExcessPlan,asapplicable,assumingnofutureserviceorcompensationincreases,andnopre-retirementmortalityortermination(i.e.,eachnamedexecutiveofficerisassumedtoretireatage65andtoreceivethebenefitofannualinterestcreditsat3.00%undertheRetirementPlanand3.00%undertheRetirementExcessPlanonhisaccountbalanceuntilsuchpoint).ThekeyactuarialassumptionsandmethodologiesusedtocalculatethepresentvalueofaccumulatedbenefitsunderboththeRetirementPlanandRetirementExcessPlanwere(i)adiscountrateof3.58%and3.10%,respectively,and(ii)theWhiteCollarPRI2012mortalitytablewithscaleMP-2019.

(3) UndertheRetirementExcessPlan,ifeitherofMessrs.BousbiborKnightlyhadexperiencedaseparationfromservicefromusforanyreasononDecember31,2019,thenhewouldhavebeenentitledtoreceiveasinglelumpsumpaymentofhisaccumulatedbenefitundertheRetirementExcessPlanonthelaterofDecember31,2019oruponattainmentofage55.Asbothnamedexecutiveofficersattainedage55priortoDecember31,2019,thepresentvalueisdeterminedasof,andthelumpsumispayableDecember31,2019,isshownabove.ThefollowingkeyactuarialassumptionsandmethodologieswereusedtocalculatethepresentvalueatDecember31,2019:theRetirementExcessPlanaccountbalanceasofDecember31,2019wasconvertedintoanannuitypayableonDecember31,2019usinga3.00%interestrateandtheGAM83UnisexMortalityTable.TheresultingannuitywasconvertedtoalumpsumpayableonDecember31,2019usinganinterestrateof2.20%andtheGAM83MortalityTable.UndertheRetirementExcessPlan,ifachangeincontroloccurs,andaparticipant’semploymentwithusisinvoluntarilyterminatedforareasonotherthancauseortheparticipantvoluntarilyterminatesemploymentwithusforgoodreasonwithin24monthsthereafter,hisaccumulatedbenefitwouldbepayableinasinglelumpsumonthedateofsuchtermination,evenifthatdateprecedesattainmentofage55.Accordingly,ifeitherofMessrs.BousbiborKnightlyhadbeeninvoluntarilyterminatedforareasonotherthancauseorhadvoluntarilyterminatedemploymentwithusforgoodreasononDecember31,2019followingachangeincontrol,theneachexecutiveofficerwouldbeentitledtoreceiveasinglelumpsumpaymentofhisaccumulatedbenefitundertheRetirementExcessPlanuponsuchtermination.AsMessrs.BousbibandKnightlyhaveeachattainedage55priortoDecember31,2019,theywouldreceivethesamepresentvalueasshownabove,asofDecember31,2019,withnoenhancementinvalue(ascomparedwithwhateachnamedexecutiveofficerwouldhavereceivedhadheterminatedemploymentonDecember31,2019notinconnectionwithachangeincontrol).

Table of Contents

76|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT IMSHEALTHDEFINEDBENEFITRETIREMENTPLANS

ThefollowingtabledescribesthedefinedbenefitpensionplansinwhichourChiefExecutiveOfficerandMr.Knightlyareeligibletoparticipate.

Plan

Description

EligibilityandVesting

BenefitsFormula

TimeandformofPayment

InternalRevenueCodeLimitations

IMSHealthRetirementPlan

Funded,tax-qualifieddefinedbenefitretirementprogram

AllU.S.-basedlegacyIMSHealthemployees,includingourChiefExecutiveOfficerandMr.Knightly

Benefitsgenerallyvestafterthreeyearsofqualifyingservice

ThisplanwasassumedbyusinconnectionwiththeMergerandclosedtonewparticipantseffectiveDecember31,2016

Benefitsaredefinedbyacashbalanceformulaexpressedintheformofanotionalor“book-keeping”accountbalance

Eachmonthaparticipant’scashbalance“account”isincreasedby(i)paycreditsof6%oftheparticipant’scompensationforthatmonthand(ii)interestcreditsbasedontheparticipant’shypotheticalaccountbalanceattheendofthepriormonth

Monthlyinterestcreditsarebasedon1/12thofthe30-yearTreasurybondyieldsineffectduringtheapplicablemonth,subjecttoafloorofa3%annualyield

Participantsmayretireearlyatage55withthreeyearsofservice

Normalretirementageis65.Pensionbenefitsarepayableasanactuariallyequivalentannuity

Lump-sumdistributionsareonlyavailableforbenefitsvaluedat$5,000orless

Employeesdonotmakecontributionstotheplan

Section401(a)(17)oftheInternalRevenueCode(the“IRC”)limitstheannualcompensationthatmaybetakenintoaccountinthecalculationofbenefitsunderatax-qualifieddefinedcontributionordefinedbenefitpensionplan,includingtheIMSHealthRetirementPlan,to$280,000in2019

Section415oftheIRClimitstheannualbenefitpayableunderatax-qualifieddefinedbenefitplanincludingtheIMSHealthRetirementPlan,to$225,000for2019

IMSHealthRetirementExcessPlan

Unfunded,non-qualifiedretirementplanutilizingthesamebenefitformula,compensationrecognition,retirementeligibilityandvestingprovisionsasthetax-qualifiedIMSHealthRetirementPlan

ThisplanprovidespensionbenefitsnotprovidedbytheIMSHealthRetirementPlanduetotheIRClimitationsnotedabove

CertaineligibleU.S.-basedlegacyIMSHealthemployees,includingourChiefExecutiveOfficerandMr.Knightly

Weprovide,outofourgeneralassets,amountsequaltothedifferencebetweentheamountthatwouldhavebeenpaidintheabsenceoftheaforementionedInternalRevenueCodelimitsandtheamountthatmaybepaidundertheIMSHealthRetirementPlan

Benefitsforthenamedexecutivesareautomaticallypayableuponterminationofemployment(subjecttoasix-monthdelay,incertaincases,undertaxrulesapplicabletonon-qualifieddeferredcompensation)intheformofanactuariallyequivalentlumpsum

None

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|77 2019NON-QUALIFIEDDEFERREDCOMPENSATION

Thefollowingtablesetsforthinformationregardingthenon-qualifieddeferredcompensationofeachofournamedexecutiveofficersforour2019fiscalyearundertheIMSHealthDCERPortheIQVIAElectiveDeferredCompensationPlan,asapplicable.Therewerenocontributionsto,or,withrespecttoournamedexecutiveofficers,distributionsfrom,eitherofsuchplansduringour2019fiscalyear.

Name

AggregateEarningsinLastFiscalYear(1)

($)

AggregateBalanceatEndofFiscalYear2019(2)

($)

AriBousbib — —MichaelR.McDonnell — —W.RichardStaub,III — —KevinC.Knightly 752,653 3,912,719EricM.Sherbet — —

(1) EarningsforMr.Knightlyrepresent(i)interestcreditedtotherespectivenamedexecutiveofficer’sDesignatedAccount(asdefinedbelow),and(ii)theincrease/decreaseinfiscalyear2019inthefairmarketvalueofsharesofourcommonstocknotionallyheldintheparticularDesignatedAccount(asdescribedbelow).

(2) TheaggregatebalanceattheendoftheyearconsistsofthevalueofMr.Knightly’saccountundertheIMSHealthDCERPasofDecember31,2019.TheStockAccount(asdefinedbelow)hasbeenvaluedusingtheclosingpriceofourcommonstockonDecember31,2019($154.51),thelastbusinessdayoffiscalyear2019.Earningsondeferredamountsinanamedexecutiveofficer’sDesignatedAccount,totheextentsuchearningsweredeemedtobe“above-market”underapplicableSECrules,havebeenreflectedinthe“SummaryCompensationTable”inthecolumnlabeled“—ChangeinPensionValueandNon-QualifiedDeferredCompensationEarnings.”

Thefollowingtabledescribesournon-qualifieddeferredcompensationplans. Plan

Description


BenefitsFormula


IMSHealthDefinedContributionExecutiveRetirementPlan(the“IMSHealthDCERP”)

Non-qualified,unfundeddefinedcontributionplan

PlanwasfrozentonewparticipantsandaccrualsasofJune30,2012

Previouslyaccruedbenefitscontinuetobeeligibletobecreditedwithaninterestcreditandnotionalinvestmentreturns.

Mr.Knightlyisfullyvestedinhisaccount

Participantswereabletoelecttohavetheiraccountnotionallycreditedwithinvestmentcredits(theportionthatissocreditedisreferredtoasa“DesignatedAccount”)or,withrespecttoadesignatedportionoftheiraccount,notionallyinvestedinsharesofIMSHealthcommonstock,whichthenbecamenotionallyinvestedinsharesofourcommonstockinconnectionwiththeMerger(theportionthatissonotionallyinvestedisreferredtoasa“StockAccount”)

AnnualinvestmentcreditstoaDesignatedAccountarecalculatedbasedontheaverageannualcorporatebondyieldsfromtheAAtoAAARated/10+YearsComponentoftheMerrillLynchU.S.CorporateMasterIndex

Aparticipant’saccountsispaidasalumpsumonorshortlyafterthedatetheparticipantterminatesemploymentwithus(subjecttoasix-monthdelay,incertaincases,undertaxrulesapplicabletonon-qualifieddeferredcompensation)

Table of Contents

78|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT Plan

Description


BenefitsFormula


IQVIAElectiveDeferredCompensationPlan

Non-qualified,deferredcompensationplan

CertainIQVIAemployeeswithintheUS,includingournamedexecutiveofficers,areeligibletoparticipate

Noneofournamedexecutiveofficersparticipatedinthisplanduring2019

Participantsmaytodeferupto80%oftheirbasesalariesasofthefirstdayofthecalendaryearorpartialyearandupto100%ofanycashbonusearnedundertheAnnualPlanandpayabletotheparticipantwithrespecttothatyear

Contributionsconsistsolelyofparticipants’electivedeferralcontributionswithnomatchingorotheremployercontributions

Participantsmayelecttoreceivedate-based,in-servicedistributionsaslongastheyareactiveparticipantsintheplanineitheralumpsumorinannualinstallmentsupto15years

Uponseparationfromservice,participantswillreceivetheirdistributioneitherasalumpsumorinannualinstallmentsupto15years(subjecttoasix-monthdelay,incertaincases,undertaxrulesapplicabletonon-qualifieddeferredcompensation)

POTENTIALPAYMENTSUPONTERMINATIONORCHANGEINCONTROL

Eachofournamedexecutiveofficersisentitledtoreceivecertainbenefitsuponaqualifyingterminationofemploymentanduponcertainchangeincontroltransactions.Belowwedescribepaymentsandbenefitsthatarepayableuponcertaintypesofterminationofemploymentorachangeincontrol,orthatareenhancedbasedonthecircumstancesofaterminationorchangeincontrol.

EmploymentAgreementandLong-TermIncentiveAwardAgreementswithourChiefExecutiveOfficer.Underthetermsofhisemploymentagreement,ifweterminateourChiefExecutiveOfficer’semploymentwithoutcause(includingasaresultofnon-renewaloftheemploymenttermbytheCompany),orifheresignsforgoodreason(assuchtermsaredefinedintheemploymentagreement)(either,a“qualifyingterminationofemployment”),ourChiefExecutiveOfficerwillbeentitledtoseveranceinanamountequaltotwotimesthesumofhisannualbasesalaryandannualtargetbonus,payableinequalinstallmentsoverthe24-monthperiodfollowingtheterminationofhisemployment,orifsuchterminationorresignationoccurswithinthe24-monthperiodfollowingachangeincontrol(asdefinedintheemploymentagreement),inalumpsum.Underthetermsofhisemploymentagreementandhisoutstandinglong-termincentiveawardagreements,intheeventofaqualifyingterminationofemployment,allofourChiefExecutiveOfficer’soutstandingtime-basedequityawardsthatremainunvestedwillvestinfulland,ifapplicable,willremainexercisablefortheirfullrespectiveterms;andallofhisoutstandingperformance-basedequityawardsthatremainunvestedwillremainoutstandingandeligibletovestbasedonperformance(or,ifaqualifyingterminationofemploymentoccurswithin24monthsfollowingachangeincontrolevent,willvestbasedondeemedachievementoftargetperformanceontheterminationdate).

IfourChiefExecutiveOfficer’semploymentisterminatedbytheCompanyduetohisdisabilityorterminatesduetohisdeath(assuchtermsaredefinedinhisagreement),allofhisoutstandingequityawardsthatremainunvestedwillvestinfull,and,ifapplicable,willremainexercisablefortheirfullrespectiveterms,withperformance-basedawardsvestingbasedondeemedperformanceattargetlevelsonthedatehisemploymentterminates.IntheeventofourChiefExecutiveOfficer’spermanentretirementfromtheCompany,withcertainlimitedexceptions,allofhisoutstandingtime-basedequityawardsthatremainunvestedwillremainoutstandingandcontinuetovestonthesamescheduleasifhehadremainedemployed,and,ifapplicable,willremainexercisablefortheirfullrespectiveterms,andallofhisoutstandingperformance-basedawardswillremainoutstandingandeligibletovest

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|79 basedonactualperformance.OurChiefExecutiveOfficerwillbeeligibleforretirementwhenheattainsage62.AsofDecember31,2019,ourChiefExecutiveOfficerwasnotretirementeligibleunderthetermsofhisagreement.

Uponaterminationforcauseoraresignationwithoutgoodreason(thatdoesnotconstitutearetirement,asdescribedabove),ourChiefExecutiveOfficerwillbeentitledtosalaryandothercompensationthataccruedbeforetermination,butnoseverancewillbepayable.

AsaconditiontoourChiefExecutiveOfficer’sreceiptoftheseverancepaymentsdescribedabove,hemusttimelyexecute(withoutrevoking)areleaseofclaimsinfavorofusandcomplywithcertainrestrictivecovenantssetforthintheemploymentagreement,includingacovenantnottocompetewithusortosolicitourclientsoremployeesduringandfor24monthsfollowinghisemploymentwithus.OurChiefExecutiveOfficerisalsoboundbyotherrestrictivecovenants,includingcovenantsrelatingtoconfidentialityandnon-disparagement.

EmploymentandLetterAgreementswithMessrs.McDonnellandStaub.Intheeventofaterminationofemploymentbyuswithoutcause(or,withrespecttoMr.McDonnellonly,aresignationbythenamedexecutiveofficerforgoodreason),eachofMessrs.McDonnellandStaubwillbeentitledtotheseverancebenefitsundereachoftheirrespectiveagreementswithusandwithrespecttoMr.McDonnell,theEmployeeProtectionPlanasitrelatestonon-salarycontinuationbenefits.

UnderMr.McDonnell’sletteragreement,ifhisemploymentisterminatedwithoutcauseorMr.McDonnellresignsforgoodreason(each,asdefinedintheletteragreement),hewouldbeentitledtoreceiveseveranceintheamountofonetimeshisannualbasesalaryplushistargetannualbonusineffectfortheyearofterminationpayableininstallmentsoveratwelve-monthperiod.Theletteragreementdoesnotprovideforanyspecificbenefitsintheeventofachangeincontrol.

UnderMr.Staub’sletteragreement,ifMr.Staub’semploymentisterminatedotherthanforcause(asdefinedintheletteragreement),hewillreceivecashseverance,payableinequalmonthlyinstallmentsonourregularpayrollscheduleduringthe24-monthnon-competitionperiodfollowingtermination,equalto(i)24monthsofMr.Staub’sbasesalaryasoftheterminationdate;(ii)Mr.Staub’stargetannualbonusineffectfortheyearoftermination;and(iii)theprojectedcostofthecontinuationofgrouphealthinsurancecoverageforMr.StaubandhiseligibledependentspursuanttoCOBRAfor18monthsfollowingthedateoftermination.

EmployeeProtectionPlan.Messrs.KnightlyandSherbet,alongwithMr.McDonnellwithrespecttonon-salarycontinuationbenefits,participateintheIQVIAEmployeeProtectionPlan(the“EmployeeProtectionPlan”),whichprovidesforcertainpaymentsandbenefitsiftheparticipant’semploymentisterminatedwithoutcause(asdefinedintheEmployeeProtectionPlan).

UndertheEmployeeProtectionPlan,upontheterminationofaparticipant’semploymentwithoutcause(asdefinedintheEmployeeProtectionPlan),heorsheisentitledtocontinuedbasesalarypaymentsforaperiodoftimeofatleasttwoweeksandamaximumof52weeks,dependingontheparticipant’ssalarygradelevelandyearsofeligibleservice(twoweeksforeachyearofservice,subjecttocertainminimumperiods),continuedmedical,dentalandvisionbenefitsthroughoutthesalarycontinuationperiod(butnotinexcessofsixmonthsregardlessofthedurationofcontinuedbasesalarypayments),andcertainoutplacementservices.Mr.Knightlywouldbeentitledtoamaximumof52weeksofseverancebenefitsundertheamendedandrestatedplan.Mr.Sherbetwouldbeentitledto26weeksofseverancebenefitsundertheamendedandrestatedplan.

AparticipantisentitledtoseverancebenefitsundertheEmployeeProtectionPlanfollowingachangeincontrolunlessheorsheunilaterallyresigns,isofferedcomparableemploymentwithusoranacquiringcompany,ortransferstoacustomerorclientinconnectionwithatransferoroutsourcingplan.BenefitsundertheEmployeeProtectionPlanceasewhentheparticipantbeginstoearncompensationfromanewemployer,andareoffsetbytheamountsofanyotherseverancepayments

Table of Contents

80|CompensationofNamedExecutiveOfficers IQVIA2020PROXYSTATEMENT thataremadetotheparticipantorbytheamountofanysign-onincentiveorsimilaramountspaiduponcommencementoftheparticipant’semployment,ifsuchpaymentsoccurredwithin12monthsofthetermination.AnysalarycontinuationorbenefitspayableundertheEmployeeProtectionPlanareconditionedupontheparticipant’stimelyexecution(withoutrevoking)ofareleaseofclaimsinfavorofusthatmayincludecertainrestrictivecovenants,includingcovenantsrelatingtonon-competitionandnon-solicitationofclientsoremployeesthatwouldapply,ineachcase,duringtheone-yearperiodfollowingtheparticipant’sterminationofemploymentor,iflonger,theparticipant’ssalarycontinuationperiod.

Summaryofpotentialpayments.Thefollowingtableestimatesthedollarvalueoftheadditionalpaymentsandbenefitsournamedexecutiveofficers,wouldhavebeenentitledtoreceiveunderapplicableplansand/orarrangementsdescribedabove,assumingtheapplicabletriggeringeventoccurredonDecember31,2019,thelastbusinessdayoffiscalyear2019.

Name TypeofPaymentorBenefit

InvoluntaryTermination

($)

TerminationDuetoDeath/

Disability($)

ChangeinControlwithout

Termination($)

InvoluntaryTerminationFollowingaChangein

Control($)

AriBousbib

SeverancePay(1)

10,200,000

—

—

10,200,000

Accelerationoftime-basedequityawards(2) 47,016,930 47,016,930 — 47,016,930

Performance-basedequityawards (3) 12,940,831 12,940,831 — 12,940,831

Total

70,157,761

59,957,761

—

70,157,761

MichaelR.McDonnell

SeverancePay(4)

1,239,500

—

—

1,239,500

Health&WelfareBenefits(5) 7,265 — — 7,265 Outplacement(8) 3,945 — — 3,945

Total

1,250,710

—

—

1,250,710

W.RichardStaub,III

SeverancePay(6)

1,724,250

—

—

1,724,250

Health&WelfareBenefits(5) 21,795 — — 21,795

Total

1,746,045

—

—

1,746,045

KevinC.Knightly

SeverancePay(7)

550,000

—

—

550,000


Total

561,239

—

—

561,239

EricM.Sherbet

SeverancePay(7)

262,500

—

—

262,500


Total

273,739

—

—

273,739

(1) RepresentstwotimesthesumofourChiefExecutiveOfficer’sbasesalaryandhistargetannualincentive,whichistheamountpayabletoourChiefExecutiveOfficerunderthetermsofhisemploymentagreementinconnectionwithaterminationofhisemploymentbyuswithoutcauseorbyhimforgoodreason.

(2) Representsthevalueoftheaccelerationofunvestedtime-basedSARsdeterminedbasedonthedifferencebetweentheexercisepriceoftheSARsandtheclosingpriceofashareofourcommonstockonDecember31,2019($154.51),thelastbusinessdayoffiscalyear2019,andthevalueoftheaccelerationofunvestedtime-basedrestrictedstockdeterminedbymultiplyingthenumberofsharesunderlyingtheawardbytheclosingpriceofashareofourcommonstockonDecember31,2019.Forpurposesofthistable,wehaveassumedthatalltime-basedSARsandrestrictedstockwouldbeassumed,continuedorsubstitutedinconnectionwithachangeincontrolandthat,asaresult,alltime-basedSARsandrestrictedstockwouldnotbecomefullyvestedinconnectionwithsuchchangeincontrolbutratheruponaqualifyinginvoluntaryterminationfollowingachangeincontrol.Theactualtreatmentoftime-basedSARsandrestrictedstockinconnectionwithachangeincontroltransactionmaybedifferent.Asdescribedabove,anyunvestedoutstandingtime-basedequityawardsheldbyourChiefExecutiveOfficerwouldbeacceleratedintheeventofaqualifyingterminationofemploymentorintheeventofaterminationduetodeathordisability.

(3) Representsthevalueofunvestedperformanceshares(assumingachievementoftheperformancegoalsattarget),determinedbymultiplyingthenumberofsharesunderlyingtheawardbytheclosingpriceofashareofourcommonstockonDecember31,2019($154.51).Intheeventofaqualifyingterminationofemployment,ourChiefExecutiveOfficer’s

Table of Contents

IQVIA2020PROXYSTATEMENT CompensationofNamedExecutiveOfficers|81

performanceshareswillremainoutstandingandeligibletovestbasedonperformance.Intheeventofaterminationduetodeathordisability,ourChiefExecutiveOfficer’sperformanceshareswouldbefullyacceleratedandpaidoutattarget.Forpurposesofthistable,wehaveassumedthatallperformanceshareswouldbeassumed,continuedorsubstitutedinconnectionwithachangeincontrolandthat,asaresult,allperformanceshareswouldnotbecomefullyvestedinconnectionwithsuchchangeincontrolbutratheruponaqualifyinginvoluntaryterminationfollowingachangeincontrol.Theactualtreatmentofperformancesharesinconnectionwithachangeincontroltransactionmaybedifferent.Asdescribedabove,anyunvestedoutstandingperformance-basedequityawardsheldbyourChiefExecutiveOfficerwouldbeacceleratedintheeventofaqualifyingterminationofemploymentfollowingachangeincontrolorintheeventofaterminationduetodeathordisabilityandwouldassumetheachievementoftheperformancegoalsattarget.

(4) Representsanamountequalto(i)12monthsofMr.McDonnell’sbasesalaryand(ii)Mr.McDonnell’stargetannualbonusineffectfortheyearoftermination.

(5) ForMessrs.McDonnell,KnightlyandSherbet,representsthecosttousofpayingourportionofpremiumsformedical,dentalandprescriptiondrugcoverageforMessrs.McDonnell,KnightlyandSherbetandtheireligibledependentsduringtheperiodduringwhichsalarycontinuationpaymentsundertheprovisionsoftheEmployeeProtectionPlan(asineffectonDecember31,2019)arebeingmade.ForMr.Staub,representstheprojectedcostofgrouphealthcarecontinuationfor18monthsforMr.Staubandhiseligibledependents,towhichhewouldbeentitledunderhisemploymentagreement.

(6) Representsanamountequalto(i)24monthsofMr.Staub’sbasesalaryand(ii)Mr.Staub’stargetannualbonusineffectfortheyearoftermination.

(7) RepresentsthesumofbasesalarycontinuationpayabletoMessrs.KnightlyandSherbetundertheprovisionsoftheEmployeeProtectionPlanasineffectonDecember31,2019.

(8) RepresentsthevalueofoutplacementservicesthatwouldbeavailabletoMessrs.McDonnell,KnightlyandSherbetintheeventofaqualifyingterminationofemploymentundertheEmployeeProtectionPlan.

CEOPAYRATIO

U.S.publicly-tradedcompaniesarerequiredtodisclosetheratiooftheirchiefexecutiveofficer’scompensationtothatoftheirmedianemployeeunderapplicablerulesthatfirstbecameeffectiveforourproxystatementthatwefiledin2017.ThisdisclosureisrequiredinthisProxyStatementandrequiresthatthemedianemployeebeselectedfromallemployees,includingfull-time,part-time,seasonalandtemporaryemployees.

OurChiefExecutiveOfficertomedianemployeepayratiowascalculatedinaccordancewithSection953(b)oftheDodd-FrankWallStreetReformandConsumerProtectionActandItem402(u)ofRegulationS-KandrepresentsareasonableestimatecalculatedinaccordancewithSECregulationsandguidance.BecausetheSECrulesforidentifyingthemedianemployeeandcalculatingthepayratiopermitcompaniestousevariousmethodologiesandassumptions,toapplycertainexclusionsandtomakereasonableestimatesthatreflecttheiremployeepopulationsandcompensationpractices,thepayratioreportedbyothercompaniesmaynotbecomparablewiththepayratiothatwehavereported.

Underthepayratiorule,acompanyisrequiredtoidentifyitsmedianemployeeonlyonceeverythreeyearssolongasduringthepriorfiscalyeartherehasbeennochangetoitsemployeepopulationoremployeecompensationarrangementsthatitreasonablybelieveswouldresultinasignificantchangeinitspayratiodisclosure.During2017,weidentifiedourmedianemployeebyusingbasesalariesorbaserateofpayasourconsistentlyappliedcompensationmeasure,forallindividuals,excludingourChiefExecutiveOfficer,whowereemployedbyusonDecember1,2017(annualizedinthecaseofpart-timeemployeesandemployeeswhojoinedtheCompanyduring2017),afterapplyinganexclusionforcertainofournon-USemployees.Becausewedidnotexperienceanymaterialchangestoouremployeepopulation,orchangesinemployeecompensationarrangements,during2019,webelieveitisreasonabletousethismedianemployeeidentifiedandreportedin2017forpurposesofcalculatingthepayratiodisclosurewithrespectto2019andthatusingthismedianemployeewouldnotsignificantlyaffectourpayratiodisclosure.

For2019,theannualtotalcompensationofourmedianemployee,calculatedunderapplicableSECrules,was$118,891.TheannualtotalcompensationforourChiefExecutiveOfficerin2019isreportedinthe“SummaryCompensationTable”above.Onthisbasis,theratioofourChiefExecutiveOfficer’sannualtotalcompensationtoourmedianemployee’sannualtotalcompensationisestimatedat186:1.

Table of Contents


ProposalNo.3:RatificationoftheAppointmentoftheIndependentRegisteredPublicAccountingFirmTheAuditCommitteehasappointedPricewaterhouseCoopersLLP(“PricewaterhouseCoopers”)asindependentregisteredpublicaccountantsforusfortheyearendingDecember31,2020.RatificationoftheappointmentofPricewaterhouseCoopersrequiresthevoteofamajorityofthesharesofourcommonstockcastaffirmativelyornegativelyonthematter.ArepresentativeofPricewaterhouseCoopersisexpectedtobeavailabletoanswerappropriatequestionsatthe2020AnnualMeetingandisfreetomakestatementsduringthe2020AnnualMeeting.

TheAuditCommitteeisnotrequiredtotakeanyactionasaresultoftheoutcomeofthevoteonthisproposal.However,ifthestockholdersdonotratifytheappointment,theAuditCommitteemayinvestigatethereasonsforstockholderrejectionandmayconsiderwhethertoretainPricewaterhouseCoopersortoappointanotherindependentregisteredpublicaccountingfirm.

Eveniftheappointmentisratified,theAuditCommitteeinitsdiscretionmaydirecttheappointmentofadifferentindependentregisteredpublicaccountingfirmatanytimeduringtheyearifitdeterminesthatsuchachangewouldbeinthebestinterestsofourstockholdersorthecompany.

THEBOARDRECOMMENDSAVOTE“FOR”RATIFICATIONOFTHEAPPOINTMENTOFPRICEWATERHOUSECOOPERSLLP

Table of Contents


AuditAUDITCOMMITTEEREPORT

TheAuditCommitteehasselectedPricewaterhouseCoopersasourindependentregisteredpublicaccountingfirmfortheyearendedDecember31,2020.TheBoardwillaskourstockholderstoratifythisselectionatthe2020AnnualMeeting.

PricewaterhouseCoopersservedasourindependentregisteredpublicaccountingfirmfortheyearsendedDecember31,2019and2018.PriortotheMerger,PricewaterhouseCoopershadbeenindependentauditorofQuintilescontinuouslysince2002andforIMSHealthcontinuouslysince1998.

Amongitsfunctions,theAuditCommitteereviewsourfinancialreportingprocessonbehalfoftheBoard.Managementhastheprimaryresponsibilityforthefinancialstatementsandthereportingprocess.TheindependentregisteredpublicaccountingfirmisresponsibleforexpressinganopinionontheconformityofourauditedfinancialstatementstoaccountingprinciplesgenerallyacceptedintheUnitedStatesofAmerica.

TheAuditCommitteehasreviewedanddiscussedtheannualauditedfinancialstatementswithmanagementandtheindependentregisteredpublicaccountingfirm,PricewaterhouseCoopers.TheAuditCommitteealsodiscussedwiththeindependentregisteredpublicaccountingfirmthemattersrequiredtobediscussedbyPublicCompanyAccountingOversightBoardAS1301,andreviewedtheresultsoftheindependentregisteredpublicaccountingfirm’sauditoftheconsolidatedfinancialstatements.

PricewaterhouseCoopershasalsoconfirmedtousthatitisincompliancewiththerules,standardsandpoliciesoftheIndependenceStandardsBoardandtheSECgoverningauditorindependence.TheAuditCommitteereceivedanddiscussedwithPricewaterhouseCoopersitswrittendisclosuresandtheletterasrequiredbyapplicablerequirementsofthePublicCompanyAccountingOversightBoardregardingtheindependentregisteredpublicaccountingfirm’scommunicationswiththeAuditCommitteeconcerningindependence.TheAuditCommitteehasconsideredwhethertheprovisionofnon-auditservicesbyourindependentregisteredpublicaccountingfirmiscompatiblewiththeauditor’sindependence.

Basedonthereviewsanddiscussionsreferredtoabove,andtheguidelinesspecifiedbytheAuditCommitteeCharter,theAuditCommitteerecommendedtotheBoardthattheauditedconsolidatedfinancialstatementsbeincludedinour2019AnnualReportforfilingwiththeSEC.

TheAuditCommitteeJamesA.Fasano,ChairMichaelJ.EvaniskoColleenA.GogginsJohnM.LeonardRonaldA.Rittenmeyer

Table of Contents

84|Audit IQVIA2020PROXYSTATEMENT FEESPAIDTOINDEPENDENTREGISTEREDPUBLICACCOUNTINGFIRM

PricewaterhouseCoopershasservedasourindependentauditorfortheyearsendedDecember31,2019and2018.Inadditiontorenderingauditservicesduringthosetwoyears,PricewaterhouseCoopersperformedvariousnon-auditservicesforusworldwide.

AuditandOtherFeesforPastTwoFiscalYears.ThefollowingtablesetsforththeaggregatefeesbilledtotheCompanyforservicesrenderedbyPricewaterhouseCoopersforthe2019and2018fiscalyears: (inthousands) 2019 2018Auditfees(1) $ 8,450 $10,365Audit-relatedfees(2) — 650Taxfees(3) 4,000 4,250Allotherfees(4) 35 20Total $12,485 $15,285

(1) Auditfeesprincipallyincludeservicesrelatedtotheannualauditoftheconsolidatedfinancialstatements,quarterlyreviewofourinterimconsolidatedfinancialstatements,statutoryauditsofforeignsubsidiaries,SECregistrationstatementsandotherfilings,andconsultationonaccountingmatters.

(2) Audit-relatedfeesconsistedprincipallyofduediligenceservicesandfinancialaccountingandreportingconsultationsforrelatedservicesnotalreadyreportedinauditfees.

(3) Taxfeesrelateprimarilytoprofessionalservicesfortaxcompliance,adviceandplanningservices.TheseservicesincludedU.S.andnon-U.S.taxservices.

(4) Allotherfeesconsistedofnon-auditandaccountingresearchservices.

Allauditandnon-auditservicestobeperformedbyourindependentregisteredpublicaccountingfirmmustbeapprovedinadvancebytheAuditCommittee.AspermittedbySECrules,theAuditCommitteealsohasdelegatedeachofitsmembers,actingsingly,withtheauthoritytopre-approveanyauditornon-auditservicesiftheneedforpre-approvalarisesbetweenregularlyscheduledmeetings.Suchinterimapprovals,togetherwithfulldocumentation,arepresentedtotheAuditCommitteeatitsnextscheduledmeeting.

Asearlyaspracticableineachfiscalyear,theindependentregisteredpublicaccountingfirmprovidestotheAuditCommitteeascheduleoftheauditandotherservicesthattheindependentregisteredpublicaccountantsexpecttoprovideormayprovideduringtheyear.Theschedulewillbespecificastothenatureoftheproposedservices,theproposedfeesandotherdetailsthattheAuditCommitteemayrequest.TheAuditCommitteewillbyresolutionauthorizeordeclinetheproposedservices.Uponapproval,thisschedulewillserveasthebudgetforfeesbyspecificactivityorservicefortheyear.

Ascheduleofadditionalservicesproposedtobeprovidedbytheindependentregisteredpublicaccountants,orproposedrevisionstoservicesalreadyapproved,alongwithassociatedproposedfees,maybepresentedtotheAuditCommitteefortheirconsiderationandapprovalatanytime.Theschedulewillbespecificastothenatureoftheproposedservice,theproposedfeeandotherdetailsthattheAuditCommitteemayrequest.TheAuditCommitteewillbyresolutionauthorizeordeclineauthorizationforeachproposednewservice.

ApplicableSECrulesandregulationspermitwaiverofthepre-approvalrequirementsforservicesotherthanaudit,revieworattestservicesifcertainconditionsaremet.Outoftheservicescharacterizedaboveasaudit-relatedandtax,nonewerebilledpursuanttotheseprovisionsinfiscal2019withoutpre-approval.

TheAuditCommitteehasconsideredthecompatibilityofnon-auditservicesperformedbyPricewaterhouseCooperswithitsindependence.OurCommitteehasconcludedthattheprovisionofnon-auditservicesbyPricewaterhouseCoopersiscompatiblewiththatfirmmaintainingitsindependencefromusanditsmanagement.

Table of Contents


SecurityOwnershipofCertainBeneficialOwnersandManagementThefollowingtablesetsforthinformationrelatingtothebeneficialownershipofourcommonstockasofFebruary12,2020,by:

• eachperson,orgroupofaffiliatedpersons,knownbyustobeneficiallyownmorethan5%oftheoutstandingsharesofourcommonstock;

• eachofournamedexecutiveofficers;

• eachofourdirectors;and

• allexecutiveofficersanddirectorsasagroup.

BeneficialownershipisdeterminedinaccordancewithSECrules.Ingeneral,undertheserulesabeneficialownerofasecurityincludesanypersonwho,directlyorindirectly,throughanycontract,arrangement,understanding,relationshiporotherwisehasorsharesvotingpowerorinvestmentpowerwithrespecttosuchsecurity.Apersonisalsodeemedtobeabeneficialownerofasecurityifthatpersonhastherighttoacquirebeneficialownershipofsuchsecuritywithin60days.Exceptasotherwiseindicated,andsubjecttoapplicablecommunitypropertylaws,thepersonsnamedinthetablehavesolevotingandinvestmentpowerwithrespecttoallsharesofcommonstockheldbythatperson.

Table of Contents

86|SecurityOwnership IQVIA2020PROXYSTATEMENT Thepercentageofsharesbeneficiallyownediscomputedonthebasisof192,816,517sharesofourcommonstockoutstandingasofFebruary12,2020.Sharesofourcommonstockthatapersonhastherighttoacquirewithin60daysofFebruary12,2020aredeemedoutstandingforpurposesofcomputingthepercentageownershipofsuchperson’sholdingsbutarenotdeemedoutstandingforpurposesofcomputingthepercentageownershipofanyotherperson,exceptwithrespecttothepercentageownershipofalldirectorsandexecutiveofficersasagroup.Unlessotherwiseindicatedbelow,theaddressforeachbeneficialownerlistedisc/oIQVIAHoldingsInc.,83WoosterHeightsRoad,Danbury,Connecticut06810. SharesBeneficiallyOwned NameofBeneficialOwners Number Percent5%stockholders: TheVanguardGroup(1) 19,475,899 10.1%BlackRock,Inc.(2) 14,685,767 7.6%Directorsandnamedexecutiveofficers: AriBousbib(3) 2,145,127 1.1%MichaelR.McDonnell(4) 91,063 *W.RichardStaub,III(5) 69,843 *KevinC.Knightly(6) 83,567 *EricM.Sherbet(7) 14,058 *CarolJ.Burt(8) 1,478 *JohnP.Connaughton(9) — —JonathanJ.Coslet(10) — —JohnG.Danhakl(11) 72,467 *MichaelJ.Evanisko(12) 72,850 *JamesA.Fasano — —ColleenA.Goggins(13) 6,752 *JohnM.Leonard(14) 8,252 *RonaldA.Rittenmeyer(15) 60,785 *ToddB.Sisitsky(16) — —Allexecutiveofficersanddirectorsasagroup(16persons)(17) 2,628,555 1.4%

* Representsbeneficialownershipoflessthanonepercentoftheoutstandingsharesofourcommonstock.

(1) AsreportedbyTheVanguardGroupinaSchedule13GfiledwiththeSEConFebruary10,2020,whichreportedholdingsasofJanuary31,2020.TheSchedule13GstatesthatTheVanguardGrouphassolevotingpowerwithrespectto264,309shares,sharedvotingpowerwithrespectto46,333shares,soledispositivepowerwithrespectto19,179,092shares,andshareddispositivepowerwithrespectto296,807shares.TheprincipalbusinessaddressofTheVanguardGroupis100VanguardBlvd.,Malvern,PA19355.

(2) AsreportedbyBlackRock,Inc.inaSchedule13GfiledwiththeSEConFebruary5,2020,whichreportedholdingsasofDecember31,2019.TheSchedule13GstatesthatBlackRock,Inc.hassolevotingpowerwithrespectto12,621,414sharesandsoledispositivepowerwithrespectto14,685,767shares.TheprincipalbusinessaddressofBlackRock,Inc.is55East52ndStreet,NewYork,NY10055.

(3) Includes414,720sharesunderlyingstockoptionsand535,070sharesunderlyingstockappreciationrightsthatarecurrentlyexercisableorscheduledtovestwithin60daysofFebruary12,2020.Alsoincludes127,292sharesofrestrictedstockthatarenotvestedasofFebruary12,2020.Ofthesharesbeneficiallyowned,543,302sharesofcommonstockareheldintrustforthebenefitofmembersofMr.Bousbib’sfamily.

(4) Includes23,400sharesunderlyingstockoptionsand51,543sharesunderlyingstockappreciationrightsthatarecurrentlyexercisableorscheduledtovestwithin60daysofFebruary12,2020.

(5) Includes13,483sharesunderlyingstockoptionsand38,631sharesunderlyingstockappreciationrightsthatarecurrentlyexercisableorscheduledtovestwithin60daysofFebruary12,2020.Alsoincludes579restrictedstockunitsthatareduetovestwithin60daysofFebruary12,2020.

Table of Contents

IQVIA2020PROXYSTATEMENT SecurityOwnership|87 (6) Includes57,122sharesunderlyingstockappreciationrightsthatarecurrentlyexercisableorscheduledtovestwithin60daysofFebruary12,2020,and18,566

notionalsharesheldundertheIMSHealthDCERP.

(7) Consistsof14,058sharesunderlyingstockappreciationrightsthatareexercisablewithin60daysofFebruary12,2020.

(8) Consistsof1,478sharesofcommonstockissuedpursuanttoCompanystockincentiveplans.

(9) DoesnotincludesharesofcommonstockheldbyBainCapitalIntegralInvestors2008,L.P.(“Integral2008”),BCIPTCV,LLC(“BCIPTCV”)andBCIPAssociates-G(“BCIP-G”and,collectively,the“BainCapitalEntities”).BainCapitalInvestors,LLC(“BCI”)istheultimategeneralpartnerofIntegral2008andgovernstheinvestmentstrategyanddecision-makingprocesswithrespecttoinvestmentsheldbyeachofBCIPTCVandBCIP-G.Mr.Connaughton,whoisoneofourdirectors,isaManagingDirectorofBCIandasaresult,maybedeemedtosharebeneficialownershipofthesharesheldbytheBainCapitalEntities.Mr.Connaughtondisclaimsbeneficialownershipofsuchsharesexcepttotheextentofhispecuniaryinteresttherein.TheaddressforMr.Connaughtonisc/oBainCapitalPrivateEquity,LP,200ClarendonStreet,Boston,MA02116.

(10) Mr.Coslet,whoisoneofourdirectors,isaPartnerofTPGCapital.Mr.CoslethasnovotingorinvestmentpoweroveranddisclaimsbeneficialownershipofthesharesheldbyTPGPartnersV,L.P.,TPGFOFV-A,L.P.,TPGFOFV-B,L.P.,TPGPartnersVI,L.P.,TPGBiotechnologyPartnersIII,L.P.,TPGFOFVISPV,L.P.,TPGIcebergCo-InvestLLC,TPGQuintilesHoldcoII,L.P.andTPGQuintilesHoldcoIII,L.P.(collectively,the“TPGFunds”)excepttotheextentofhispecuniaryinteresttherein.TheaddressofMr.Cosletisc/oTPGGlobal,LLC,301CommerceStreet,Suite3300,FortWorth,TX76102.

(11) Consistof70,989sharesofcommonstockheldforthebenefitofMr.Danhakl’sfamily.Alsoincludes1,478sharesofcommonstockissuedpursuanttoCompanystockincentiveplans.

(12) Consistsof5,250sharesofcommonstockissuedpursuanttoCompanystockincentiveplansand67,600sharesunderlyingstockoptions,heldforthebenefitofMr.Evanisko’sfamily,thatareexercisablewithin60daysofFebruary12,2020.

(13) Consistsof5,759sharesofcommonstockissuedpursuanttoCompanystockincentiveplansand993notionalsharesheldundertheIQVIAHoldingsInc.Non-EmployeeDirectorDeferralPlan.



(16) ToddB.Sisitsky,whoisoneofourdirectors,isaPartnerofTPGCapital.Mr.SisitskyhasnovotingorinvestmentpoweroveranddisclaimsbeneficialownershipofthesharesheldbytheTPGFundsexcepttotheextentofhispecuniaryinteresttherein.TheaddressofMr.Sisitskyisc/oTPGGlobal,LLC,301CommerceStreet,Suite3300,FortWorth,Texas76102.

(17) Includes1,217,940sharesunderlyingstockoptionsandstockappreciationrightsthatarecurrentlyexercisableorscheduledtovestwithin60days,579sharesunderlyingrestrictedstockunitsscheduledtovestwithin60days,18,566notionalsharesheldundertheIMSHealthDCERPand993notionalsharesheldundertheIQVIAHoldingsInc.Non-EmployeeDirectorDeferralPlan.

Table of Contents


CertainRelationshipsandRelatedPersonTransactionsRELATEDPARTYTRANSACTIONSAPPROVALPOLICY

Wehaveadoptedapolicywithrespecttothereview,approvalandratificationofrelatedpartytransactions.Underthepolicy,ourAuditCommitteeisresponsibleforreviewingandapprovingrelatedpartytransactions.Forpurposesofthispolicy,arelatedpersontransactionincludesanytransactionrequiredtobedisclosedpursuanttoItem404(a)ofRegulationS-KadoptedbytheSEC.Inthecourseofitsreviewandapprovalofrelatedpartytransactions,ourAuditCommitteewillconsidertherelevantfactsandcircumstancestodecidewhethertoapprovesuchtransactions.RelatedpartytransactionsmustbeapprovedorratifiedbytheAuditCommitteebasedonfullinformationconcerningtheproposedtransaction,includingtherelatedpersonsinvolved,theirrelationshiptotheCompany,theirinterestandroleinthetransaction,theproposedtermsofthetransaction,includingmaterialityandcharacteroftherelatedparty’sdirectorindirectinterest,thebenefitsandperceivedbenefits,orlackthereof,totheCompanyandtherelatedparty,theavailabilitytotheCompanyofalternativemeansortransactionsbywhichtoobtainlikebenefits,termsthatwouldprevailinasimilartransactionwithanunaffiliatedthirdparty,theactualorapparentconflictofinterestoftherelatedparty,andsuchotherinformationasourAuditCommitteedeemsappropriate.OurpolicyprovidesthatwegenerallyshouldnotengageinrelatedpartytransactionsunlesstheAuditCommitteehasdeterminedthat,uponconsiderationofallrelevantinformation,theproposedtransactionisin,ornotinconsistentwith,thebestinterestsoftheCompanyanditsstockholders.

SHAREHOLDERSAGREEMENT

InconnectionwiththemergerofIMSHealthHoldings,Inc.(“IMSHealth”)withandintoQuintilesTransnationalHoldingsInc.(“Quintiles”)onOctober3,2016(the“Merger”),weenteredintoashareholdersagreement(the“ShareholdersAgreement”)withcertainofthelargestpost-Mergershareholders,includingcertainfundsaffiliatedwithTPGGlobal,LLC(collectively,“TPG”),certainaffiliatesofBainCapitalInvestors,LLC(collectively,“BainCapital”),CPPInvestmentBoardPrivateHoldingsInc.(“CPPIB”),Dr.DennisB.Gillingsandcertainofhisaffiliates(the“DGShareholders”),andLeonardGreen&Partners,L.P.(“LGP”).TheDGShareholdersandLGParenolongerpartiestotheShareholdersAgreement.TPG,BainCapitalandCPPIBaretheonlyremainingpartiestotheShareholdersAgreement.TPG,BainCapitalandCPPIBaresometimesreferredtoasthe“SHAParties”inthisProxyStatement.

TheShareholdersAgreementprovidesthatnopartytheretooritsaffiliateswill,exceptforcertainpledges,transferstopermittedtransfereesandcertaintransfersinconnectionwithunderwrittenpublicofferings,(x)transfermorethan1%ofouroutstandingcommonstockinanycalendarquarteror(y)transferanysharesofouroutstandingcommonstocktoathirdpartythat,tosuchshareholder’sknowledge,asaresultofsuchtransferwouldown10%ormoreofouroutstandingcommonstock.

TheSHAPartieshavecertaincustomaryregistrationrightswithrespecttotheirsharesofourcommonstock.PursuanttotheregistrationrightsprovisionsoftheShareholdersAgreement,theSHAPartieshavedemandregistrationrights,includingshelfregistrationrights,inrespectofanysharesofourcommonstockheldbythem,subjecttocertainconditions.Inaddition,intheeventthatweregistersharesofourcommonstockforsaletothepublic,wearerequiredtogivenoticeofsuchregistrationtotheSHAParties,and,subjecttocertainlimitations,includesharesofourcommonstockheldbytheminsuchregistration.TheShareholdersAgreementincludescustomaryindemnificationprovisionsinfavoroftheSHAParties,anypersonwhoisormightbedeemedacontrolperson(withinthemeaningofthe

Table of Contents

IQVIA2020PROXYSTATEMENT CertainRelationships|89 SecuritiesActandtheExchangeAct)andrelatedpartiesagainstcertainlossesandliabilities(includingreasonablecostsofinvestigationandlegalexpenses)arisingoutoforbaseduponanyfilingorotherdisclosuremadebyusunderthesecuritieslawsrelatingtoanysuchregistration.

TheShareholdersAgreementwillterminatewithrespecttoanycurrentpartythereto(i)withrespecttoprovisionsregardingourBoard,atsuchtimeasthepartyisnolongerentitledtodesignateanominee,(ii)withrespecttoprovisionsregardingregistrationrights,untilsuchtimeasthepartyhassoldallofitssharesofouroutstandingcommonstockorhastheabilitytosellsuchsharespursuanttoRule144oftheSecuritiesActwithoutvolumelimitations(providedthattheshareholdergrouptowhichsuchpartybelongsthenholdslessthan3%ofouroutstandingcommonstock)and(iii)withrespecttotheremainderoftheShareholdersAgreement,atsuchtimeasthepartynolongerholdsanysharesofourcommonstock.TheBoarddesignationrightsforeachofthepartiestotheShareholdersAgreementhaveceased.

CORPORATEOPPORTUNITIES

OurCertificateofIncorporationwasapprovedbystockholdersinconnectionwiththeMergerandprovidesthatTPG,BainCapital,CPPIBandLGP,andcertainoftheirrespectiveaffiliates,willnothaveanyfiduciaryorotherdutytorefrainfromengagingdirectlyorindirectlyinthesameorsimilarbusinessactivitiesorlinesofbusinessastheCompanyoranyofitssubsidiaries.TheCertificateofIncorporationfurtherprovidesthattheCompany,onbehalfofitselfanditssubsidiaries,renouncesanyinterestorexpectancyinbeingofferedanopportunitytoparticipateinbusinessopportunitiesthatarepresentedtoTPG,BainCapital,CPPIB,LGP,orcertainoftheirrespectiveaffiliates.Thisprovisionappliestothesestockholders(andassociatedparties)onlyforsolongassuchstockholdercontinuestohavetherightundertheShareholdersAgreementtodesignateonenomineeandanomineedesignatedbysuchstockholderatanytimecontinuestoserveontheboard.TheBoarddesignationrightsforeachofthepartiestotheShareholdersAgreementhaveceased,butTPG,BainCapital,CPPIBandLGPcontinuetohaveatleastonecurrentorformerdesigneeservingontheBoard.

Table of Contents


Aboutthe2020AnnualMeetingWhatisthepurposeofthe2020AnnualMeeting?Atthe2020AnnualMeeting,holdersofsharesofourcommonstockwillconsiderandactuponthefollowingitemsofbusiness:

• ElectionofthethreeClassIdirectornomineesnamedinthisProxyStatementforathree-yearterm

• Advisory(non-binding)votetoapproveexecutivecompensation(say-on-pay)

• RatificationofourAuditCommittee’sappointmentofPricewaterhouseCoopersLLPasourindependentregisteredpublicaccountingfirmfor2020

• Transactionofanyotherbusinessthatmayproperlycomebeforethe2020AnnualMeeting

TheBoardrecommends:(i)avoteFORtheelectionofthethreenomineesproposedforelectionasClassIdirectors,(ii)avoteFORtheapprovalofthecompensationpaidtoournamedexecutiveofficersand(iii)avoteFORtheratificationoftheappointmentofPricewaterhouseCoopersLLPasourindependentregisteredpublicaccountingfirmfor2020and,onanyotherbusinessproperlybroughtbeforethe2020AnnualMeeting,inaccordancewiththebestjudgmentofthenamedproxies.

WhoaretheClassIdirectorsthatwillbevotedonatthe2020AnnualMeeting?ThefollowingaretheClassIdirectorsthathavebeennominatedforelectiontoourBoard:

• CarolJ.Burt

• ColleenA.Goggins

• RonaldA.Rittenmeyer

Informationregardingeachofourdirectorsissetforthbelowunder“Proposal1—ElectionofDirectors.”

Whoisentitledtovoteatthe2020AnnualMeeting?OnlystockholdersofrecordonFebruary12,2020,therecorddateforthe2020AnnualMeeting,areentitledtoreceivenoticeofandtovoteatthe2020AnnualMeeting.Onthatdate,wehad192,816,517sharesofcommonstockoutstanding.

Whatconstitutesaquorum?Aquorumofsharesisnecessarytoholdavalidstockholders’meeting.OurBylawsprovidethatamajorityofthesharesentitledtovote,presentinpersonorrepresentedbyproxy,willconstituteaquorumatmeetingsofstockholders.Sharesforwhichastockholderdirectsan“abstention”fromvoting,aswellassharesthatabrokerholdsin“streetname”andvotesonsomemattersbutnotothers(“brokernon-votes,”whichresultwhenbrokershavenotreceivedvotinginstructionsfromtheircustomersoncertainnon-routinematters),willbecountedforpurposesofestablishingaquorum.

Whatvoteisrequiredtoapproveeachitemofbusiness?Thechartbelowsummarizesthevotingrequirementsandeffectsofbrokernon-votesandabstentions,asprescribedbyourcorporategovernancedocumentsandDelawarelaw,ontheoutcomeofthevotefortheproposalsattheAnnualmeeting. Proposal VoteRequired EffectofAbstentionsandBrokerNon-Votes

ElectionofDirectors

Pluralityofvotescast

A“withhold”voteorbrokernon-votewillhavenoeffectontheoutcome

Advisoryvotetoapproveexecutivecompensation(say-on-pay)

NotApplicable1

Notconsideredasvotescastandhavenoeffectontheoutcome

Ratificationofindependentauditor

Majorityofvotescast

Notconsideredasvotescastandhavenoeffectontheoutcome

1 Becausethisisanadvisoryvote,thereisnorequiredapproval.

Table of Contents

IQVIA2020PROXYSTATEMENT Aboutthe2020AnnualMeeting|91 OurBylawsprovidethatdirectorsareelectedbyapluralityofvotescast,whichmeansthatthenomineeswiththelargestnumberofvoteswillbeelectedasdirectorsuptothemaximumnumberofdirectorstobeelectedatthe2020AnnualMeeting.OurCorporateGovernanceGuidelinesprovidethat,inanuncontestedelection,whichisanelectioninwhichthenumberofnomineesisnotgreaterthanthenumberofdirectorstobeelected,adirectorwhoreceivesanumberof“withhold”votesthatisgreaterthan50%ofallvotescastwithrespecttothatnominee’selectionshallpromptlytenderhisorherresignationfromtheBoard.TheNominatingandGovernanceCommitteeshallthenmakearecommendationtotheBoardastowhethertoacceptorrejectthetenderedresignation,orwhetherotheractionshouldbetaken.TheNominatingandGovernanceCommitteeandtheBoard,inmakingitsrecommendationordecision,asapplicable,shallconsiderwhatitbelievesisinthebestinterestsoftheCompanyanditsstockholdersandmayconsideranyfactororotherinformationitdeemsrelevant.TheBoardshallactonthetenderedresignation,takingintoaccounttheNominatingandGovernanceCommittee’srecommendation,andshallpubliclydiscloseitsdecisionregardingtheresignationwithin90daysaftertheresultsoftheelectionarecertified.Iftheresignationisnotaccepted,thedirectorshallcontinuetoserveuntilthenextannualmeetingofstockholdersatwhichsuchdirectorfacesre-electionanduntilsuchdirector’ssuccessoriselectedandqualified.Astheelectionofdirectorsatthe2020AnnualMeetingwillbeuncontested,thedirectornomineeswillbeelectedbyapluralityofthevotes,subjecttotheforegoingprocedure.

Althoughtheadvisoryvoteonexecutivecompensationisnon-binding,theLDCCommitteewillconsiderandtakeintoaccountthevotingresultswhenmakingfutureexecutivecompensationdeterminations.

Whatarethevotingrightsofstockholders?Eachshareofourcommonstockisentitledtoonevote.Thereisnocumulativevoting.

Whatisthedifferencebetweenholdingsharesasastockholderofrecordandasabeneficialowner?Ifyoursharesareregistereddirectlyinyournamewithourtransferagent,AmericanStockTransferandTrustCompany,LLC(“AST”),youareconsidered,withrespecttothoseshares,the“stockholderofrecord.”ProxymaterialsoraNoticeofInternetAvailabilityofProxyMaterialshavebeensentdirectlytoyoubyus.

Ifyoursharesareheldinastockbrokerageaccountorbyabankorothernominee,youareconsideredthe“beneficialowner”ofsharesheldinstreetname,andtheseproxymaterialsoraNoticeofInternetAvailabilityofProxymaterialsarebeingforwardedtoyoutogetherwithavotinginstructioncard.Asthebeneficialowner,youhavetherighttodirectyourbroker,bankorothernomineehowtovoteyoursharesbyfollowingtheirinstructionsforvoting.Pleasenotethatbecauseabeneficialownerisnotthestockholderofrecord,youmaynotvotethesesharesinpersonatthemeetingunlessyouobtaina“legalproxy”fromthebroker,bankorothernomineethatholdsyourshares,givingyoutherighttovotethesharesatthemeeting.

Howdostockholdersvote?Ifyouareastockholderofrecord,youmayhaveyoursharesvotedonmatterspresentedatthe2020AnnualMeetinginanyofthefollowingways:

• Inperson—youmayattendthe2020AnnualMeetingandcastyourvotethere.Ifyouhavealreadyvotedonline,bytelephoneorbymail,yourvoteatthe2020AnnualMeetingwillsupersedeyourpriorvote.

Table of Contents

92|Aboutthe2020AnnualMeeting IQVIA2020PROXYSTATEMENT • Byproxy—stockholdersofrecordhaveachoiceofvotingbyproxy:

• overtheInternetatwww.voteproxy.com;

• byusingthetoll-freetelephonenumber1-800-PROXIES(1-800-776-9437)intheUnitedStatesor1-718-921-8500fromforeigncountriesfromanytouch-tonetelephoneandfollowtheinstructions,asnotedonyourproxycard;or

• bycompletingaproxycardandmailingitinthepostage-paidenvelopeprovided.Pleaseallowsufficienttimefordeliveryofyourproxycardifyoudecidetovotebymail.

TheInternetandtelephonevotingfacilitiesforstockholdersofrecordwillcloseat11:59p.m.E.D.T.onApril5,2020.

Ifyouareabeneficialownerholdinginstreetname,pleaserefertoyourproxycardorthevotinginformationformforwardedbyyourbroker,bankorothernomineetoseewhichoftheabovechoicesareavailabletoyou.BrokersarenotpermittedtovoteforProposals1or2ifthebrokerhasnotreceivedinstructionsfromthebeneficialownerofshares.Itisparticularlyimportant,ifyouholdyoursharesthroughabrokerorothernominee,thatyouinstructyourbrokerhowyouwishtovoteyoursharesbecausebrokerswillhavediscretionaryvotingauthorityonlywithrespecttoProposal3ifyoudonotdoso.

Acontrolnumber,locatedonyourproxycard,isdesignedtoverifyyouridentityandallowyoutovoteyourshares,andtoconfirmthatyourvotinginstructionshavebeenproperlyrecordedwhenvotingovertheInternetorbytelephone.PleasebeawarethatifyouvoteovertheInternet,youmayincurcostssuchastelephoneandInternetaccesschargesforwhichyouwillberesponsible.

Ifastockholdergivesaproxy,howarethesharesvoted?Regardlessofthemethodyouchoosetovote,theindividualsnamedontheenclosedproxycard(your“proxies”)willvoteyoursharesinthewaythatyouindicate.TheindividualsnamedasproxiesontheproxycardareMr.Bousbib,ourChairmanandChiefExecutiveOfficer(referredtohereinasour“ChiefExecutiveOfficer”),Mr.McDonnell,ourExecutiveVicePresidentandChiefFinancialOfficer,andMr.Sherbet,ourExecutiveVicePresident,GeneralCounselandSecretary.WhencompletingtheInternetortelephoneprocessesortheproxycard,youmayspecifywhetheryoursharesshouldbevotedfororwithheldfromtheelectionofdirector,orvotedfororagainstortoabstainfromvotingonall,someornoneoftheotheritemsofbusinesstocomebeforethe2020AnnualMeeting.

Ifyouproperlysignyourproxycardbutdonotindicatehowyoursharesshouldbevotedonamatter,thesharesrepresentedbyyourproperlysignedproxywillbevotedastheBoardrecommends,whichrecommendationsaresetforthabove.

Itispossiblethatitemsofbusinessotherthanthoselistedabovemaybebroughtbeforestockholdersatthe2020AnnualMeeting.IfwewerenotawareofthematterareasonabletimebeforethemailingofthisProxyStatement,thepersonsnamedasproxiesontheproxycardwillvotesharesforwhichyouhavegivenaproxyonthematterasrecommendedbytheBoard,or,ifnoBoardrecommendationisgiven,theproxieswillvotethesharesintheirdiscretion.Inanyevent,theindividualsnamedasproxiesmustcomplywiththerulesoftheSECwhenvotingsharesonadiscretionarybasis.AtthedateofthisProxyStatement,wehavenotreceivedanynoticeregardinganyothermattertocomebeforethe2020AnnualMeetingthatwastimelyinaccordancewithourBylaws.

IfIvotebyproxy,mayIstillattendthe2020AnnualMeeting?VotingovertheInternet,bytelephoneorbysendinginasignedproxycardwillnotpreventyoufromattendingthe2020AnnualMeetingandvotinginperson.

Table of Contents

IQVIA2020PROXYSTATEMENT Aboutthe2020AnnualMeeting|93 WhoCanAttendthe2020AnnualMeeting?AnyCompanystockholderasofthecloseofbusinessonFebruary12,2020mayattendthemeeting.Youwillneedproofofownershiptoenterthemeeting.Evenifyouplantoattendthemeeting,pleasevoteyoursharesbysubmittingaproxy.

Ifyoursharesareheldinstreetname(beneficiallyheldinthenameofabroker,bankorotherholderofrecord),youmustpresentproofofyourownership,suchasabankorbrokerageaccountstatement,tobeadmittedtothemeeting.Pleasenotethatifyouareabeneficialholderandwouldliketovoteatthemeetinginperson,youwillneedtobringalegalproxyfromyourbroker,bankorotherholderofrecord.

Stockholdersmustalsopresentavalidformofphotoidentification,suchasadriver’slicense,inordertobeadmittedtothemeeting.Nocameras,recordingequipment,largebagsorpackageswillbepermittedinthemeeting.

Fordirectionstothemeeting,youmaycontacttheSecretaryoftheCompanyat100IMSDrive,Parsippany,NewJersey07054.

HowcanIrevokeaproxy?Youhavetherighttorevokeaproxy,whetherdeliveredovertheInternet,bytelephoneorbymail,atanytimebeforeitisexercised,byvotingagainatalaterdatethroughanyofthemethodsavailabletoyou,bygivingwrittennoticeofrevocationtoourSecretary,whichmustbefiledwiththeSecretarybythetimethe2020AnnualMeetingbegins,orbyattendingthe2020AnnualMeetingandvotinginperson.

Whoispayingthecostsofthisproxysolicitation?Wearepayingthecostsofthesolicitationofproxies.Wewillreimbursebrokers,banksorothercustodians,nomineesandfiduciariesfortheirchargesandexpensesinforwardingproxymaterialstobeneficialowners.Certainofourdirectors,officersandemployees,withoutadditionalcompensation,mayalsosolicitproxiesonourbehalfinperson,bytelephone,orbyelectroniccommunication.Inaddition,wehaveengagedMorrowSodaliLLCtoassistinthesolicitationfrombrokers,banknomineesandinstitutionalholdersforafeeof$12,000plusout-of-pocketexpenses.

HowcanIfindouttheresultsofthevotingatthe2020AnnualMeeting?ASTwillreceiveandtabulatethevoteinconnectionwiththe2020AnnualMeeting.RepresentativesofASTwillactastheindependentInspectorsofElectionandinthiscapacitywillsupervisethevoting,decidethevalidityofproxiesandcertifytheresults.ASThasbeeninstructedthatthevoteofeachstockholdermustbekeptconfidentialandmaynotbedisclosed(exceptinlegalproceedingsorforthepurposeofsolicitingstockholdervotesinacontestedproxysolicitation).

VotingresultswillbeannouncedbythefilingofaCurrentReportonForm8-KwiththeSECwithinfourbusinessdaysafterthe2020AnnualMeeting.Iffinalvotingresultsareunavailableatthattime,wewillfileanamendedCurrentReportonForm8-Kwithinfourbusinessdaysofthedaythefinalresultsareavailable.

WhydidmyhouseholdonlyreceiveonepapercopyoftheNotice?HowcanIobtainanadditionalcopyoftheproxymaterials?WehaveadoptedaprocedureapprovedbytheSEC,knownas“householding.”Underthisprocedure,wedeliverasinglecopyoftheNoticeand,ifrequested,ourproxymaterials,tomultiplestockholderswhosharethesameaddressunlesswehavereceivedcontraryinstructionsfromoneormoreofthestockholders.Thisprocedurereducesourprintingandmailingcostsandtheenvironmentalimpactof

Table of Contents

94|Aboutthe2020AnnualMeeting IQVIA2020PROXYSTATEMENT ourannualmeetings.Stockholderswhoparticipateinhouseholdingwillcontinuetobeabletoaccessandreceiveseparateproxycards.Uponwrittenororalrequest,wewilldeliverpromptlyaseparateNoticeoracopyofthisProxyStatementandour2019AnnualReporttoanystockholderatasharedaddresstowhichwedeliveredasingleNotice.

ToreceivefreeofchargeaseparatecopyofthisProxyStatementandour2019AnnualReport,stockholdersmaywriteorcallusatthefollowing:

InvestorRelationsDepartment100IMSDrive

Parsippany,[email protected](973)316-4000

Stockholderswhoholdsharesinstreetnamemaycontacttheirbrokeragefirm,bank,broker-dealerorothersimilarorganizationtorequestinformationabouthouseholding.

HowcanIreceiveelectronicaccesstoproxymaterials?Ifyouholdsharesregisteredinyourname,youmaysignupatwww.investordelivery.comtoreceiveelectronicaccesstoproxymaterialsforfuturemeetings,ratherthanreceivingmailedcopies.Ifyouchooseelectronicaccess,youwillreceiveanemailnotifyingyouwhenthe2019AnnualReportandProxyStatementareavailable,withelectroniclinkstoaccessthedocuments(inPDFandHTMLformats)onawebsiteandinstructionsonhowtovoteonline.Yourenrollmentforelectronicaccesswillremainineffectunlessyoucancelit,whichyoucandouptotwoweeksbeforetherecorddateforanyfutureannualmeeting.

Ifyouownyoursharesinstreetname,youmaybeabletoobtainelectronicaccesstoproxymaterialsbycontactingyourbroker,bank,trusteeorotherintermediary,orbygoingonlineatwww.proxyvote.com.

IfIcannotattendthe2020AnnualMeeting,whatarethedeadlinesforvoting?IfyouchoosetovoteovertheInternetorbytelephone,youmustcompletetheprocessnolaterthan11:59p.m.E.D.T.onSunday,April5,2020andinthatcaseitisnotnecessaryforyoutoreturnyourproxycard.

Ifyouchoosetovotebymailingaproxycard,youshouldmailyoursignedproxycardsufficientlyinadvanceforittobereceivednolaterthan9:00a.m.E.D.T.onMonday,April6,2020.

Table of Contents


OtherRelevantInformationCOMPENSATIONCOMMITTEEINTERLOCKSANDINSIDERPARTICIPATION

During2019,theLDCCommitteeoftheBoardconsistedofMessrs.Connaughton,Danhakl,Greenberg(untilhisretirement),Rittenmeyer(Chair)andSisitsky.NoneofthemembersofthecommitteehaveatanytimebeenanofficeroremployeeoftheCompanyoranyofitssubsidiaries.During2019,noneofourexecutiveofficersservedasamemberoftheboardofdirectorsorcompensationcommitteeofanyentitywhichhasoneormoreexecutiveofficersservingasamemberoftheBoardortheLDCCommittee.

Mr.SisitskywaselectedtotheBoardpursuanttotheShareholdersAgreement,whichasdiscussedaboverequiresthatallpartiestotheShareholdersAgreementvoteinfavoroftheelectionofcertainnomineesdesignatedinaccordancewiththeShareholdersAgreement.Mr.SisitskyisassociatedwithTPG,whichisapartytotheShareholdersAgreement.Informationregardingourrelationshipwiththisentityanditsaffiliatesisdescribedaboveunder“CertainRelationshipsandRelatedPersonTransactions.”

OTHERMATTERS

Weknowofnomatters,otherthanthosereferredtointhisProxyStatement,thatwillbepresentedatthe2020AnnualMeeting.If,however,anyotherappropriatebusinessisproperlypresentedatthe2020AnnualMeeting,thepersonsnamedintheenclosedproxycardwillhavediscretiontovoteonthosemattersforyou.

STOCKHOLDERPROPOSALSANDNOMINEESFOR2021ANNUALMEETINGOFSTOCKHOLDERS

UnderSECrules,forastockholderproposaltobeincludedinourproxystatement(andformofproxy)forpresentationatour2021annualmeetingofstockholders,theproposalmustbereceivedbyus,markedtotheattentionofSecretaryoftheCompanyat100IMSDrive,Parsippany,NewJersey07054byOctober21,2020.AstherulesoftheSECmakeclear,merelysubmittingaproposaldoesnotguaranteeitsinclusion.

OurBylawsprovideforarightofproxyaccess.Thisbylawenablesstockholders,underspecifiedconditions,toincludetheirnomineesforelectionasdirectorsinourproxystatement.UnderourBylaws,astockholder,oragroupofupto20stockholders,whohascontinuouslyownedatleast3%ofouroutstandingsharesofcommonstockforatleastthreeconsecutiveyearsmaynominateupto20%oftheBoard(butinanyeventatleasttwodirectors)andhavesuchnominee(s)includedinourproxystatement,ifthestockholder(s)andthenominee(s)satisfytheapplicablerequirementssetforthinourBylaws.Stockholdersseekingtohaveoneormorenomineesincludedinour2021proxystatementmustdeliverthenoticerequiredbyourBylawstotheattentionofSecretaryoftheCompanyat100IMSDrive,Parsippany,NewJersey07054noearlierthanOctober21,2020,andnolaterthanSeptember21,2020.

UnderourBylaws,andaspermittedbySECrules,certainproceduresareprovidedthatastockholdermustfollowtonominatepersonsforelectionasdirectorsortointroduceanitemofbusinessatanannualmeetingofstockholders,butthatarenotincludedinourproxystatementforthatmeeting.

Table of Contents

96|OtherRelevantInformation IQVIA2020PROXYSTATEMENT Theseproceduresprovidethatnominationsfordirectornomineesand/oranitemofbusinesstobeintroducedatanannualmeetingofstockholdersmustbesubmittedinwritingtotheSecretaryoftheCompanyat100IMSDrive,Parsippany,NewJersey07054.Wemustreceivethenoticeofyourintentiontointroduceanominationorproposeditemofbusinessatour2021annualmeetingofstockholdersnoearlierthanDecember7,2020,andnolaterthanJanuary6,2021.

If,however,thedateofour2021annualmeetingofstockholdersismorethan30daysbeforeoraftertheanniversarydateofthe2020AnnualMeeting,wemustreceivenoticeonorbeforetendaysafterthedayonwhichthedateofour2021annualmeetingofstockholdersisfirstdisclosedinapublicannouncement.

ThenominationmustcontaintheinformationspecifiedinourBylaws.

INCORPORATIONBYREFERENCE

InourfilingswiththeSEC,informationissometimes“incorporatedbyreference.”ThismeansthatwearereferringyoutoinformationthathaspreviouslybeenfiledwiththeSECandtheinformationshouldbeconsideredaspartoftheparticularfiling.AsprovidedunderSECregulations,the“AuditCommitteeReport”andthe“CompensationCommitteeReport”containedinthisProxyStatementspecificallyarenotincorporatedbyreferenceintoanyotherfilingswiththeSEC.Inaddition,thisProxyStatementincludesseveralwebsiteaddresses.Thesewebsiteaddressesareintendedtoprovideinactive,textualreferencesonly.TheinformationonthesewebsitesisnotpartofthisProxyStatement.

SOLICITATIONOFPROXIES

ProxieswillbesolicitedonbehalfoftheBoardbymail,telephone,otherelectronicmeansorinperson,andwewillpaythesolicitationcosts.Copiesofproxymaterialsandofthe2019AnnualReportwillbesuppliedtobrokers,banksornominees,forthepurposeofsolicitingproxiesfrombeneficialowners,andwewillreimbursesuchrecordholdersfortheirreasonableexpenses.Certainofficers,directorsandregularemployeesoftheCompany,whowillreceivenoextracompensationfortheirservices,maysolicitproxiesbymail,telephone,facsimile,e-mailorpersonally.

REDUCEMAILINGS

Ifmorethanonecopyofour2019AnnualReporthasbeenmailedtoyouraddressandyouwishtoreducethenumberofreportsyoureceiveandsaveusthecostofproducingandmailingthesereportsorifyouwishtoreceiveyourreportsviatheInternet,pleaseletusknow.Wewilldiscontinuethemailingofreportsontheaccountsyouselectifyoumarkthedesignatedboxontheappropriateproxycard(s).AtleastoneaccountmustcontinuetoreceiveanannualreportandproxystatementeitherviamailorviaInternetdelivery.

CAUTIONARYNOTEREGARDINGFORWARD-LOOKINGSTATEMENTS

ThisProxyStatement,aswellasotherwrittenreportsandoralstatementsthatwemakefromtimetotime,includesstatementsthatexpressouropinions,expectations,beliefs,plans,objectives,assumptionsorprojectionsregardingfutureeventsorfutureresultsandthereforeare,ormaybedeemedtobe,“forward-lookingstatements”withinthemeaningofthePrivateSecuritiesLitigationReformActof1995(the“Act”).Thewords“expect,”“anticipate,”“intend,”“plan,”“believe,”“seek,”“see,”“will,”“would,”

Table of Contents

IQVIA2020PROXYSTATEMENT OtherRelevantInformation|97 “target,”similarexpressions,andvariationsornegativesofthesewordsareintendedtoidentifyforward-lookingstatements,althoughnotallforward-lookingstatementscontaintheseidentifyingwords.Forward-lookingstatementsarenotguaranteesthatthefutureresults,plans,intentionsorexpectationsexpressedorimpliedwillbeachieved.Matterssubjecttoforward-lookingstatementsinvolveknownandunknownrisksanduncertainties,includingregulatory,competitiveandotherfactors,whichmaycauseactualfinancialoroperatingresultsorthetimingofeventstobemateriallydifferentthanthoseexpressedorimpliedbyforward-lookingstatements.Importantfactorsthatcouldcauseorcontributetosuchdifferencesinclude,butarenotlimitedto:mostofourcontractsmaybeterminatedonshortnotice,andwemayloseorexperiencedelayswithlargeclientcontractsorbeunabletoenterintonewcontracts;impositionofrestrictionsonouruseofdatabydatasuppliersortheirrefusaltolicensedatatous;anyfailurebyustocomplywithcontractual,regulatoryorethicalrequirementsunderourcontracts,includingcurrentorchangestodataprotectionandprivacylaws;breachesormisuseofourorouroutsourcingpartners’securityorcommunicationssystems;hardwareandsoftwarefailures,delaysintheoperationofourcomputerandcommunicationssystemsorthefailuretoimplementsystemenhancements;failuretomeetourproductivityorbusinesstransformationobjectives;failuretosuccessfullyinvestingrowthopportunities;ourabilitytoprotectourintellectualpropertyrightsandoursusceptibilitytoclaimsbyothersthatweareinfringingontheirintellectualpropertyrights;theexpirationorinabilitytoacquirethirdpartylicensesfortechnologyorintellectualproperty;anyfailurebyustoaccuratelyandtimelypriceandformulatecostestimatesforcontracts,ortodocumentchangeorders;therateatwhichourbacklogconvertstorevenue;ourabilitytoacquire,developandimplementtechnologynecessaryforourbusiness;consolidationintheindustriesinwhichourclientsoperate;risksrelatedtoclientortherapeuticconcentration;therisksassociatedwithoperatingonaglobalbasis,includingcurrencyorexchangeratefluctuationsandlegalcompliance,includinganti-corruptionlaws;risksrelatedtochangesinaccountingstandards;generaleconomicconditionsinthemarketsinwhichweoperate,includingfinancialmarketconditionsandrisksrelatedtosalestogovernmententities;therisksassociatedwithbusinessdisruptionscausedbynaturaldisasters,pandemicssuchastheCOVID-19(coronavirus)orinternationalconflictorotherdisruptionsoutsideofourcontrol;theimpactofchangesintaxlawsandregulations;andourabilitytosuccessfullyintegrate,andachieveexpectedbenefitsfrom,ouracquiredbusinesses;andtheotherfactorssetforthinthe“RiskFactors”sectionofourAnnualReportonForm10-KforthefiscalyearendedDecember31,2019,filedwiththeSEC,assuchfactorsmaybeamendedorupdatedfromtimetotimeinoursubsequentperiodicandotherfilingswiththeSEC,whichareaccessibleontheSEC’swebsiteatwww.sec.gov.Giventheserisksanduncertainties,youarecautionednottoplaceunduerelianceontheseforward-lookingstatements,whichspeakonlyasofthedatehereof.Weundertakenoobligationtoupdateanyforward-lookingstatementsortopubliclyannouncetheresultsofanyrevisionstoanyofthosestatementstoreflectfutureeventsordevelopmentsorotherwise.

ByOrderoftheBoardofDirectors,

ERICM.SHERBETExecutiveVicePresident,GeneralCounselandSecretary

Dated:February18,2020Danbury,Connecticut

Table of Contents


AppendixAFinancialReconciliationsUSEOFNON-GAAPFINANCIALMEASURES

ThisProxyStatementincludesfinancialmeasuresnotpreparedinaccordancewithgenerallyacceptedaccountingprinciplesintheUnitedStates(“GAAP”).Non-GAAPfinancialinformationisprovidedtoenhanceunderstandingofourfinancialperformance,butnoneofthesenon-GAAPfinancialmeasuresarerecognizedtermsunderGAAP,andnon-GAAPmeasuresshouldnotbeconsideredinisolationfrom,orasasubstituteanalysisfor,ourresultsofoperationsasdeterminedinaccordancewithGAAP.Weusenon-GAAPmeasuresinitsoperationalandfinancialdecisionmakingandbelievethatitisusefultoexcludecertainitemsinordertofocusonwhatitregardstobeamoremeaningfulindicatoroftheunderlyingoperatingperformanceofthebusiness.Forexample,weexcludealltheamortizationofintangibleassetsassociatedwithacquiredcustomerrelationshipsandbacklog,databases,non-competeagreementsandtrademarks,tradenamesandotherfromnon-GAAPexpenseandincomemeasuresassuchamountscanbesignificantlyimpactedbythetimingandsizeofacquisitions.Althoughweexcludeamortizationofacquiredintangibleassetsfromournon-GAAPexpenses,webelievethatitisimportantforinvestorstounderstandthatrevenuegeneratedfromsuchintangiblesisincludedwithinrevenueindeterminingnetincomeattributabletotheCompany.Internalmanagementreportsfeaturenon-GAAPmeasures,whicharealsousedtopreparestrategicplansandannualbudgetsandreviewmanagementcompensation.Wealsobelievethatstockholdersmayfindnon-GAAPfinancialmeasuresusefulforthesamereasons,althoughstockholdersarecautionedthatnon-GAAPfinancialmeasuresarenotasubstituteforGAAPdisclosures.Non-GAAPmeasureshavelimitationsasananalyticaltool.TheyarenotpresentationsmadeinaccordancewithGAAP,arenotmeasuresoffinancialconditionorliquidityandshouldnotbeconsideredasanalternativetoprofitorlossfortheperioddeterminedinaccordancewithGAAPoroperatingcashflowsdeterminedinaccordancewithGAAP.

Non-GAAPmeasuresarefrequentlyusedbysecuritiesanalysts,investorsandotherinterestedpartiesintheirevaluationofcompaniescomparabletous,manyofwhichpresentnon-GAAPmeasureswhenreportingtheirresults.Non-GAAPmeasuresarenotnecessarilycomparabletosimilarlytitledmeasuresusedbyothercompanies.Asaresult,stockholdersshouldnotconsidersuchperformancemeasuresinisolationfrom,orasasubstituteanalysisfor,ourresultsofoperationsasdeterminedinaccordancewithGAAP.Stockholdersareencouragedtoreviewthereconciliationsbelowofthesefinancialmeasures.

Table of Contents

IQVIA2020PROXYSTATEMENT AppendixA|99

IQVIAHOLDINGSINC.ANDSUBSIDIARIESNETINCOMETOADJUSTEDEBITDARECONCILIATION

(inmillions)(unaudited)

YearEndedDecember31,2019

NetIncomeAttributabletoIQVIAHoldingsInc. $191Provisionforincometaxes 116Depreciationandamortization 1,202Interestexpense,net 438Lossinunconsolidatedaffiliates 9Incomefromnon-controllinginterests 36Deferredrevenuepurchasingaccountingadjustments 10Stock-basedcompensation 146Otherincome,net (6)Lossonextinguishmentofdebt 24Restructuringandrelatedcharges 77Acquisitionrelatedcharges 56Integrationrelatedcosts 101AdjustedEBITDA $2,400

Table of Contents

100|AppendixA IQVIA2020PROXYSTATEMENT

IQVIAHOLDINGSINC.ANDSUBSIDIARIESNETINCOMETOADJUSTEDNETINCOMERECONCILIATION

(inmillions,exceptpersharedata)(unaudited)

YearEndedDecember31,2019

NetIncomeAttributabletoIQVIAHoldingsInc.$ 191

Provisionforincometaxes 116Purchaseaccountingamortization(1) 914Lossinunconsolidatedaffiliates 9Incomefromnon-controllinginterests 36Deferredrevenuepurchasingaccountingadjustments 10Stock-basedcompensation 146Otherincome,net (6)Lossonextinguishmentofdebt 24Restructuringandrelatedcharges 77Acquisitionrelatedcharges 56Royaltyhedgegain 6Integrationrelatedcosts 101AdjustedPreTaxIncome

$ 1,680

Adjustedtaxexpense (359)Incomefromnon-controllinginterests (36)Minorityinteresteffectinnon-GAAPadjustments(2) (9)AdjustedNetIncome

$ 1,276

Adjustedearningspershareattributabletocommonstockholders: Basic

$ 6.54

Diluted$ 6.39

Weighted-averagecommonsharesoutstanding: Basic 195.1Diluted 199.6

(1) Reflectsalltheamortizationofacquiredintangibleassets.

(2) ReflectstheportionofQ2Solutions’after-taxnon-GAAPadjustmentsattributabletotheminorityinterestpartner.

Table of Contents

IQVIA HOLDINGS INC.

Proxy for Annual Meeting of Stockholders on April 6, 2020

Solicited on Behalf of the Board of Directors

The undersigned hereby appoints Ari Bousbib, Michael R. McDonnell, and Eric M. Sherbet, and each of them, with full power of substitution andpower to act alone, as proxies to vote all the shares of Common Stock which the undersigned would be entitled to vote if personally present and acting at theAnnual Meeting of Stockholders of IQVIA HOLDINGS INC., to be held on April 6, 2020 at 9:00 a.m., E.D.T., at The Ethan Allen Hotel, 21 Lake AvenueExtension, Danbury, Connecticut 06810, and at any postponements or adjournments thereof, as follows:

(Continued and to be signed on the reverse side.)

Table of Contents

ANNUAL MEETING OF STOCKHOLDERS OF

IQVIA HOLDINGS INC.

April 6, 2020

NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIAL:The notice of meeting, proxy statement, form of proxy card and 2019 annual report

are available at https://materials.proxyvote.com/46266C INTERNET – Access www.voteproxy.com and follow the on-screen instructions orscan the QR code with your smartphone. Have your proxy card available when youaccess the web page. TELEPHONE – Call toll free 1-800-PROXIES (1-800-776-9437) in the UnitedStates or 1-718-921-8500 from foreign countries from any touch-tone telephone andfollow the instructions. Have your proxy card available when you call. Vote online/phone until 11:59 PM EAST the day before the meeting. MAIL – Sign, date and mail your proxy card in the envelope provided as soon aspossible. IN PERSON – You may vote your shares in person by attending the Annual Meeting. GO GREEN – e-Consent makes it easy to go paperless. With e-Consent, you canquickly access your proxy material, statements and other eligible documents online,while reducing costs, clutter and paper waste. Enroll today via www.astfinancial.comto enjoy online access.

Please detach along perforated line and mail in the envelope provided, IF you are not voting via telephone or the Internet.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL NOMINEES, “FOR” PROPOSAL 2 AND “FOR” PROPOSAL 3.PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN

HERE ☒ FOR AGAINST ABSTAIN

1.

The election of three Class Idirectors.

2.

An advisory (non-binding) voteto approve executivecompensation (say-on-pay).

☐

☐

☐

Nominees:

○ Carol J. Burt ☐ FOR ALL NOMINEES

○ Colleen A. Goggins○ Ronald A. Rittenmeyer

3.

The ratification of theappointment ofPricewaterhouseCoopers LLPas IQVIA Holdings Inc.’sindependent registered publicaccounting firm for the yearending December 31, 2020.

☐ ☐ ☐

☐

WITHHOLD AUTHORITYFOR ALL NOMINEES

☐

FOR ALL EXCEPT(See instructions below) INSTRUCTIONS: To withhold authority to vote for any individual nominee(s),

mark “FOR ALL EXCEPT” and fill in the circle next to each

nominee you wish to withhold, as shown here: ●

In their discretion, the proxies are authorized to vote upon such otherbusiness as may properly come before the Annual Meeting. This proxy whenproperly executed will be voted as directed herein by the undersignedstockholder. If no direction is made, this proxy will be voted FOR ALLNOMINEES in Proposal 1 and FOR Proposals 2 and 3.

To change the address on your account, please check the box at right and indicate your newaddress in the address space above. Please note that changes to the registered name(s) onthe account may not be submitted via this method.

☐

Signature of Stockholder Date: Signature of Stockholder Date:

Note:

Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator,attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title assuch. If signer is a partnership, please sign in partnership name by authorized person.